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ABSTRACT




Pr, cyclohexyl), with the exception of 
t
BuMgCl, 
undergo exclusive or exceptionally highly regioselective 1,4-addition reactions to acyclic 
,–,-unsaturated ketones, while aryl and heteroaryl Grignard reagents give mixed
results ranging from exclusive 1,4-addition (1-naphthyl, 2-N-methylpyrrolyl) to 
regioselective 1,2-addition (2-furyl, 2:1). All alkyl, aryl, and heteroaryl Grignard reagents 
examined gave exclusive 1,4-addition reactions with ,–,-unsaturated thiol esters, 
with the exception of 
t
BuMgCl which gave an 80:20 mixture of 1,4-:1,6-addition 
products. The high chemo- and regioselectivity observed for these reactions is attributed 
to a radical or radical-like pathway for the alkyl Grignard reagents and possibly a 
carbanion pathway for aryl Grignard reagents.  The ,-dienyl thiol esters provide for a 
one-pot tandem 1,4-addition-nucleophilic acyl substitution reaction sequence to afford 3-
substituted 4-enone moieties. 
Allylic opening of functionalized vinyloxiranes has been investigated with Grignard 
reagents and both catalytic and stoichiometric amounts of copper (I) salts. Specifically, 
α,β-epoxy-γ,δ-enones were found to undergo allylic opening of the epoxide ring in the 
presence of either CuCN or CuBr·SMe2 in THF or CH2Cl2 from -55 
°
C to -78 
°
C to give
δ-substituted-β,γ-unsaturated-α-hydroxyketones in 3 hours. 
While reactions were conducted with stoichiometric amounts of CuCN, sub-
stoichiometric (20 mol%) and catalytic ( 5-10 mol%) amounts of CuBr·SMe2 could also 
be used to effect clean transfer of alkyl Grignard reagents to the substrates. Interestingly, 
iii 
it required two equivalents of the allyl and aryl Grignard reagents with stoichiometric 
CuBr·SMe2 to effect complete transfer in 3 hours. The CuCN-mediated reaction gave at 
best 70:30 mixture of the E/Z stereoisomers of the δ-substituted-β,γ-unsaturated-α-
hydroxyketones. However, with the use of CuBr·SMe2 only the E-isomer was observed. 
A tentative model was proposed to rationalize the marked differences in the 
stereoselection associated with these copper salts.  
Allowing the reaction to warm to room temperature resulted in the oxidation of the α-
hydroxy alcohol to the corresponding δ-substituted-β,γ-unsaturated dione. In the absence 
of any copper salts, 1,2-addition product arising from nucleophilic attack on the carbonyl 
carbon was obtained.   
Alkylmagnesium cuprates and zincates reacted with ethyl 6-bromo-α, β, γ, δ-dienoates to 
give exclusively the SN2 product while their lithium versions gave mixed results favoring 
the SN2′ product. When the substrate was changed to ethyl 6-chloro-α, β, γ, δ-dienoates, 
cuprates and zincates of lithium gave only the SN2′ products while their magnesium 
versions gave mixed results favoring the SN2′ product. These results suggest that both the 
leaving group ability of the halide, and the magnesium vs lithium as counter ion in the 
cuprate or the zincate influenced the regioselectivity of the ethyl 6-halo-α, β-γ, δ-
hexadienoates and a model is proposed to explain the differences. 
iv 
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CHAPTER 1 
SELECTIVE OVERVIEW OF CONJUGATE ADDITION AND ALLYLIC 
SUBSTITUTION REACTIONS 
1.1 Introduction 
Conjugate addition of carbon nucleophiles to electron-deficient olefins offers a unique 
and reliable method for the creation of carbon-carbon (C-C) bonds, which is the 
backbone of organic synthesis. It provides access to the formation of tertiary or 
quaternary C-C stereocenters that may be otherwise difficult to achieve with other 
existing methods. Thus, key steps in total syntheses of many complex natural products 
and important bioactive molecules involve conjugate additions, as there are a wide range 
of donors (organometallic reagents, Michael donors, and other carbanions) and acceptors 
(α, β-unsaturated aldehydes, ketones, esters, nitriles, phosphates, sulfones, and 
nitroalkenes) available to the synthetic chemist. In conjugate addition, the nucleophile 
(usually carbanion from the organometallic) reacts with the sp
2
 carbon of an electron
deficient alkene to convert it to a stereogenic sp
3
 carbon, or an sp carbon of an alkyne to
an alkene. The asymmetric version of this reaction is particularly highly desirable as the 
need for the synthesis of new enantiopure biologically active compounds and 
pharmaceutical products continue to increase.  
Although, the American chemist, Arthur Michael is widely credited with the 
development of the conjugate addition reaction which bears his name, it is actually 
Komnenos who reported the first example in 1883. This first report
1 
described the
addition of diethyl sodiomalonate (1) to diethylidenemalonate
 
(2) (Scheme 1.1) 
2 
Scheme 1.1. Komnenos's first report of conjugate addition 
However, the chemistry of conjugate addition did not begin until the work of Arthur 
Michael in 1887 when he published a series of work
2
 involving the additions of sodium
salts of malonates (5) and β-ketoesters (8) to ethyl cinnamates
 
(6) (eq. 1&2). These 
pioneering studies focused mainly on the addition of stabilized carbanions and enolates 
(soft nucleophiles) from malonates and β-ketoesters as nucleophiles (Michael donors) to 
electron deficient alkenes (Michael acceptors).   
The use of these π-stabilized carbanions led to the development of the Robinson 
annulation reaction, which employs ketone enolates as nucleophiles. Generally, it was 
observed that the reactivity of acceptors to the various soft nucleophiles followed the 
trend: α,β-unsaturated aldehydes > > α,β-unsaturated ketones > α,β-unsaturated nitriles > 
α,β-unsaturated esters > α,β-unsaturated amides. During this time, the use of unstabilized 
3 
carbanions (hard nucleophiles) in conjugate additions was rather limited due to their very 
reactive nature resulting in additions to the carbonyl carbon (1,2-addition) instead of 
adding to the vinylogous β-carbon (1,4-addition). Thus, it was known that the addition of 
Grignard reagents and/or organolithiums to α,β-unsaturated aldehydes gave only 1,2-
adducts, while additions of organolithiums to α,β-unsaturated ketones afforded 
predominantly 1,2-adducts.
3
 Indeed, these limitations restricted the use of unstabilized
carbon nucleophiles in conjugate additions until 1941 when Kharasch and  
Tawney discovered that catalytic amounts of copper (I) chloride promoted 1,4-addition of 
alkylmagnesium halides to isophorone.
4
 Soon, the reactive species in this reaction was
determined by House, Respess, and Whitesides to be an organocopper species.
5
 The work
of Gilman, and Kirby also showed that organometallics of the Group II elements (e.g. 
R2Cd, and R2Zn) and the Group III (R3Al) also promoted 1,4-additions to 1,3-
diphenylpropen-1-one.
6
 What followed was an explosion of research and application of
1,4-conjugate addition that expanded the methodology to include tandem 1,4-conjugate 
addition electrophile-trapping,
7
 and Michael initiated ring closure (MIRC) 
8a-e 
reactions.
These wide applications also inspired the development and characterization of other 
organometallic reagents such as organoboron, and diorganozinc reagents that were more 
selective and tolerated several functional groups on either the donor or the acceptor 
molecules. Methods were also developed to widen the scope of acceptor molecules to 
include α-silylvinyl carbonyl species and any alkene with functional group capable of 







In the early years of development, the basic reactivity and selectivity principles of the 
conjugate addition reaction were studied and it was observed that factors such as the 
electronegativity of the metal, hard and soft acid-base (HSAB) character, structure of the 
acceptor, and reaction conditions and solvents all played a role in the outcome of the 
reaction.
9
 For example, the Group IA and IIA metals, which are very electropositive, 
form organometallics ( e.g RK, RNa, RLi, and RMgX) that are ionic in character and thus 
very reactive towards acceptors compared with the less ionic organometallics of the 
Group IB (RCu), and IIB (R2Cd and R2Zn) with the IIIB organometallics (R3Al and R3B) 
being intermediate. The differences in reactivities are a result of the differences in 
electronegativities between the metal and carbon atom leading to polarization of the 
carbon-metal σ-bond. Because the Group IB and IIB organometallics are less reactive, 
their nucleophilicity is usually increased by using them in their corresponding ‘ate’ 
complexes. The hard-soft acid base concept is often invoked
3
 to explain the chemo- and 
regioselectivities of the conjugate addition of these organometallics to α,β-unsaturated 
carbonyls. Since the lithium ion is a harder acid than the magnesium ion (soft acid), and 
the carbonyl functionality a harder base at the oxygen than at the β-carbon of the α,β-
unsaturated carbonyl substrate, addition of organolithiums tend to attack the carbonyl 
carbon (1,2- selectivity), while Grignard reagents favor addition to the β-carbon (1,4-
selectivity), probably through free radical pathway.
3 
The electronic and steric effects on 
conjugate acceptors can also determine the 1,2- vs 1,4-selectivities. It is generally 
observed that the substitution of a bulky group on the carbonyl carbon of the acceptor 
favors 1,4- over 1,2-addition possibly due to steric effects while conjugated aldehydes 
5 
 
will only undergo 1,2-additon.
10
 Solvent effects and reaction conditions also play a 
significant role in the selectivity of conjugate additions. While polar solvents encourage 
the formation of solvent-separated ion pairs and thus minimize the effect of counter ions 
in a reaction, non-polar solvents on the other hand favor contact ion pairs. In conjugate 
additions, non-polar solvents and low temperatures are observed to favor 1,2-selectivity 
while polar solvents and high temperatures tend to promote the thermodynamically more 
stable 1,4-adducts.
11
 In short, it is generally observed that conditions that favor 1,4-
addition of π-stabilized carbanions to α,β-unsaturated carbonyls include: polar solvents 
(e.g HMPA), larger counterions, higher reaction temperatures, increased delocalization of 
the carbanion formed, longer reaction times, and increased steric hindrance in the 
reactants at the carbonyl carbon (except at the β-carbon of the acceptor). 
 
Over the past four decades, intense research efforts were devoted to developing diastereo- 
and enantioselective conjugate additions of diorganozinc, Grignard reagents, 
organolithiums, organoaluminum, and cuprate reagents generated from these 
organometallics, to Michael acceptors. The early strategies were largely based on chiral 
auxiliaries and chiral substrates mediated by copper salts.
12
 Strategies based on 
organocopper reagents with chiral non-transferable ligands (dummy ligands) such as 
chiral amidocuprates and alkoxycuprates were also developed and being employed during 
this time to achieve some successful results.
12
  However, the need to use stoichiometric 
amounts of chiral auxiliaries, chiral substrate or copper salts was a major drawback that 
drove the search to find new methods that used catalytic amounts of metal salts and chiral 
ligands. Moreover, insights gained from the use of chiral auxiliaries in conjugate addition 
6 
 
were invaluable in understanding the factors controlling catalytic enantioselective 
conjugate addition of organometallics to Michael acceptors. For example, the 
stoichiometric copper protocols revealed that the conjugate addition is sensitive to almost 
every parameter of the reaction such as solvents, counterion, stoichiometry, Lewis acids, 
and the use of achiral or chiral additives; thus the control of these factors was key to 
developing catalytic procedures. Furthermore, the difficulty faced in developing 
asymmetric 1,4-addition of organometallic reagents catalytic in copper salts was 
discovered to involve the competition reaction between noncatalyzed addition of the very 
reactive organometallic reagents to the carbonyl carbon (resulting 1,2-adduct and racemic 
1,4-product) and the catalyzed enantioselective reaction.       
The possibility of using Grignard reagents in catalytic enantioselective conjugate addition 
was first demonstrated by Lippard and wo-workers 
13a
 in 1988 when they reported the 
addition of 
n
BuMgBr to cyclohexenone employing 4% of N,N′-dialkyl-substituted 
aminotroponeimine based catalysts  15 to achieve enantioselectivity up to 14%. They 
soon discovered that addition of HMPA and silyl chloride reagents could accelerate the 
reaction and improve the enantioselectivity.
13b
 Shortly after this seminal work appeared, 
the introduction of the chiral bidentate arylthiolate ligated and monophosphine copper 
complexes 10-11 as catalysts for the addition of Grignard reagents in 1991
14
 was 
reported.  Structure 12 shows the proposed catalyst-Grignard-substrate intermediate 
responsible for the induction of stereoselectivity (Figure 1). The highest 
enantioselectivity (ee), reported for this class of catalysts was 87% from the laboratory of 
Zhou and Pfaltz
15




C for cyclic enones but only 20% ee when acyclic enones were used. The work of 
Tomioka and co-workers
16
 revealed that 32 mol% of chiral aminophosphine ligands and 
8 mol% of Cu salt in Et2O at -78 
o
C could effect conjugate addition of alkyl Grignard 
reagents to cyclic enones (e.g 13) to achieve enantioselectivity as high as 92% (eq. 3). 
Examination of the scope of substrate and Grignard reagents showed that, the high 
enantioselectivity could only be obtained with the addition of linear Grignard reagents to 
cyclopentenone and dihydropyranones. An improvement over this methodology was 
provided by Stangeland and Sammakia
17
 when they employed a phosphine ligand with 
planar chirality and stereogenic center in its structure to reach enantioselectivity of 92% 
for the addition of 
n
BuMgCl to cyclopentenone. The advantage of their method over that 
of Tomioka and co-workers is that only 12 mol% of the chiral ligand and 10 mol% of CuI 
in Et2O were required compared with that of Tomioka’s which needed 32 mol% of the 
phosphine ligand to achieve similar enantioselectivity. Another important observation 
from their protocol was that, similar enantioselectivity could be achieved with acyclic 
substrates just like that of the cyclic substrates. 
 







1.2 Definitions of Conjugate Additions 
The term conjugate addition is used to describe the 1,4-addition ( also includes 1,6-, 1,8-, 
and higher order) of any type of nucleophile to a π-system (in conjugation with an 
electron-withdrawing group. It is often used interchangeably with the term ‘Michael 
addition’. However, Michael addition is the 1,4-addition of any carbanion to any π-
system in conjugation with an electron-withdrawing group. On the other hand, Michael 
reaction refers to the 1,4-addition of β-dicarbonyl-stabilized enolates to  π-systems in 
conjugation with a carbonyl group. If G represents any activating or electron-
withdrawing group (EWG), then any conjugate acceptor could be described by the 
general representations below (Figure 1.2), although sometimes some acceptors have two 
or more activating groups acting in concert or against each other (Figure 4, 17 B & C). In 
such situations, the activating group with the stronger influence controls the 
regioselectivity of the conjugate addition. This influence can loosely be interpreted as the 






Figure 1.2. General representation of conjugate acceptor 
 
NO2 > RCO > CO2R > SO2R > CN ~ CONR2 
Figure 1.3. The order of carbanion stabilizing ability 
19
 
The terminology of the conjugate addition has been developed with respect to α,β-
unsaturated carbonyl compounds because the initial studies were conducted with these 
compounds. Thus 1,2-, 1,4-, 1,6-addition, refers to the numbering in the α,β-unsaturated 
carbonyl substrate  beginning with the carbonyl oxygen as shown in equation 4. The 
carbons can also be designated α,β,γ referring to the C3, C4, and C5 positions 
respectively (Figure 4). In 1,4-addition for example, the nucleophile goes to the carbon 
number 4 while the metal counter ion goes to position number 1, and the same holds for 
1,2-, 1,6-, 1,8-additions and so on. There is however other acceptors that do not fit these 
descriptions very well and an example include silylvinyl ether (eq. 6). 
 






1.2.1 anti-Conjugate additions 
This refers to the addition of nucleophiles to the α-carbon of conjugated carbonyl 
compounds (Scheme 1.2). This phenomenom has been observed in reactions involving 
the additions of phenoxide (i. e, PhO
-
) or thiophenoxide (i.e, PhS
-











1.2.2 Radical Conjugate Addition 
 The use of carbon-centered radicals in conjugate addition reactions create new carbon-
carbon (C-C) σ bonds from an existing π bond and has one clear advantage over the 
traditional polar addition reactions. Normally, radical species are formed in situ, and 
therefore the need for the preformation of reactive air sensitive organometallic reagents is 
avoided. Radical conjugate addition involves two steps: 1) the generation of the radical 
from non-radical species, followed by 2) their addition to conjugate acceptors resulting in 
another radical species with the formation of the C-C bond (Scheme 1.3).
21 
The radical 
species may be generated by single-electron transfer (SET), (Scheme 1.3) or by 
atom/group transfer reactions. The atom transfer may be either hydrogen atom transfer 
(HAT) or halogen atom transfer and it provides an alternative method to creating radical 
species by transfer of hydrogen or halogen atom to an alkene (Scheme 1.4). Free radical 
additions to conjugate acceptors generally lack regio and stereo- control unless the 
acceptor is either directly or through an auxiliary group coordinated to a chiral Lewis acid 
or co-catalyst during the radical addition step (Scheme 1.5).
21 
This strategy has been 
employed to achieve high chemo-, regio-, diastereo-, and enantioselectivities in radical 
conjugate additions. Some of the early examples of asymmetric radical conjugate 
additions employed chiral bis(oxazoline) ligands, 31 capable of forming complexes with 
Mg, Zn, or Cu in which the resulting radical intermediates were trapped with allyl 
stannanes to generate vicinal C-C stereocenters in a single step with enantioselectivities 
as high as 90% (eq. 7).
22
 The report showed that the enantioselection was controlled by 
12 
 
steric hindrance of the radical species as the introduction of a tert-butyl  group gave a 
higher enantiomeric ratio than the use of a methyl group (eq. 8).
23 





Other Michael acceptors that have been reported to undergo radical addition-allyl 
trapping include vinyl sulfones,
24 
vinylsulfoxides, and α′-phosphoric enones (eq. 9).
25
 
Scheme 1.4. Carbon atom radical generation by hydrogen atom transfer and its 



















1.3 Addition of organolithiums to Michael acceptors 
Due to the high ionic character of the lithium-carbon bond, most additions of 
organolithiums to α,β-unsaturated aldehydes, α,β-unsaturated ketones, as well as those of 
esters result in 1,2-addition products except in situations where the carbonyl carbon is 
sterically hindered or deactivated with an electron donating group (e.g conjugated 
amides) in which case the 1,4-adduct is chemoselectively formed. Thus, the addition of 
organolithium reagents to the trityl enone 32 yields 1,4-adduct 33 as a result of the 
carbonyl carbon being shielded by the trityl moiety.
26 
(eq. 10). This is further 
demonstrated by β,β-disubstituted α,β-unsaturated carbonyl substrates’ resistance to 
conjugate additions of carbanions, although steric effect seems to be less for 
intramolecular cyclization.
27
 In addition, the 1,2-adduct can be suppressed by charge-
directed 1,4-addition,
28
 where the presence of a negative charge on the atom adjacent to a 
carbonyl carbon makes the carbonyl carbon unresponsive to addition of organometallic 
reagents. Examples of these acceptors include anilides
29 
36 (eq. 12), amides and ylides, 







Several variations of this strategy have been reported that include intramolecular 
cyclization
31
 and Michael initiated ring closure (MIRC) protocols, both of which employ 
substrates with leaving groups (I, Br, Cl) at the ω-position. The intramolecular 
cyclization employs ω-iodo substrates which are converted to the corresponding 
organolithium via lithiation by treatment with 
n
BuLi at -100 
°
C or magnesiation (of the 
bromides, or chlorides) resulting in intramolecular 1,4-addition to give cyclic esters or 
ketones. The MIRC on the other hand, involves initial intermolecular reaction of an 
organolithium with the ω-bromide or chloride substrate to form an intermediate 
carbanion followed by ring closure to form the cyclic esters. Other variants that involve 
substrates with trimethylsilyl group substituted at the α-position enable efficient 1,4-
addition of organolithiums to α,β-unsaturated acids
32
 whereupon the silyl group is easily 
removed by base hydrolysis using sodium hydroxide. The range of substrates that are 
known to yield 1,4-adduct with organolithiums are α,β-unsaturated thioamides, α,β-
unsaturated N-(trimethylsilyl)thioamides, and N,N-dimethylthiosorbamide. α,β-
Unsaturated aldehydes, ketones and carboxylic acids on the other hand solely produce 
16 
 
1,2-adducts with organolithium reagents and to achieve 1,4-additions, their corresponding 
imidates or imines have to be used and then be converted back to the aldehydes
33
 (e.g 40 
&42, Scheme 6), ketones, or the acids
34
 (45) after the 1,4-addition (Scheme 1.7).  
Scheme 1.6. 1,4-Addition of organolithiums to α,β-unsaturated imines 
 
 
Scheme 1.7. 1,4-Addition of organolithiums to α,β-unsaturated imidates (oxazoline) 
 














to achieve efficient syntheses of some useful 
complex molecules. Thus, despite the high reactivity of organolithiums, choice of the 




1.4 Grignard Reagents 
The Grignard reagent is an organometallic reagent represented by the general formula 
RMgX, where R is an organic moiety usually alkyl, alkenyl, alkynyl, or aryl group and X 
a halide (F, Cl, Br, I). The reagent is named after its discoverer, Victor Grignard (1871-
1935) who in his attempt to optimize conditions for what is known today as the Barbier 
reaction
40
 (eq. 13) during his time as a graduate student in 1900 decided to make first, 
what he thought was the intermediate as RMgX, before adding it to the ketone. What 
followed was the observation that alkyl halides in general react readily with elemental 
magnesium in diethyl ether and the resulting intermediate (RMgX) could react with 
ketones and aldehydes as well. For this discovery and its subsequent development, 
Grignard shared the 1912 Nobel Prize in chemistry with Paul Sabatier.  
 
 
Grignard reagents have been the most widely used organometallic reagents
41
 in chemical 
synthesis since their discovery over a century ago due partly to their ease of preparations 
from organic halides and magnesium metal in ethereal solvents (almost always diethyl 





1.4.1 Mechanism of Formation of Grignard Reagents 
The classical method for the preparation of Grignard reagents is from magnesium metal 
(Mg) and an organic halide (RX) in an ether solvent (usually Et2O, and THF), although 
other aprotic solvents such as tertiary amines can be used sometimes. Perhaps, the role of 
coordinating solvents in Grignard reagent formation is demonstrated by the crystal 
structures of some Grignard reagents where the magnesium forms four (tetrahedron), 
five, or even six coordinate structures from the organic, halide, and solvent molecules as 
ligands (Figure 1.5).
42





Grignard formation and the solvation of the ionic Mg
2+
 by coordinating solvent 
molecules provides the thermodynamic driving force for the reduction of the organic 
halide by magnesium.  However, it is also known that additives such as MgBr2, I2, and 
BrCH2CH2Br can all be used to reduce the induction period of the Grignard reaction. 
Also, “entrainment” is sometimes used to promote Grignard reactions that are slow to 
occur, by including very reactive organic halide with the less reactive organic halide 
whose Grignard reagent is being prepared. 
 
Figure 1.5. Solvation of Magnesium ion by solvent molecules 
19 
 
The fact that by-products of Grignard reaction include RR, RH, radical trapping products, 
and isomerization/cyclization of Grignard products from 5-hexenyl halides
43 
50 (Scheme 
1.8) suggest the formation of organic radical intermediates during the Grignard formation 
(vide infra). 
Scheme 1.8. Isomerization/cyclization of Grignard products from 5-hexenyl halide 
 
Thus, it is generally accepted that the formation of Grignard reagent from the classical 
method involves radical mechanism, and that single electron transfer (SET) from the 
magnesium metal surface to the organic halide occurs to form organic halide radical 
anion (RX·
-





 combines with the electron-deficient Mg·
+
 to form magnesium halide radical 
(·MgX) on the metal surface. Meanwhile, it has been shown that some of the R· react 
with ·MgX on the surface to form RMgX. However, the Kharasch-Reinmuth-Walborsky 
model proposes two possible pathways where SET from the surface magnesium atom to 
the alkyl halide’s σ*-orbital results in radical anion in tight contact with the magnesium 
cation (Scheme 1.10, pathway 1). This tight radical anion-radical cation pair may 
collapse to give the Grignard reagent (pathway 4), or it may dissociate to free radical 
(pathway 3) where it may have time to racemized (parhway 5). Meanwhile the rest may 
20 
 
escape the solvent caged or the magnesium surface into the solution where they can 
dimerize to form R-R, or abstract hydrogen atom from the solvent molecules (RH) or 
return to the magnesium surface to accept single electron from the ·MgX to form more 
RMgX (pathway 6).
44 
The newly formed RMgX may quickly disproportionate to the 
Schlenk equilibrium products depending on the viscosity, basicity, and π-electron-
donating ability of the solvent. Solvents that are basic in nature stabilize the ·MgX and 
thus allows it to react with the R· to form RMgX. Less basic solvents are unable to 
stabilize ·MgX, and so the R· is freed to diffuse into the solution where it undergoes 
dimerization and other side reactions, resulting in a decreased yield of the Grignard 
reaction. On the other hand viscous solvents slow down the diffusion of R· from the 
magnesium surface into the solution and so the dimerization and other side reactions are 
avoided, thereby increasing Grignard yield. 





However, π-donating solvents stabilize R· and decreases its reactivity towards ·MgX. In 
such instances, R· is free to diffuse from the surface of the magnesium into the solution 
and thus decrease the yield of the Grignard reaction. 
RX 
Mg 
SET RX·  
Mg·+ 
 ¯ R·X  
Mg·+ 
 ¯ 





Scheme 1.10. Proposed mechanism of Grignard reagent formation from magnesium 
metal and alkylhalide 
 
 
1.4.2 Other methods for preparation of Grignard reagents 
Today, there are several alternative methods that permit the formation of functionalized 
Grignard reagents from substrates with sensitive functional groups such as nitro, imines, 




 These new methods 
including lithium-halogen/hydrogen exchange followed by lithium-magnesium 
transmetallation, and lithium-magnesium exchange have broaden the scope and 




a. Lithium-Halogen/hydrogen exchange: the lithium-halogen exchange reactions was 
reported independently by Wittig and Gilman in the 1930s and since then it has 
become useful method for synthesizing aryl and heteroaryl Grignard reagents via 
transmetallation of organolithium reagents with magnesium bromide. Aryl and 
heteroaryl iodides and bromides easily undergo lithium-halogen exchange reactions 
with 
n
butyl lithium in ethers (Et2O, THF) at low temperatures to form the 
corresponding aryl or heteroaryl lithium (Scheme 1.11 A&B). The aryl or heteroaryl 
lithium could also be generated from direct lithiation of the aryl or heteroaryl ring 
bearing the appropriate directed metalation group (DMG) before transmetallating the 
lithium intermediate
46
 with MgBr2·OEt2 to form the corresponding Grignard reagent 
(Scheme 1.11 C). To prevent aggregation and also minimize the effect of the lithium 
ion on the Grignard reagent, a lithium ion chelating agent such as TMEDA is used 
very often as an additive during the lithiation stage to break up the aggregation 
before the transmetallation with the magnesium bromide.  The mechanism of the 








Scheme 1.11. Grignard reagent formation by Lithium-Halogen/hydrogen exchange 
 
More powerful reagents such as 2,2,6,6-tetramethylpiperidinylmagnesium chloride 
lithium chloride complex (TMPMgCl·LiCl), and di-(2,2,6,6-tetramethylpiperidinyl) 
magnesium chloride lithium chloride complex (TMP2Mg·2LiCl) are available that can 
effect chemoselective and directed lithiation with highly functionalized aromatic and 
heterocyclic compounds to make the corresponding Grignard reagents
47
 (eq. 14). These 
conditions leave an ester, carbonate, and an aryl ketone unaffected by the Grignard 




b. Halogen-magnesium exchange: the methodology involves the stirring of aryl/ 
heteroaryl iodides with 
i
PrMgBr in ethereal solvents (Et2O, THF) at low 
temperatures (often -20 
°
C and below) 
48
 to produce the corresponding aryl or 
heteroaryl Grignard reagents. Due to the mild reaction conditions involved, very 
sensitive functional groups are tolerated thus opening an entry to a wide range of 
functionalized Grignard reagents, hence broadening the scope of application of 
Grignard reagents in organic and organometallic syntheses. Some of the 
polyfunctional heteroaryl compounds that have been prepared through this method 
include imidazoles, pyridines, thiophenes, pyrines, furans, pyrroles, and uracils
49
 
derivatives which can function as intermediates for synthesizing biologically active 
compounds. The presence of chelating and/or electron-withdrawing groups in the 
heteroaryl iodides tends to enhance the exchange reaction (Scheme 1.12B),
49
  thus 
enabling the extension of the procedure to even heteroaryl bromides and chlorides 
(Scheme 1.12E). In substrates containing multiple halides, the electron density of the 
aromatic ring usually increases after the first halogen/magnesium exchange thereby 
preventing further exchange with a second halogen
50


















The bromine-magnesium exchange only works best when the heterocycle is substituted 
with electron-withdrawing groups. The unfunctionalized bromo-heterocycles usually 
require 
i
Pr2Mg at rt in order to effect the exchange (Scheme 1.13).
 49
  




Some of the bromine-magnesium exchanges have been developed in solid-phase (vide 
infra) form where the heterocyclic bromide is attached to Wang resins and after treatment 
with excess 
i
PrMgBr at low temperatures (-30 
°
C); the immobilized Grignard can be 
reacted with the electrophile and then cleaved from the resin with trifluoroacetic acid 





Chlorine-magnesium exchange however, requires several electron-withdrawing groups 
on the heterocycle and warmer temperatures in THF to enable the magnesium exchange
 49
 
(Scheme 1.12E).  
27 
 
More efficient reagents have been developed for the bromine-magnesium exchange that 
utilizes lithium chloride (LiCl)-accelerated 
i
Pr2Mg complex in THF allowing even 
electron rich aryl and heteroaryl bromides to undergo the exchange. The reagent is 
prepared by mixing 
i
PrMgCl (2.0 equiv.), flame-dried LiCl (1.0 equiv.), and 1,4-dioxane 
(10 vol. %) in THF and filtering the resultant precipitate to obtain the soluble Grignard 
reagent.
51
 [15]crown-5 can be used in place of the 1,4-dioxane and the use of these 
additives bind the magnesium chloride and precipitate it out to push the equilibrium to 




The mechanism for the bromine-magnesium exchange is said to involve two pathways. It 
is proposed that a one-step transition-state (pathway 1) or a two-step ate complex 






Scheme 1.14. Mechanism of bromine-magnesium exchange reaction 
 
 
1.4.3 Structure and Composition in Solutions 
Although Victor Grignard initially used RMgX to represent Grignard reagents, the true 
structure and composition of Grignard reagents in solution has been the subject of much 
controversies and extensive research till this day but the general consensus is that the 
composition in solution is much complicated than the RMgX initially suggested Grignard 
himself. The earliest major suggestion about the structure in ether was proposed by 
Baeyer and Villiger 
52
 as the onium compound, A which was later modified by Grignard 
as structure B.  
 
Figure 1.6. Early Structure of Grignard reagents in ether 
The idea of Grignard compounds being in equilibrium in solution was first put forward 
by Abegg 
53
 in 1904 (eq. 18), an equilibrium which was later “proven right” by Wilhelm 
29 
 
Schlenk and his son by precipitating MgX2 from ethereal solution of some Grignard 
reagents with the addition of 1,4-dioxane,
54
 and then went on to propose what is now 
widely recognized as the Schlenk equilibrium (eq. 19). This equilibrium has been found 
to be dependent on temperature, steric bulk and nature of the organic group on the 




It is of general notion that in diethyl and THF solutions, Grignard reagents are associated 
in either dimeric or polymeric aggregates
56
 and that several species including charged 
species and radical pairs may exist in addition to the RMgX. The extent of association is 
found to depend on the concentration, the nature of the solvent, and the kind of halide 
involved. While alkyl and aryl Grignards of chlorides, bromides, and iodides are said to 
be monomeric in THF over a wide concentration range, the fluoride version of those 
Grignard reagents are dimeric
55
 over the same concentration range in THF. However, in 
Et2O both alkyl and aryl Grignard of bromides and iodides are monomeric only at low 
concentrations (< 0.5 M) and dimerize at higher concentrations (0.5-1.0 M)-meanwhile, 
the chloride and the fluoride versions are dimeric even at low concentrations.
55
 
Theoretical (generalized-valence-bond-restricted-configuration-interaction, GVB-RCI) 
calculations on monomeric structures have shown that in general, while the carbon-
magnesium bond in Grignard reagents is polar covalent in nature, the magnesium-halide 
30 
 
bond for chlorides, and bromides is essentially dative bond. In organomagnesium 
fluorides, the carbon-magnesium bond is still polar covalent but the magnesium-fluoride 
bond is ionic with positive and negative charges residing on the organomagnesium 
moiety and the fluorine atom respectively (Figure 1.7A).
57
 The situation is however, 
somewhat opposite of the monomers for dimeric structures (Figure 1.7B) where the 
monomers are bridged by the two halide atoms. The C-Mg bond in the dimers is polar 
covalent just as the monomers but among the halogens (F, Cl, Br), the Mg-X bond is the 
inverse in character to those found in the monomers.  
 
Figure 1.7. Nature of bonds in chlorides, bromides, and fluorides of Grignard 
reagents 
The Mg-F bond in the dimer is dative (Figure 1.8) while that for the Cl, and Br are ionic 
in character
57
 (Figure 1.9). Barbosa and coworkers have proposed a mechanism for dimer 
formation based on calculations of Gibbs free energies (ΔG) of methylmagnesium halides 
in ethereal solution. They suggested that the RMgX and X
-
 are both present in Grignard 
solution in various proportions that they may react to form RMgX2
-
as an intermediate 
species which may in turn react with RMg
+







Figure 1.8. Nature of chemical bonds in dimeric Grignard reagents of fluorides 
obtained from GVB-RCI calculations 
 
 
Figure 1.9. Nature of chemical bonds in dimeric Grignard reagents of chlorides, and 
bromides obtained from GVB-RCI calculations 
 
Experiments indicate that in ether solutions (Et2O, and THF), both ionic and radical 
species of Grignard reagents exist
58
 in addition to the neutral structures depicted in the 
Schlenk equilibrium. It has been inferred from experimental data that these radical and 
ionic species are formed via the mechanism of the Grignard formation and that this 
mechanism may be different for the different alkyl and aryl halides. Thus while R· may 
be the only long-lived radical formed from alkyl bromides, both R· and R
-
 may be present 
from Grignards formed from alkyl chlorides and fluorides. 




Today, it is convenient to represent Grignard reagents as RMgX in its applications in 
organic chemistry. 
 
1.5 Addition of Organomagnesium Reagents to Michael acceptors 
Grignard reagents have found broad application in organic synthesis due to their ease of 
preparation and wide variety of functional groups that can be tolerated.
59
The discovery of 
new methods to activate magnesium
60
 has allowed successful preparation of Grignard 
reagents with even sensitive functional groups. Due to their low reactivity compared with 
organolithiums, Grignard reagents are well suited for both stoichiometric (including 
substrates with chiral auxiliaries) and catalytic stereoselective conjugate addition 
reactions. Although additions of Grignard reagents to α,β-unsaturated aldehydes and to 
some extent α,β-unsaturated ketones generally result in 1,2-adducts, 
61
 numerous 
examples of exclusive formation of 1,4-products from substrates with unique structural 
features have been reported. Thus the addition of m-methoxybenzylmagnesium chloride 
to α-methylene ketone (44) (eq. 20), followed by trapping with acetic anhydride yields 
74% of the enol acetate 45.
62a-c
 The regioselectivity has been explained to be due to 1,3-
diaxial interactions between the axial methyl and the incoming m-methoxybenzyl 
ligand,
62d
 thus indicating that steric effects as well as electronic factors of the substrate 
are crucial in controlling selectivities of addition of Grignard reagents to Michael 




To avoid direct attack of the Grignard reagents to the carbonyl carbon, most of the 
research efforts have been directed at substrates with reluctant 1,2-addition due to 
electronic effects. Thus, Grignard additions to N,N-disubstituted-α,β-unsaturated amides
63
 
(crotonamides, and sorbomides), sulfone lactams, thioamides, sulfones, and nitroalkenes 
have been extensively explored.
64a-b 
Reported examples include exclusive 1,4-addition of 
Grignard reagents to N,N-diethylsorbomide (46) while copper-mediated additions yield 
only the 1,6-product (Scheme 1.17). 
Scheme 1.17. Addition of Grignard reagents to N,N-diethylsorbomide 
 
 
Many of the earlier successful reports on additions to amides and sulfone lactams 
involved chiral auxiliaries on the substrates where different levels of asymmetric 
inductions as high as 97% ee were achieved. The stereoselectivity has been proposed to 
be due to the aggregating and chelating effect of the Grignard reagent with lone pairs on 
oxygen and nitrogen in the acceptor (50) 
64c
 such as shown in Scheme 1.18.  
34 
 
Scheme 1.18. Stereocontrol through aggregating and chelating effect 
 
Addition of allylic Grignard reagents to α,β-unsaturated dithioesters have also been 
reported to give exclusive 1,4-adduct 53, with allylic transposition (eq. 21).
65
 It has also 
been shown that, phenylalkynyl Grignard reagents also add 1,4- to α-nitroalkene 54 to 
form magnesium nitronate intermediate 55 (Scheme 1.19), which can be trapped with 





Reports on comparative studies of 1,4-additions of alkylmagnesium halide and 
dialkylmagnesium reagents to conjugated acceptors is rather limited but the few that exist 
appear to show variation in substrate and ligands.
67
 One such report suggests that addition 
of alkylmagnesium halides to 2-cyclohexen-1-one and trans-3-pentenone tend to favor 




It is proposed that the 
selectivity depends on temperature since at low temperatures (-78 
°
C) magnesium halide 





Scheme 1.19. Conjugate Addition of Alkynyl Grignard Reagent to Nitroalkenes 
 
 
1.5.1 Copper-Mediated Addition of Grignard Reagents 
The conjugate additions of Grignard reagents to electron-deficient alkenes have been 
extensively studied, and majority of the work describes reactions mediated by transition 
metal salts. Among them, copper salts are the most widely used ever since their first 
application by Kharasch and Tawney to catalyze conjugate addition of Grignard reagents 
reported in 1941.
69
 In its early stage, organocopper chemistry lacked reproducibility and 
dependability due to lack of knowledge of the true reactive species and the experimental 
factors affecting the reaction. However, most of the inconsistent results were as a result 
of contamination of the copper (I) with copper (II), and the poor solubility of the copper 
(I) salt, which resulted in heterogeneous reaction mixtures. The poor solubility was 
overcome by complexing the copper (I) salts with dialkyl sulfides leading to complexes 
such as CuBr·SMe2, and CuCN·2Li while at the same time improving the thermal 
stability of the alkylcuprate reagents. The various copper sources that have been widely 
employed in organomagnesium additions include copper(I) acetates, the copper(I) 
36 
 
halides, copper(I) cyanide, copper(I) thiophenolate, copper(I) bromide-dialkylsulfide 
complexes, copper (I) triflate (CuOTf), and copper (II) triflate Cu(OTf)2. These salts have 
been used in stoichiometric (includes organocopper and cuprates) or sub-stoichiometric 
(catalytic) amounts with Grignard reagents in conjugate additions to electron deficient 
alkenes and alkynes. It is observed that the stereoselectivity of cuprate additions to 
conjugate acceptors is identical for either stoichiometric or copper-catalyzed addition of 
Grignard reagents. Generally, while Grignard reagents predominantly add 1,2- to α,β-
unsaturated aldehydes and ketones in the absence of any transition metal salt, an 
exclusive 1,4-addition product results in the presence of stoichiometric or catalytic 









 Grignard additions mediated by copper 
salts (catalytic or stoichiometric) are known to favor the 1,6- over the 1,4-addition 
product. Thus, additions of alkyl, aryl,  and vinyl Grignards reagents to cycloalkenones, 
and alkylidenecycloalkenones with >20 mol% of Cu(I) salts yield exclusive 1,4-
products.
74
 Some of these transformations are key steps in the synthesis of many 
important complex molecules (60 & 62, Scheme 20) and natural products
75








Scheme 1.20. Copper-mediated addition of Grignard reagents to cyclic enones  
 
1,1-doubly activated Michael acceptors, also undergo copper-catalyzed addition of 





1.6 Organocopper reagents 
Elemental copper and its salts played important roles in many ancient cultures and 
civilizations
77
 and still continue to play very significant roles in modern societies 
including the chemist’s workbench. Its uses range from electrical conducting wire, 
biological oxygenation
78
 and chemical synthesis. Perhaps its unique properties are as a 
result of it lying on the border between the transition metals and the main group elements 
in the periodic table. Among the transition metal complexes, copper reagents are some of 
the most widely employed in synthesis.
79
 It is involved in many reactions such as the 
Sandmeyer reaction,
80
 the Ullmann coupling,
81
 alkylations, allylations, conjugate 
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addition, and carbocupration, which cannot be achieved with the other transition metals.
82 
The first reported isolation of an organocopper reagent can be traced back to Bötteger in 
1859 when he published the synthesis and isolation of dicopper acetylide (an explosive 
powder), which gave off acetylene (first isolation of pure acetylene) upon addition of 
aqueous acid.
83
 This was followed by the report of Glaser in 1870 when he described the 
coupling of terminal alkynes catalyzed by copper.
84
 Then Reich in 1923 reported his 
preparation of phenylcopper from PhMgBr and CuI, although his efforts to prepare 
alkylcopper were not successful.
85
 However, 13 years later, Gilman and Straley reported 





 which decomposed above -18 
°
C. But in 1941 Kharasch and 
Tawney reported their observation that they could preferentially achieve 1,4-addition of 
methylmagnesium bromide to 3,5,5-trimethylcyclohex-2-en-1-one in the presence of 1.0 
mol% of CuCl.
87
 However, the active species responsible for the reaction was not known. 
Two years later, Gilman and coworkers reported the preparation of methylcopper from 
methyllithium and CuCl, but this yellow precipitate (polymer) was not soluble in diethyl 
ether and was explosive.
88
 In 1952 he discovered that the yellow precipitate was formed 
when 1.0 equiv. of MeLi was added to CuI but it dissolved when another equivalent of 
MeLi was added to it and the yellow colored solid dissolved and turned colorless.
89
 This 
colorless copper reagent was generally formulated as R2CuLi, which would later be 




Scheme 1.21. Reactions of EtCu prepared by Gilman and Straley 
 
 
Scheme 1.22. First preparation of the Gilman reagent 
 
Copper is usually employed as a nucleophilic organocopper (I) reagent that is generated 
in situ by addition of stoichiometric or catalytic amounts of a copper salt to Grignard 
reagents, organolithiums, organozinc, or other organometallic reagents at very low 
temperatures (usually below -45 
°
C). They are generally represented as RCu (simple 
organocopper), R2CuM (metal homo cuprates), RCu(X)M (hetero cuprates), and 
RR′CuM (mixed cuprates), where R, R′ can be any alkyl, aryl, allyl, or vinyl group, M is 






), and X is halide, cyanide, aryl thiolate). 
With the exception of the RCu, these copper reagents are very efficient for transferring 
alkyl, vinyl, allyl, aryl or heteroaryl carbanions to electrophilic acceptors via reactions 
such as allylic alkylations, conjugate additions, carbocupration, substitution, acylation, 




Scheme 1.23. Reactions of organocopper reagents 
 
 
1.6.1 Structures of Organocopper compounds 
Organocopper compounds may be classified into three groups as (1) Neutral 
Organocopper (I) Compounds (RCu) (2) Organocuprates and (3) Organocopper (III) 
Complexes.
90
 The organocopper (I) Ate complexes are the most relevant and heavily 
studied, since they are the best nucleophilic form of the organocopper reagents, usually 
employed in organocopper-mediated carbon-carbon bond forming reactions.  
1.6.2 Neutral Organocopper (I) Compounds, RCu 
These are the simplest and unreactive form of the organocopper reagents (Scheme 24) 
and therefore not useful synthetically. Although in ethereal solutions they mainly exist in 
polymeric aggregates, monomeric clusters can be formed by adding a strong donor ligand 
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that has high affinity for copper (e.g. phosphines)
91
 to them, thereby increasing their 
reactivity.  However, in solution the neutral RCu may actually exist as halocuprate since 
alkali metal salts are introduced in solution from the procedure used to prepare the RCu, 
and reports in the past of crystal structure of some mixed alkylhalocuprate (Scheme 1.24) 
have confirmed this.
92 
Scheme 1.24. Structure of MeCu·LiCl in crystals 
 










1.6.3 Organocopper (I) Ate Complexes 
Organocopper (I) ate complexes can be described as heterocuprates [RCu(X)M], or 
homocuprates (R2CuM) where R is an organic group, X is a halide or cyanide ion, and M, 
a main group counter cation. Diorganocuprate (I) complexes are formed when two 
equivalents of organometallics are added to one equivalent of copper (I) salt. 
Organocuprates generated from one or two equivalents of organolithiums and CuCN used 
to be called lower-order or higher-order cuprates respectively due to the possibility of 
forming tricoordinated dianionic reactive copper (I) species but numerous investigations 
42 
 
have shown that the cyanide anion is not in the coordination sphere of the cuprate.
96
In the 
presence of a crown ether to coordinate the lithium ion in THF, a linear free 
organocuprate [R2Cu]
-
 is formed and the bond angle of the R-Cu-R is 180
o 
(ground state). 
While organocuprates occur as contact ion pairs (CIP) in ethereal solutions, in THF they 
exist as solvent separated ion pairs (SSIP)
97 
and are usually unreactive toward conjugate 





. However, in the presence of lithium ion, the linear free 
organocuprate forms a cluster by coordinating the lithium ion as a result of the partial 
charges on the two ends of the R groups of the cuprate, resulting usually in an eight-
centered closed cluster dimer 68 (R2CuLi)2. Studies show the CIP eight-centered closed 
cluster dimer is the dominant structure in both diethyl ether solutions and crystal 
structures of the cuprate where the lithium ion is coordinated also to two ethereal solvent 
molecules. On the other hand, in THF, equilibrium exists between the CIP and SSIP 















 suggest Gilman cuprates to form more complex aggregate 
structures than the CIP-SSIP equilibrium dimers shown in THF (Scheme 1.25). It has 
been proposed from these results that these organocuprates can form oligomeric 
aggregates made up of one or two homodimeric core structures bridged by lithium salts 
or solvent molecules. 
1.6.4 Organocopper (III) Complexes 
Tricoordinated organocopper (III) species have been frequently invoked as reactive 
intermediates 
99
 in nucleophilic organocuprate reactions but had never been detected until 
recently.
100 
These unstable complexes have a T-shaped geometry and are found to be 
thermodynamically stabilized by coordinating a fourth ligand with an electron 
withdrawing ability such as polyfluoroalkyl group to form a square-planar tetra-





following that, numerous complexes have been isolated and reported as their square-
planar tetra-coordinated complexes
101 
in agreement with the d
8
 electron configuration of 
the copper (III)
 
(Figure 1.10).  
            
Figure 1.10. Examples of copper (III) complexes  
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The square-planar geometry makes the Cu
III
 easier to complex with porphyrins and 
similar macrocyclic compounds (Figure 1.12), many of which have been reported (Figure 
11).
102 
 Since these reports, Cu
III
 intermediates have been detected as intermediates with 
the aid of NMR in conjugate additions employing Me2CuLi·LiI in the presence of 
Me2SiCN and Me2CuLi·LiCN in the presence of Me3SiCl to cyclohexanone (72).
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Additionally neutral trialkylcopper (III) complexes of monodentate phosphorus and 
nitrogen ligands have been prepared from ligand exchange at low temperatures (75).
104 
 











1.6.5 Geometry of Diorganocurates (I) 
Copper-mediated/catalyzed addition of organometallic reagents to electrophiles usually 
involves three main steps. (1) Transmetallation of the organometallic reagent with the 
copper (I) salt (2) nucleophilic attack (oxidative addition) of the organocuprate to the 
electrophile (3) and reductive elimination of the resulting organocopper (III) intermediate 
to form the C-C bond. While the driving force for the oxidative addition is the molecular 
orbital interactions between the electrophile and the cuprate, and the binding of the Lewis 




MgX) to the electrophile, the reductive elimination is 
often the rate-determining and regio- or stereochemistry-determining step.
96
 The 
understanding of the relationship between the coordinating geometry and electronic 
structure of the organocuprate is very important in understanding the reactivities of 
organocuprate reagents. The C-Cu-C bond angle of diorganocuprates is 180
°
 and the 
HOMO of this linear molecule is mostly the 3dz
2
 due to its out-of-phase interactions with 
the alkyl 2p orbitals.
105
 This HOMO has the same symmetry suitable for interaction with 
the σ*(C-X) of an alkyl halide (or heteroatom) but not with the π* of olefins. The 
bending of the C-Cu-C bond to < 150
°
 bond angle causes destabilization and the mixing 
of the copper 3dxz with the 2p orbitals of the ligand thus raising the energy level of the 





the organocuprate can have two different HOMOs, (based on orbital symmetry) 




Scheme 1.26. Orbital interactions in allylic substitution
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Oxidative addition of the organocuprate to the electrophile is driven by the donation and 
back-donative interaction between the HOMO of the organocuprate and the LUMO of the 
electrophile and these participating orbitals must have the same orbital symmetry to 
ensure in-phase interaction. The HOMO of the linear (ground state) R2Cu
-
 molecule is the 
3dz
2
, whose symmetry is out of phase with the π* of the C=C or triple bonds but in-phase 
with the σ* of the c-x bond, thus would have made the linear R2Cu
-
 only capable of 




However, thermal vibrations allow the R-Cu-R to be bent which disposes the new 
HOMO (dxz) of the cuprate to the LUMO (π*) of the electrophile of the proper symmetry 
to interact and form the π-complex (Scheme 1.26B) leading to a T-shaped organocopper 
(III) intermediate. This T-shaped Cu
III
 intermediate is kinetically unstable and unless it is 
converted to a square-planar complex with a ligand, it will undergo reductive elimination 
to form the new C-C bond without any energy barrier.
107
 In the process, the copper atom 
retrieves its d-electrons from the Cu-C σ-bond to the electrophile creating an empty 
orbital on this carbon thus enabling the incoming alkyl ligand to be transferred to this 
47 
 
carbon of the electrophile and the Cu
III




 Several kinetic studies 
have shown that the reductive elimination of the organocopper (III) intermediate is the 
rate-determining step of the cuprate mediated/catalyzed C-C bond forming reaction.
109 
 
1.7 Copper Mediated/Catalyzed Conjugate Additions 
Conjugate addition of carbon nucleophiles to Michael acceptors is among the most 
important C-C forming reactions in organic synthesis and as a result, its mechanism is 
among the most extensively studied. For copper mediated/catalyzed conjugate addition, 
the reaction has been observed to be first order with respect to the conjugate acceptor 
with the initial step involving reversible π-complexation between cuprate and the Michael 
acceptor, followed by intramolecular rate-determining step converting the intermediate to 










Scheme 1.27. Mechanism of copper-mediated conjugate addition 
 
 
Beside the π-complexation, the lithium ion also coordinates to the carbonyl oxygen 
during the oxidative addition. The intramolecular rate-determining step has been shown 
to involve the reductive elimination of the β-cuprio (III) enolate intermediate formed 
from the oxidative addition step.
110
 
As mentioned before, in the reductive elimination the Cu
III
 is modeled to retrieve its d-
electrons from the β-carbon of the enolate thus creating a vacant orbital on the Cβ of the 
enolate of which the incoming ligand easily transfers to fill up. For α,β-unsaturated 
carbonyl compounds, the regioselectivity of the conjugate addition is influenced by the 
cuprate’s ability to form a stable π-complex with the C=C rather than with the C=O 
double bond (Figure 1.13) thus explaining its exclusive formation of 1,4-adduct over the 




Figure 1.13. Cuprate-enone π complex 
In the case of polyconjugated Michael acceptors, a similar mechanism is envisioned to 
explain its mode of selectivity. That the oxidative addition leads to a β-cuprio (III) 
enolate which then goes through a series of σ/π-allylcopper(III) migration until it reaches 
the terminal end of the unsaturation. This terminal copper (III) intermediate is kinetically 
unstable and so decays via reductive elimination to afford the 1,6-adduct. 
 
1.8 Organozinc Reagents 
Organozinc compounds are one of the oldest organometallic compounds to be 
synthesized.
111
 Although they all contain a direct polar covalent C-Zn bond which is 
polarized toward the carbon, they are not as nucleophilic as their corresponding Grignard 
and organolithium reagents. Ethylzinc iodide and diethylzinc were the first organozinc 
compounds to be synthesized in 1848 by Edward Frankland
112
 when he heated ethyl 
iodide with zinc metal and produced a volatile colorless liquid which was observed to 
inflame spontaneously in air. Soon, the use of dialkylzinc reagents in carbon-carbon 







and esters became common until interest in them waned when the more reactive Grignard 
and organolithiums reagents were discovered around the 1900s, although zinc ester 
50 
 
enolates (Reformasky reaction) were still in use. Their low reactivity, limited their use in 
organic synthesis for nearly sixty years, until research interest in organozinc compounds 
was renewed in the 1960s partly as a result of the discovery of the generation of carbene 
from ICH2ZnI by Simmons and Smith in 1958.
116
  However, this low reactivity turned 
out to be their biggest asset as they tolerate a wide range of functional groups enabling 
them to be employed as nucleophilic reagents in multi-step transformations of more 
complex poly-functional organic compounds. Besides their functional group tolerance, 
nearly all of them have low toxicity, making them easy to handle and dispose of. Also, 
their ability to function as excellent catalysts and co-catalysts for a wide range of 
reactions coupled with their propensity to undergo transmetallation with metals such as 
Pd, Cu, Ti, Zr, Ni, enable them to form new reactive species with novel physical and 
chemical properties. Organozinc compounds are in principle electron-deficient due to the 
fact that out of the four low lying orbitals (4s, 4p) available for bonding, only two valence 
electrons are provided by zinc for bonding. These empty orbitals have a profound effect 
on the coordination number of zinc thus resulting in different classes of organozinc 
compounds. An important difference between organozinc and organocopper reagents is 
that, organozinc compounds are stable at higher reaction temperatures than organocopper 
reagents.     
1.8.1 Classification of Organozinc Compounds 
Depending on the number of carbon ligand attached to the zinc metal, organozinc 
compounds can be divided into four groups as: 
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1. Organozinc halides(RZnX) 
 
2. Diorganozinc compounds(R2Zn) 
3. Lithium triorganozinc (‘ate’ complex) (LiR3Zn) 
4. α-(alkoxycarbonyl)alkyl zinc halide) (Reformasky reagents) 
 
1.8.2 Organozinc halides 
Organozinc halides, represented by the general formula (RZnX), are among the first 
organozinc compounds to be synthesized. Due to the thermal instability, they are 
normally generated in situ, and were in their early days only accessible via alkyl 
iodides. However, with the discovery of new ways to activate zinc metal, they can 
now be prepared from organic bromides and even chlorides. The organozinc halides 
may be synthesized from their corresponding organic halide via 1) oxidative addition 
of the organic halide to activated zinc, 2) transmetallation between Grignard or 
organolithium reagents and zinc halide, 3) transition-metal catalyzed reaction 
between diorganozinc and organozinc halide, and 4) comproportionation of 
diorganozinc and zinc dihalide. 
In the oxidative addition, an organic halide is reacted with finely divided activated zinc 
(Zn*) produced by reduction of zinc halide in THF (Rieke zinc), shown in the (Schemes 





Scheme 1.28. Oxidative Addition of Tertiaryalkyl Bromide with Rieke Zinc 
 
 
Scheme 1.29. Oxidative Addition of Functionalized Alkylhalide to Rieke Zinc 
 
Alkylzinc halides can also be formed from alkyl iodides and diethylzinc catalyzed by 
Ni and Pd complexes, with Ni(acac)2 being the most effective of the nickel (II) 
catalysts
117
  at 55 
°
C temperature.  
 
1.8.3 Organozincates (‘Ate’ complexes) 
These compounds are represented as M[ZnR3] and M2[ZnR4] where M is an alkali or 
alkaline earth metal ion and R is an organic group. Unlike the diorganozinc and the 
organozinc halides, the zincates are more reactive toward electrophiles. They are broadly 
classified into lithium/magnesium triorganozincates M[ZnR3], and lithium/magnesium 
tetraorganozincates M2[ZnR4]. Triorganozincates have trigonal-planar geometry while 













} and are usually 
prepared by addition of three or four equivalents of Grignard or organolithium reagents to 
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zinc salts (ZnX2) or the parent diorganozinc (ZnR2) reagents (1:1). In some cases, they 
can also be prepared from a disproportionation reaction of diorganozinc in the presence 
of a macrocyclic ligand to form organozinc cations and organozincates. Examples of the 
different types of preparation are shown below (Scheme 1.30). 




Method 1 involves addition of 1 equivalent of organolithium or Grignard reagent to an 
equivalent of homoleptic diorganozinc to form the heteroleptic triorganozincate. This 
method was one of the first reported, and it is particularly useful when salt-free 




The zincate can also be prepared by addition of 3 









 Although, it is observed that 
the homoleptic (symmetrical) zincates give better yields of conjugate addition, the 
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heteroleptic (unsymmetrical zincates) provide opportunity to selectively transfer only the 
precious ligand and avoid wastage in which alkynyl, aryl, and methyl ligands do not 
transfer as fast as alkyl ligands because of stabilized covalent carbon-Zn bond.
120
 In 
general, the order of ligand transfer preference is as shown Figure 1.14. 









Figure 1.14. ligand transfer preference for unsymmetrical zincates 
 
1.8.4 Synthesis application 
Scheme 1.31. Application of Mixed Triorganozicate in the Synthesis of 
Prostaglandins 
 
The synthetic utility of the mixed triorganozincates have been demonstrated in the 
synthesis of some prostaglandins where the preferential transfer of vinyl ligand over 
methyl groups was employed in the mixed zincate (Scheme 1.31). Some alkyl 
heterozincates, prepared from t-butoxide and alkyl Grignard reagents have also been 
found to be highly efficient for 1,4-additions to α,β-enones than their heteroaryl 
versions.
121 
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Compounds of tetraorganozincates are quite common and solid-state structures of some 
of these compounds have been reported. An example of homoleptic tetraorganozincate is 
potassium or rubidium tetraacetylido zincate, K2[Zn(C2H)4] which can be prepared from 






1.8.5 Reactions of organozinc compounds in organic synthesis 
Due to their high tolerance for a wide range of functional groups, organozinc reagents 
tend to be chemoselective, and this makes them very useful in polyfunctional multi-step 
organic synthesis. Also, the discovery of new synthetic methods has made a wide 




 organozinc reagents available for synthesis. 
Furthermore, their ability to transmetallate with transition metals such as Pd, Ni, Cu, Ti, 
Zr, Fe, and Co has broadened their applications in organic synthesis.  
  
 
1.8.6 Additions to enones 
Addition of organozinc reagents to Michael acceptors usually occurs in the presence of 
copper salts or Lewis acids to produce the 1,4-adduct. High levels of enantioselectivities 
have been achieved from the additions of dialkyl- and diarylzinc reagents to enones and 
related Michael acceptors (eq. 22) catalyzed by Cu(I) salts and an array of chiral ligands 
















The biphenol-based phosphoramidites have been employed on both enones and α-
nitroalkenes to achieve highly enantioselective 1,4-addition of Et2Zn as well (eq. 23). 
These reactions usually employ chiral ligand and copper salts such as Cu(OTf)2, 
copper(I) 2-thiophenecarboxylate, Cu(CH3CN)4ClO4, and Cu(CH3CN)4BF4, as well as 
copper complexes with well-defined optically active centers such as aminoarenethiolate 
(Figure 1.15). The active catalyst has copper(I) center and it is believed that the copper 
(II) from the salt initially gets reduced to Cu(I) in the reaction medium before it 
undergoes transmetallation with the diorganozinc reagent to form a more reactive 
complex. 
 





 TRANSITION METAL-MEDIATED/CATALYZED ALLYLIC ALKYLATIONS 
 
1.9 Definition of allylic substitution (SN2 vs SN2′) 
 Copper-catalyzed allylic substitutions have become important methods for creating 
carbon-carbon(C-C) and carbon-heteroatom (C-X) bonds, which continue be active 
frontiers of modern synthetic organic chemistry as the need for enantiomerically enriched 
compounds for biological assays and research, continue to increase. Allylic alkylation 
occurs when the carbon nucleophile of an organometallic reagent reacts with an allylic 
substrate (unsaturated unit adjacent to a carbon bearing a leaving group) to expel the 
leaving group. The carbon nucleophile can have a direct attack on the carbon bearing the 
leaving group at the α-position resulting in an SN2 product or can react with the sp
2
 
carbon at the γ-position converting it to an sp
3
 carbon with the double bond relocating to 
form an SN2′ product (Scheme 1.32). With the two substituents being different (R ≠ R
1
), 
two regioisomeric products can be formed. Factors controlling which of these two will 
predominate in any reaction include, structural and electronic features of the substrate, 
solvent, the type of the organometallic reagent, temperature, and the nature of the leaving 
group. Numerous allylic substrates have been reacted with copper salts and 
organometallic reagents; notable among them are the allylic halides, acetates, phosphates, 
vinyloxiranes, and vinylaziridines. Besides copper (I) salts, metals such as Pd, W, Mo, Ir, 
Ni, Rh, Zn, and Ru have also been employed in allylic substitution reactions, although Pd 




Scheme 1.32. The two types of allylic substitutions 
 
 
1.9.1 Mechanism of allylic substitution
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The SN2′ reaction with organocopper reagents results in inversion of configuration due to 
the overwhelming anti-stereoselectivity with respect to the leaving group in the allylic 
substrate of the copper-catalyzed allylic substitution reaction. E. J. Corey and Boaz 
proposed in 1984 that the diffuse d
10
 orbitals of the incoming cuprate forms a bidentate 
overlap with the π
*
 (LUMO) of the olefin and loosely interact with the antibonding σ
*
-
orbital of the leaving group in the allylic system (Figure 1.16). This model requires that 
the leaving group is perpendicular to the double bond to enable anti-selectivity at the 
reaction center. Sometimes, this stereoelectronic requirement is overridden by steric 
factors or chelating effects of the leaving group, leading to syn-selectivity. Examples 




     




Figure 1.16. Corey-Boaz model for orbital overlap of d
10 




The widely accepted mechanism for allylic substitution was put forward by Bäckvall and 
van Koten which suggests a transient intermediacy of a Cu
III
 species. The first step 
involves formation of copper (I) π-complex, I (Scheme 1.33) due to the binding of the 
organocuprate to the allylic π bond as depicted by the Corey-Boaz model (Figure 1.14). 
This step establishes the stereochemistry of the product as it leads to an oxidative 
addition of the copper (I) to the double bond anti to the leaving group resulting in σ-allyl 
Cu
III
 species, II (Scheme 1.33). From this, the regiochemistry of the final product is 
determined by the relative rates of the reductive elimination, k1, to form SN2′ product or 
isomerization (k2) to π-allyl Cu
III
, III, and then to the (k3) σ-allyl complex, IV which 
eventually undergoes reductive elimination to form the SN2 product. It is suggested that, 
when the copper salt’s counter ion is electron-deficient, rapid reductive elimination of the 
σ-allyl complex II occurs, favoring the formation of the SN2′ product. While, on the other 
hand, an electron-rich counter ion (e.g alkyl as in R2CuLi) stabilizes the σ-allyl complex 
II, allowing it to equilibrate to π-allyl Cu
III
, III, and then reductive elimination to the SN2 




Figure 1.17. Some syn-Directing substrates;
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A) carbamates, B) benzothiazole, C) 
o-(diphenylphosphanyl)benzoyl 
It must be pointed out that the Cu
III
 species in the mechanism has not been isolated or 
detected experimentally. However, Bäckvall et al have given indirect evidence of its 
existence
129









1.10 Computational Studies of Copper Mediated/Catalyzed Allylic Substitution 
Reaction 
Alkylation reactions mediated/catalyzed by copper are known to involve square-planar 
tri- or tetra-alkyl Cu(III) intermediates
131
 where there is a tendency of the cuprate alkyl 
group to be in a cis arrangement to the alkyl group of the electrophile. Unlike the 
conjugate additions, the rate determining step of the copper-mediated/catalyzed SN2 
alkylation on sp
3
 carbon is the displacement of the leaving group (oxidative addition) by 
the nucleophilic organocuprate (I) to form a T-shaped trialkylcopper(III) intermediate 
coordinated by a fourth ligand (halide, cyanide, alkyl, and phoshine) in a square-planar 
geometry before undergoing reductive elimination. This oxidative addition is initiated by 
both the coordination of the Lewis acid counter cation to the leaving group, and the 
interaction of the 3dz
2
 orbital of the linear dialkylcuprate with the σ* orbital of the 
electrophile. However, mechanisms of substitutions on allylic substrate (SN2′) is a bit 
more complex than as described above due to the possibility of the new C-C bond being 
formed at α, or γ, and anti or syn to the leaving group. Experiments show that allylic 
substitutions in general are anti selective and that the syn SN2′ will only occur if the 
leaving group has the ability to coordinate to the cuprate.
132
 Although the regioselectivity 
of Gilman cuprate is sometimes observed to be substrate controlled, the SN2′ 
regioselectivity is mostly controlled by reagents and the reaction conditions.
133
 
Theoretical work has suggested that the oxidative addition involves a reversible square-
planar π-complexation of the cuprate and the olefin resulting in the departure of the 
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leaving group in an anti- manner with the aid of the Lewis acid
134
 to form π-allylcoper 
(III) complex (Scheme 1.34). 
Scheme 1.34: Computational model of the Allylic alkylations of unsymmetrical 
allylic electrophile 
 
Due to favorable mixing of the cuprate’s 3dxz orbital and the C=C π*/C-O σ* of the 
allylic substrate, the anti- elimination of the leaving group is favored over its syn 
counterpart. Equilibrium sets up between the π-allylcoper (III) complex and σ-allylcopper 
(III) but both can undergo reductive elimination to form the product. Thus in a 
symmetrically substituted allylic electrophile and homocuprate, this equilibrium would 
lead to lack of regospecificity in the allylic substitution since the regiospecificity is 
determined at the reductive elimination step. 
1.11 Asymmetric Allylic Alkylations 
The basis for the bioactivities of some important compounds and some potent 
pharmaceuticals is the presence of stereogenic centers in their molecules and therefore an 
increase in demands for these compounds calls for the need for chemists to design and 
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develop methods that are easy to use, cheap, and capable of providing these products in 
high purity and desired quantities. Asymmetric allylic alkylations mediated/catalyzed by 
transition metal complexes enable the introduction of carbon nucleophiles such as alkyl, 
alkenyl, and aryl groups to allylic substrates to create C-C stereogenic centers and a 
double or triple bonds for further functionalization. The initial developments involved 
formidable challenges as the need to control the regio- and stereochemical outcome of the 
allylic substitution reactions became necessary. Early attempts to control stereochemistry 
involved the use of stoichiometric chiral sources including chiral substrates and chiral 
auxiliaries.
135
 High levels of diastereoselectivities were achieved but the insights gained 
from these methods set the stage for the successful development of enantioselective 
catalytic allylic alkylation procedures. The challenges that confronted catalytic 
enantioselective allylations were the need to achieve synthetically useful levels of 
enantioselectivities by avoiding competition reactions from catalyzed SN2 reactions as 
well as noncatalyzed addition of very reactive organometallic reagents to substrates to 
form racemic mixture of either SN2 or SN2′ products.  
1.11.1 Diastereoselective Allylic Alkylations 
This strategy involves two approaches where: (1) An existing stereogenic information in 
the substrate is used to direct diastereofacial addition, and (2) chiral auxiliary in place of 
the leaving group to direct addition. The first report of diastereoselective allylic 





substrates (Figure 1.18) derived from crotonaldehyde, which were commonly known to 
induce enantioselectivity in asymmetric synthesis at the time.  
 
Figure 1.18. Structure of C2 symmetric chiral ethylenic acetal 
 
1. 11.1a Chiral Substrates: Most additions to chiral substrates results in SN2′ products 
with inversion of configuration where the new substituent is anti- to the leaving group 
and the translocated double bond is usually E in geometry. Some of the substrates that 
have been employed include aziridines, carbamates, acetates, and carbonates. This 
approach has also been used to prepare all-carbon quaternary stereogenic centers
137
 (eq. 







An interesting observation is that the lithium cuprate gives an E-alkene while magnesium 
cuprates give the Z-geometry from the same carbamate substrate. The proposed 
explanation for the Z-selectivity of the magnesium cuprates with the carbamates suggests 
two intermediates (Scheme 1.35) for the reaction where the first intermediate is formed 
from either the lithium or magnesium cuprate. Lithium cuprates will undergo reductive 
elimination from intermediate 100 to give the E-alkene but magnesium cuprate may 
proceed to intermediate 102 due to the less reactive magnesium cuprate and anti-
elimination from this will exclusively produce the Z-isomer.  






Methods for selective formation of the syn products have also been developed where o-
diphenylphosphanylbenzoyl (o-DPPB) moiety was used to direct selectivity by 
coordinating the organocopper reagent to afford all carbon tertiary and quaternary 
stereogenic centers from both cyclic and acyclic chiral substrates.
139a-e
 It was observed 
that the coordination property of the o-DPPB could be removed by oxidation of the 
phosphane, thus resulting in anti- selective product. In this way, both enantiomer of the 
product could be obtained from the same enantiomer of substrate by just switching the 
properties of the same catalyst. 
 
1.11.1b Chiral Auxiliaries: The lack of many examples of auxiliary-based 
diastereoselective allylic substitutions reported has been attributed to their ineffectiveness 
as a result of the high conformational freedom of the auxiliaries when attached to the 
substrate.
140 
Some of the few examples reported include diastereoselective SN2′ alkylation 
of allylic substrate with chiral sulfide leaving group (eq. 26).
141
 Excellent 
diastereoselectivities have also been obtained from additions of Grignard reagents to o-










1.11.2 Enantioselective Allylic Alkylations 
Catalytic enantioselective allylic alkylation is an attractive procedure as only a small 
amount of a transition metal complex is needed, and only tiny fraction of valuable 
organometallic is lost during the reaction as an unreacted reagent. Copper-catalyzed 
asymmetric allylic alkylation with Grignard reagents was first reported by Bäckvall, and 
co-workers in which arenethiolato-copper (I) species developed by van Koten was used 
to catalyze allylation of allylic acetates (eq. 28) with 
n
BuMgI to achieve up to 42% ee.
143 
After observing that the selectivity is influenced by changes in temperature, mode of 
addition of reagents, solvent, ligand to metal ratios, and the coordinating abilities of the 
leaving groups, they were able to improve the ee to 50% and then later to 64% ee using a 
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ferrocenyl-based  chiral catalyst (L2). The reaction intermediate was said to involve π-
complex formation of copper with the olefin while magnesium binds to the carbonyl 
oxygen of the acetate (Figure 1.19) thereby activating the starting material. 
 




The conjugate addition of carbon nucleophiles to Michael acceptors followed the path of 
the initial report by Komnenos in 1883 and its development by Arthur Micheal into very 
useful synthetic method. Initially involving only stabilized carbanion (β-carboxyl 
enolates), it gradually grew to include hard nucleophiles (unstabilized carbanion) as the 
discovery 
4
 of copper salts by Kharasch and Tawney in 1941 enabled the employment of 
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organolithium and Grignard reagents to effect 1,4-addition to Michael acceptors. The 
identification of organocopper as the reactive species in the coper-mediated 1,4-additions 
by whitesides and co-workers
5
 inspired the development of other organometallic reagents 
from the Group II (e.g. R2Cd, and R2Zn) and the Group III (organoborons and R3Al) 
elements. The wide functional group tolerance of these new reagents greatly broadened 
the scope and application of the conjugate addition reaction and also set the stage for the 
asymmetric version to be developed.   
Current knowledge indicate that factors controlling the reactivities and the selectivities of 
the conjugate addition reaction include hard-soft acid base (HSAB) character of the 
reactants involved, the structure of the conjugate acceptor, solvent polarity, temperature, 
steric hindrance, and the nature of the counter ion to the organometallic reagent. These 
factors resulted in the use of additives such as HMPA, TMSCl, LiCl, and BF3·OEt2 in 
combination with the organometallic reagent via methods that are either stoichiometric or 
catalytic in copper salts in conjugate addition. These factors also influenced the 
development of the different copper salts (e.g, CuCl, CuCN, CuBr·SMe2, Cu(OTf)2, 
CuTC) that are available for conjugate reaction today. 
Uncatalyzed (i.e, in the absence of transition metal salts) conjugate addition of 
organometallic reagents to Michael acceptors is however limited by its unselective nature 
especially when dealing with extended Michael acceptors with carbonyl carbon reactivity 
where mixed results can occur arising from 1,2-, 1,4-, and 1,6- additions. As a result, 
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substrates with reluctant carbonyl carbon reactivity such as esters, amides, and 
nitroalkenes dominate the substrate scope. 
Allylic alkylation results from either direct attack of a carbon nucleophile on the carbon 
bearing the leaving group in the allylic substrate (SN2 pathway) or the reaction of the 
nucleophile with the sp
2
 carbon at the γ-position to relocate the double bond and 
expelling the leaving group in the process (SN2′ pathway). The SN2′ pathway is largely 
mediated or catalyzed by transition metal salts (e.g. Pd, W, Mo, Ir, Ni, Rh, Zn, and Ru) of 
which copper and palladium salts are the most widely used. 
The regio and stereochemical outcome are also largely dependent on substrate type, the 
electronic effect of the reagent, solvent polarity, steric hindrance, temperature, and the 
nature of the leaving group. Generally, while the SN2′ reactions give overwhelming anti- 
products with respect to the leaving group, syn-products dominate in reactions involving 
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REGIOSELECTIVE 1,4-CONJUGATE ADDITION OF GRIGNARD REAGENTS 
TO α,β−γ,δ-DIENONES AND α,β−γ,δ-DIENYL THIOL ESTERS 
 
2.1 Introduction 
Conjugated diunsaturated carbonyl compounds have three potential electrophilic sites 
(carbonyl carbon, Cβ, and Cδ) that make them excellent substrates for creating C-C bonds, 
which is central to organic syntheses. Thus, for a typical α,β,γ,δ-diunsaturated ketone 1 
(Figure 1), there could be C-C bond formation at the carbonyl carbon (1,2-addition), or a 
new C-C bond β- to the carbonyl carbon (1,4-addition), leading to an unconjugated C=C 
bond in the backbone of the product enabling further manipulation. Still, the new C-C 
bond may occur at the δ-position (1,6-addition) leading to an extended dienolate with 
either a β,γ-unconjugated or an α,β-conjugated double bond after selective protonation or 
trapping with an electrophile. In addition to reactions at these carbons, the diene unit 
could be coupled with a dienophile for the Diels-Alder reaction, or can undergo 
epoxidation at either the α,β- or γ,δ- bonds to form α,β-epoxy or γ,δ-epoxy enones, 
respectively. It is therefore not surprising that the conjugate addition of carbon 
nucleophiles to extended Michael acceptors has undergone a period of intense research 
for the past 15 years and still continues to be an area of active research. However, the rich 
functionality in this class of molecules also means that unless there are suitable reaction 
protocols to control chemo-, regio-, and stereoselectivities, these substrates will not be 




Figure 2.1. Reactivity profile and conformations of α,β,γ,δ-dienones 
Despite an overwhelming number of publications on conjugate additions to simple 
electron-deficient olefins, that of their vinylogous electron-deficient dienes is 
considerably limited. This is as a result of the challenges in overcoming chemo- (1,2- vs 
1,4-, & 1,6-), regio- (1,4- vs 1,6-), and stereoselectivity (diastereo- and 
enantioselectivities), in these reactions. Stereocontrol is particularly challenging in 
acyclic versions of these substrates due to the s-cis and s-trans conformations 2 & 3, 
where the conjugated double bonds may assume (Figure 1) different orientations. Over 
the years, strategies to tackle these selectivity issues have evolved from using steric 
effects to shield the carbonyl carbon,
1
 (4, Figure 2) to converting the carbonyl carbon to a 
relatively inert functional group unresponsive to 1,2-addition (5, 6, & 7, Figure 2). Thus 







 dienenitriles, and dienesulfones.  
 
Figure 2.2. Examples of Michael Acceptors with Reduced 1,2-addition Reactivity 
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The difficulty in stereocontrol also shifted research attention to cyclic and bicyclic 
dienones
5, 6 
where conformation is fixed (e.g 8-10, Figure 3). Although, generally the 
selectivity of the conjugate addition to electron-deficient alkenes has been thought to be 
substrate or condition-dependent and thus difficult to predict which factors favor 1,4- 
over 1,6-, it is apparent that for any substrate, any of electronic effects, steric effects and 
the nature of the nucleophile being added that dominate may determine the outcome of 
the reaction.
7
   
 
Figure 2.3. Examples of Some of the Cyclic Dienones that have been investigated 
Some of the earliest reports on transition-metal free addition of Grignard reagents to 
dienones employing these strategies came from the laboratory of Fusson and co-workers
1
 
where they successfully achieved regioselective 1,4-addition of phenyl and benzyl 
magnesium bromides to sorbomesitylene (11) and sorbodurene (13), respectively to 
obtain modest to very good yields (Eq. 1 &2) of conjugated adducts. Here, the o-methyl 
groups are assumed to block the two faces of the carbonyl carbon, shielding it from 




Later strategies to achieve regio and stereocontrol in acyclic extended Michael acceptors 
employed the use of Lewis acidic metal centers that are capable of binding the substrate 
in a fixed conformation before the ligand transfer. The simultaneous reports of Näf 
8 
and 
co-workers’ involving highly regioselective 1,6-addition of lithium divinyl cuprates to 
ethyl or methyl  pentadienoates, 15 (eq. 3), and Corey’s
9 
stereoselective 1,6-addition of 
vinyl and methallylcopper to the same substrate, (i.e 15, eq. 4) in 1972 marked the first 
application of transition metal-mediated addition of unstabilized carbanions to extended 
Michael acceptors. These were followed later in 1982 by Yamamoto’s report
10
 that 
tuning of the electron density of the copper reagent with Lewis acid determined 1,4- vs 
1,6- selectivity in linear dienoates such as methyl sorbate, 18. In this work, it was 
observed that the use of the cuprate (n-BuCu/BF3) regioselectively gave the 1,4-adduct, 
19, while the Gilmann reagent gave exclusively the 1,6-adduct 20 in high yield (Eq. 5). 
Similar results were reported
11
 by Miginiac and co-workers on the electron-deficient 
diene motif 21 in 1983 transfering alkyl, allyl and alkenyl ligand to obtain 22 in low to 





These pioneering works set the stage for the asymmetric versions of this important 
reaction to be developed later. Fillion and co-worker’s report
12
 of copper-catalyzed 
asymmetric 1,6-additions of dialkylzinc to Meldrum’s acid derivatives 23 marked the 
beginning of the asymmetric conjugate additions (ACA) to extended acyclic Michael 
acceptors. In this work, an isopropyl substituent at the Cβ of the substrate favored high 
1,6-selectivity while enantiomeric excess was controlled with the chiral phosphoramidite 
ligand 25 (eq.7). Two years later, Feringa’s group
13
 reported the first enantioselective (> 
90% ee) copper-catalyzed 1,6-addition of alkyl Grignard reagents to linear δ-substituted 
2,4-dienoates 26 employing catalytic copper(I) bromide-dimethyl sulfide complex and 
reverse josiphos (+) ligand 29 (eq. 8). Their studies also revealed that the structure of the 
catalyst was necessary to achieve asymmetric 1,6-addition as the switching of the ligands 
led to complex mixtures. The synthetic potential of this electron-deficient diene motif and 
the protocol was demonstrated with a short total synthesis of the sulfated natural product 
30 (Figure 4) from ethyl sorbate in 55% over all yield. However, a limitation of the 
protocol was that the transfer of methyl group from the corresponding Grignard reagent 
to the dienoate substrates gave very poor yield (< 10 %) due to the low reactivity of the 
magnesium methyl cuprate reagent. This was overcomed by switching the dienoates to 
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their corresponding thioldienoates, which gave regioselective (97%) 1,6-adduct of 93% 
ee and 85% yield. In a follow up study, they synthesized 1,3-deoxypropionate units  from 
different thiol dienoates via the CuBr·SMe2/29 complex that catalyzed 1,6- asymmetric 
conjugate addition where the β,γ-double bond was reconjugated (32) with DBU and 
further subjected to 1,4- asymmetric conjugate addition using CuBr·SMe2/ 42 as the 
catalyst system to enable the formation of syn-33 or anti-34 addition product (Scheme 1). 
In the same year Alexakis and co-workers
14
 reported copper (II) triflate-catalyzed 1,4-
addition of Grignard reagents to cyclic 2,4-dienones, 36 & 40 employing N-heterocyclic 
carbene (NHC) 39 as chiral ligand  to obtain all carbon quaternary stereogenic 
centers(e.g, 38 & 41) with enantioselectivity in excess of 92% (eq. 9 & 10).  
 
 
In this work, it was also revealed that the 1,6-additon to the same substrate (i.e 36) could 
be achieve with a combination of diethylzinc or triethylaluminum in the presence of 
Cu(OTf)2 and phosphoramidite ligands 44 & 45 demonstrating that asymmetric conjugate 
additions to these α,β,γ,δ-diunsaturated six membered dienones depend on the nature of 







Figure 2.4. Sulfated alkene isolated from Echinus Temnopleurus hardwickii 
The asymmetric 1,4-addition of trimethylaluminum to acyclic conjugated nitrodienes and 
nitroenynes has also been reported
15
 by the same group using a combination of copper 
thiophene 2-carboxylate (CuTc) and josiphos (35) as a ligand. It was shown that in the 
case of the nitrodienes (46) methyl Grignard reagent and trimethylaluminum both had 
preference for the 1,4-adduct 47 while dimethylzinc gave exclusively the 1,6-adduct,  (eq. 
12). When the substrate was switched to nitrodienes with an ester group at the Cδ (i.e 48) 
an exclusive 1,6-adduct 49 with respect to the nitro group and enantiomeric excess of 
91% was obtained (eq. 13). This reversal of regioselectivity was rationalized to be due to 
the coordination of the ester moiety to the catalyst favoring the 1,6-adduct. 
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Scheme 2.1. Synthesis of 1,3-deoxypropionate units  from thiol dienoates 
 
 
The same group used a combination of Cu(OTf)2 and diphenylphosphino-azomethinylate 
(DiPPAM) salt as the catalyst system to effect asymmetric 1,6-addition of organozinc 
cuprate reagents to different five- and six-membered ring dienones to achieve regio- and 







In the recent past, the 1,4-asymmetric addition of Grignard reagents to aryl and 
heteroaryl-substituted acyclic dienones 50 has been reported
17
 where 
tetrakis(acetonitrile)copper(I) perchlorate and  the bidentate ferrocene-based ligand 52 
were used to acieve regio and enantioselectivities as high as 97%  ee (eq. 14).  











 as well as organocatalysts
23
 have also been used to catalyze 1,6-
conjugate addition to extended Michael acceptors. The 1,4-version of the organocatalysts 
has also been reported.
24
 Generally, copper and aluminum
25
 catalysts are used for transfer 
of alkyl-derived organometallics such as Grignard, organozinc, or organolithium reagents 
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in conjugate additions. However, for aryl and vinyl ligands, rhodium, iridium or 
palladium salts are catalysts of choice and may employ boronic acids in addition to other 
unreactive organometallics such as tin, silicon, zinc or titanium, indium, and zirconium as 
the transmetallating reagents. Whiles there are several reports on transition metal-
catalyzed additions of various nucleophiles to extended Michael acceptors, very few 
reports on that of the uncatalyzed addition of organomagnesium and organolithium 
reagents actually exist.  
 
Due to the high reactivity of the organolithium and Grignard reagents, in the absence of 
any transition metals, additions to activated dienes tend to either favor the 1,2-adduct or 
are rather regio- and stereo- unselective for most substrates. As as result, research 
attention skewed towards substrates that are resistant to 1,2-addition, such as dienamides, 
dienoates, and nitrodienes. Thus, Cooke and co-workers reported
26
 a successful 1,4-
addition of MeLi to diunsaturated acyl ylide substrate 53 followed by trapping with MeI, 
where the carbonyl carbon was deactivated by the neighboring ylide moiety (Scheme 
2.2). The uncatalyzed addition of Grignard and organolithium reagents to activated 
dienes tend to favor 1,4- over 1,6- if direct 1,2-addition is prevented. Later attention was 
directed at the use of chiral auxiliaries to control regio- and stereoselectivities of the 1,4-
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additions as this is one of the most reliable methods for obtaining enantiopure 
compounds.  
Scheme 2.2. Conjugate addition of MeLi to diunsaturated acyl ylide substrate 
 
The use of chiral auxiliary leads to diastereomers, allowing a clean separation of major 
products to afford compounds in very high optical purity, which is essential in large-scale 
pharmaceutical syntheses. Thus, Oppolzer and co-workers have reported
27
 regio- and 
stereoselective 1,4-addition of EtMgBr to (E,E)-2,4-hexadienoylsultam 56 to obtain good 
yield and 100% diastereoselectivity (Scheme 2.3). To explain the high regio- and 
diastereoselectivity, the authors proposed a cyclic transition state (i.e, 57) where the   
substrate is chelated to one equivalent of the Grignard reagent through the magnesium 
atom, forcing the SO2 and the carbonyl moiety in a syn-periplanar conformation while the 








Scheme 2.3. Conjugate addition of EtMgBr to (E,E)-2,4-hexadienoylsultam 
 
The chelation of another equivalent of Grignard reagent results in 1,4- attack of the 
nucleophile from the Si-face of the double bond in a six-membered transition state 
leading to product 59 after protonation and hydrolysis with LiOH in a THF-H2O mixture.  
Urabe and co-workers have in the recent past used the sugar-derived pyrrolidine-based 
chiral auxiliary 60 to effect selective 1,4-addition of α-substituted vinylmagnesium 
bromides 61 to dienoic acids (Scheme 2.4).
28
 The high 1,4-selectivity is induce by 
chelation of the magnesium to the carbonyl oxygen and that of the acetal during the 
transition state (i.e, 65) thus transferring the nucleophile to the β-carbon due to its 
proximity to form the 1,4-adduct. Moreover, the resulting magnesium enolate could be 
trapped with MeI to form the vicinal disubstituted product 62 in high yield and excellent 
syn-diastereoselectivity. Regio- and stereoselectivities of additions of organolithium 
reagents to (S,S)-(+)-pseudoephedrine-based chiral dienamide 66 have also been 
reported
29
 recently by Badía and co-workers where the high regio- and stereoselectivities 
were rationalized with a transition state in which the organolithium is bound to the 
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aminoalkoxide chain while the carbonyl oxygen and C-H bond α to the nitrogen lying in 
syn-s-cis conformation 69 (Scheme 2.5). The lithium alkoxide is the stereodirecting 
moiety that directs the incoming nucleophile to the Re-face of the β-sp
2
 carbon. 
On the other hand, reports on uncatalyzed addition of Grignard reagents to conjugated 
acyclic dienones and their thioldienoates analogues are very few to non existant. To the 
best of our knowledge, only two examples of uncatalyzed addition of Grignard reagents 
to conjugated acyclic dienones
1, 30
 exist in literature (eq. 1 & 2).  
 






Scheme 2.5. Addition of lithium reagents to (S,S)-(+)-pseudoephedrine-based chiral 
dienamide 
 
Recently, our laboratory reported
31a 
zinc-catalyzed 1,4-addition of Grignard reagents to 1-
nitrodienes 70 (eq. 15) where the zinc salts were discovered to be necessary to induce 
high regioselectivity. In our efforts to explore the reactions of extended Michael 
acceptors, we decided to apply these protocols to dienones and thioldienoates. Herein, we 
report our findings on transition-metal free (uncatalyzed) 1,4-additions of Grignard 









Previous work with 1-nitrodienes led us to begin our investigations with screening of zinc 
salts for the conjugate addition of alkyl Grignard reagents to the dienone 73a in diethyl 
ether at -20 
°
C. Addition of ethyl magnesium chloride to a mixture of 73a and catalytic 
amounts of anhydrous zinc bromide in diethyl ether at -20 
°
C gave an 85:15  mixture of 
the 1,4- 75aA and the 1,2-adducts 79aA, respectively (Table 2.1, entry 1). Not satisfied 
with the result, the salt was changed to zinc triflate and under the same reaction 
conditions a clean 1,4-adduct 75aA was obtained in excellent yield (Table 2.1, entry 2) 
with no trace of the 1,6- product 77aA. Surprisingly, the amount of the zinc salt could be 
reduced down to 0.5 mol% and still obained excellent 1,4- selectivity and very good yield 
(Table 2.1, entries 3, & 4) with no trace of the 1,2- or the 1,6- products. However, when 
the Grignard reagent was changed to n-butylmagnesium chloride, a modest 1,4- 
regioselectivity was obtained (Table 1, entry 5), with minor amount of the 1,6-adduct. At 
this point, we turned our attention to thioldienoates and with the same protocol excellent 
1,4-selectivities were observed (Table 2.1 entries 6, and 7), even though isolated yields 
were lower than those of the dienones.  
These results left us wondering if the zinc salt had any catalytic effect on the reaction and 
so we conducted a control reaction without any transition metal (zinc) salt. As was 
expected, ethylmagnesium bromide added cleanly to the dienone in diethyl ether at -20 
°
C 
to give excellent selectivity for the 1,4-adduct (75aA) just as it did with the zinc triflate ( 
Table 2.2, entry 1). n-Butyl and i-Propyl Grignard reagents all gave excellent 1,4-
selectiviies with some trace amounts of the 1,2- product (79aB) in the case of the n-butyl 
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Grignard (Table 2.2, entries 2, and 3) reagent. While cyclohexyl Grignard reagent also 
gave clean 1,4-addition product 75aE, the t-butyl Grignard reagent gave the 1,4- (75aD), 
1,6- (77aD), and the 1,2-addition (79aD) products in a ratio of 42:42:16 respectively 
(Table 2.2, entry 4).  
Table 2.1. Reaction of Alkyl Grignard Reagents with α,β,γ,δ-Unsaturated Carbonyl 












1 73a Et ZnBr
2
(0.1) 75aA, 79aA  85:0:15
c
 70-80 
2 73a Et Zn(OTf)
2
(0.1) 75aA 100:0:0 90 
3 73a Et Zn(OTf)
2
(0.01) 75aA 100:0:0 87 
4 73a Et Zn(OTf)
2





(0.01) 75aB, 77aB 87:13:0
d
 89 
6 74a Et Zn(OTf)
2
(0.1) 76aA 100:0:0 71 
7 74a Et Zn(OTf)
2
(0.01) 76aA 100:0:0 69 
       
 
a
All reactions were carried out in Et2O at -20 
°
C and quenched at rt. 
b
Yields of the 
product mixture determined from the combined mass of isolated products after flash 
chromatography. 
c
Product ratios were determined from the ratios of the heights of the 
signals of the olefinic carbons from each regioisomer in the 
13
C-NMR spectra at δ 125.2 
& 133.9 ppm for the 1,4-adduct and the average height of the peaks occurring at δ 128.0, 
128.9, 131.5, & 134.7 ppm for the 1,2-adduct. 
d
Product ratios were determined from the 




C-NMR spectra at δ 124.9 & 134.2 ppm for the 1,4-adduct and at δ 125. 4 & 133.8 ppm 
for the 1,6-adduct.  
 
To investigate the effect of solvents on selectivity, the reaction was conducted in 
dichloromethane, benzene, and THF but the regioselectivity did not show any significant 
change from that of those conducted in diethyl ether (Table 2.2, entries 6-8). During the 
addition however, the benzene froze at the reaction temperature (-20 
°
C) and so the 
Grignard reagent was just added to it and the solid was allowed to gradually melt while it 
warmed to room temperature over 12 hours. To explore the scope of the substrate for the 
reaction, the substituents on the carbonyl carbon (G) and that on the double bond (R) 
were varied. Thus, the addition of ethylmagnesium bromide to the n-hexyl- substituted 
substrate 73b gave 91:9 1,4- : 1,2-selectivity at -20 
°
C in 78% yield. However, when the 
reaction was conducted at room temperature, an improved 1,4-selectivity of  100:0 was 
obtained (Table 2.2, entry 9&11). 
The phenyl substituted substrates 73c, 81a, and 81b all gave excellent 1,4- addition 
without any trace of the 1,2- or the 1,6-adducts (Table 2.2, entries 12-18). These phenyl 
substituted substrates are solids and are not very soluble in diethyl ether at -20 
°
C, the 
temperature at which the reactions were carried out so the initial reactions were giving 
complex mixtures because of this insolubility. As a result, the substrates were added as 
dichloromethane solutions to a stirred solution of the Grignard reagents in diethyl ether 
and this gave clean crude products and improved yields. Besides -20 
°
C, these reactions 
also work well at room temperature. The diphenyl-substituted substrate 81c also gave 
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very high 1,4-selectivity with both alkyl and vinyl Grignard reagents (Table 2.2, entries 
20 & 21).  
The mode of addition of the Grignard reagents was also investigated to see if it had any 
effects on the chemo- and regioselectivity (Table 2.3). In the previous reactions, the 
Grignard reagents were added dropwise to stirring solutions of the dienones or the 
thioldienoates (reversed mode). In the normal mode of addition, the substrate in a 
solution of diethyl ether (or the other reaction solvents) was added dropwise to a stirred 
solution of the Grignard reagent in the flask (Table 2.3, entry 1). It was observed that, 
reversing the mode of addition did not have any observable effect on either the selectivity 






























1 73a Et Et2O -20 75aA 100:0:0 92 
2 73a 
n





Pr Et2O -20 75aC 100:0:0 79-84 
4 73a 
t




C6H11 Et2O -20 75aE 100:0:0 72-85 
6 73a Et CH2Cl2 -20 75aA 100:0:0 86 
7 73a Et PhH
e
 -20 75aA 100:0:0 83 
8 73a Et THF -20 75aA 100:0:0 80 




Bu Et2O  25 75bB 100:0:0 28-95 
11 73b 
i
Pr Et2O  25 75bC 100:0:0 81 
12 73c Et Et2O  25 75cA 100:0:0 91 
13 73c 
n
Bu Et2O -20 75cB 100:0:0 86 
14 73c 
i
Pr Et2O -20 75cC 100:0:0 92 
15 81b Et Et2O -20 82bA, 84bA 90:0:10
c
 86 
16 81a Et Et2O -20 82aA, 84aA 90:0:10
c
 94 
17 81a Et Et2O  0 82aA 100:0:0 95 
18 81a 
n
Bu Et2O -20 82aB 100:0:0 87 
19 81a 
i
Pr Et2O -20 82aC 100:0:0 82 
20 81c Et Et2O -20 82cA 100:0:0 64-90 
21 81c 2-
n




The substrate was added drop wise to a stirring solution of the Grignard reagent (normal 
addition) at -20 
°
C and allowed to warm to room temperature unless otherwise noted. 
b
Yields are based upon isolated products purified by column chromoatography.
 c
Ratio 
based on mass of isolated product from column chromatography. 
d
Ratios were 
determined from the heights of the 
13
CNMR signals of the tert-butyl groups occurring at 
δ 27.4 and 27.3 ppm for the 1,4-, and 1,6- adducts respectively-the 1,2-aduct was not 
formed when the reaction was done in CH2Cl2 (1,4- : 1,6- 63:37). 
 e
The PhH with the 
starting material froze at the initial reaction temperature (-20 
°
C). The Grignard reagent 
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was thus added to the solid and the mixture allowed to warm up to room temperature. 
The Grignard reagent was added to the solid and the mixture allowed to warm up to room 
temperature. 
f
Ratios were determined from  the average heights of the signals of the 
olefinic carbons in the 
13
CNMR spectrum occurring at δ 125.5 & 133.7 ppm for the 1,4-
adduct, and the average height of the peaks at δ 128.1, 128.2, 131.1 & 136.5 ppm for the 
1,2-adduct.  
  
Table 1.3. Mode of Addition of Grignard Reagents and Substrates. 
 
 






1 Normal Et2O 100:0 75 
2 Reverse Et2O 100:0 90 
3 Normal Et2O 98:2 80-90 
4 Reverse THF 100:0 90 
5 Normal THF 100:0 92 
Normal mode: the solution of the substrate in the reaction solvent was added drop wise 
to a stirring solution of the Grignard reagent in the flask. 
Reverse mode: Grignard reagent was added dropwise to a stirred solution of the starting 
material in the flask. 
 
Having successfully transferred alkyl and vinyl ligands, we set our sight on transferring 
aryl Grignard reagents to these Michael acceptors. The reaction of substrate 73a with 
phenyl magnesium chloride (85Aa) in diethyl ether gave at best a 1:1 mixture of the 1,2-, 
and the 1,4- adducts (Table 2.4, entry 1) even after trying different solvents, and 
temperatures. However, in the presence of 3 equivalents of HMPA at room temperature 
an 88:12 mixture of the 1,4-, and 1,2- adducts was obtained, respectively (Table 2.4, 
entry 2). On the other, 1-naphthyl and 2-(N-methylpyrrolyl) Grignard reagents (i.e, 85Ba 
& 85Ca) transferred cleanly in a 1,4- fashion and in good yields without the need for any 
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additives (Table 2.4, entries 3-4). The addition of p-(N,N-dimethylanilinyl) Grignard 
reagent 85Da gave an improved 1,4-selectivity over that of the phenyl magnesium 
Grignard reagent (Table 2.4, entry 5) with excellent yield. 














1 85Aa (1.2) ---- Et2O  25 51:49
b 77 
2 85Aa (1.2) HMPA(3.0) Et2O  25 88:12
c 88 
3 85Ba (1.2) --- Et2O  25 100:0 75 
4 85Ca (1.2) --- Et2O -20 100:0 66-85 
5 85Da (1.2) --- Et2O
d  25 65:35e 90 
6 85Ea (1.2)f TMEDA(1.2) Et2O  0 36:64
g 70 
7 85Ea (1.2) f TMEDA(1.2) Et2O
h  25 24:76g 86 
8 85Ea (1.2) f TMEDA(1.2) Et2O
i  25 23:77g 88 




 --- Et2O  25 50:50
g 94 
11 85Ea (1.3)f HMPA(3.0) Et2O  25 20:80
g 76 
12 85Ea (1.3) f HMPA(3.0 Et2O  25 0:100 73 
13 85Eb  (1.2) TMEDA(1.2) Et2O -20 0:100 90 
14 85Fa (1.2)
l
  TMEDA(1.2) Et2O
m  25 26:74n 78 
15 85Fa (1.2)
 l





Yields are based upon combined mass of isolated products after flash chromatography.
 
b
Product ratios were determined from the equivalent carbons in the phenyl rings 
occurring at δ 127.4005 & 128.3543 for the 1,4-adduct, and at δ 125.5 and 128.0 ppm for 
the 1,2-adduct.
 c
Product ratio was determined from the mass of isolated products from 
flash chromatography. 
d
A solvent mixture of Et2O:THF (4:5) was employed.
 e
Ratios 
determined from the equivalent carbons in the phenyl rings occurring at δ 128.0 & 112.9 
ppm for the 1,4-adduct, and at δ 126.4 and 112.1 ppm for the 1,2-adduct. 
f
The Grignard 
reagent was generated from 2-lithiothiophene (1.2 equiv.) and MgBr2 (1.2 equiv.) in 
Et2O. 
 g
Product ratios were determined from the heights of the absorption peaks at d 
151.3 and 148.0 ppm in the 
13
C-NMR spectra corresponding to the quaternary carbons in 
the 2-thienyl moieties of the 1,2- and 1,4-additon products, respectively, as distinguished 
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with DEPT-45 experiments. 
h
A solvent mixture of Et2O:THF:CH2Cl2 (1:2:4) was used. 
 
i
A solvent mixture of  Et2O:THF (2:1) was used. 
 j
The Grignard reagent was generated 
from 2-lithiothiophene (1.4 equiv.) and MgBr2 (1.6 equiv.) in Et2O.
  k
The 2-thienyl 
magnesium bromide was generated by reductive metallation with of 2-bromothiophene 
with activated magnesium turnings in Et2O. 
 l
The Grignard reagent was generated from 2-
lithiofuran (1.2 equiv.) and MgBr2 (1.2 equiv.) in Et2O.  
m
A solvent mixture of 




were determined from the heights of the 
absorption peaks at δ 158.0 &156.8 ppm in the 
13
C-NMR spectra corresponding to the 
quaternary carbons in the 2-furyl moieties of the 1,2- and 1,4-adducts respectively. 
 
The addition of 2-thienyl magnesium bromide (85Ea), a heteroaryl Grignard reagent, 
resulted in a 36:64-selectivity in favor of the 1,2-adduct (Table 2.4, entry 6). The use of 
solvent mixtures and elevated temperature resulted in a slight decrease in the selectivity 
of the 1,4-adduct (Table 2.4, entries 7-8). When the amount of the magnesium bromide 
used was increased to 1.6 equivalents, a roughly 1:1 ratio of the 1,2- vs 1,4- adducts was 
observed (Table 2.4, entry 9) with excellent yield. This observation prompted us to reason 
that the presence of lithium ion from the transmetallation procedure for making the 
Grignard reagents might be playing a role in the 1,2- selectivity. We therefore prepared 
the 2-thienylmagnesium bromide from direct magnesiation of 2-bromothiophene in 
diethyl ether at room temperature. However, the addition of this lithium free Grignard 
reagent (i.e., 85Ea) resulted in selectivities (Table 2.4, entry 10) not significantly different 
from those obtained with the transmetallation procedures. When the organometallic was 
switched to the lithium reagent 85bE, only the 1,2-adduct was obtained in excellent yield 
(Table 2.4, entry 13). The furyl Grignard reagents gave similar results to that obtained 
with the thiophene Grignard reagents (Table 2.4, entries 14-15). 
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 Our attempts to transfer alkynyl ligands to the dienones in a 1,4- fashion was not 
successful. The hexynylmagnesium bromide was first prepared by transmetallation from 
hexynyllithium and MgBr2·OEt2 complex in diethyl ether and the substrate added drop 
wise to it at -20 
°
C to obtain the 1,2-product  89a (Table 2.5, entry 1). To verify the 
influence of the lithium ion on the 1,2-selectivity, a lithium free Grignard reagent was 
prepared by refluxing 1-hexyne in diethyl ether solution of ethylmagnesium bromide for 
6 hours before it was cooled to 0 
°
C or room temperature and then added diethyl ether 
solution of the substrate drop wise to it (Table 2.5, entries 2-3). Both of these gave only 
the 1,2-adduct even after running the reaction in THF (Table 2.5, entry 4). When the 
reaction was conducted with catalytic amounts of Zn(OTf)2 in different solvents and 
temperatures, a clean sample of crude product showed that only the 1,2- adduct was 
obtained with good to excellent yields and none of the reaction runs showed even a trace 










Table 5. Grignard Reagents Effecting 1,2-Additions to Dienone 73a 
 






product yield a 
(%) 
1 88aA (1.0)b TMEDA (1.0) Et2O -20 89a 90 
2 88aA (1.0)
c
 -- Et2O  0 89a 89 
3 88aA (1.1)
c
 -- Et2O -20 89a 88 
4 88aA (1.1)
c,d
 -- THF  0 89a 85 
5 88aA (1.1)
c,e
  Zn(OTf)2(0.1) Et2O -20 89a 91 
6 88aA (1.1)
c,e
 Zn(OTf)2(0.1) Et2O -20 89a 85 
7 88aA (1.1)
 c,e
 Zn(OTf)2(0.1) CH2Cl2  0 89a 73 
8 88bA (1.1) HMPA (3.0) Et2O  0 89b 81 
9 88bA (1.2) -- CH2Cl2  0 89b 71 
10 88bA (1.2) -- THF  0 89b 82 
11 88bA (1.2) -- 
t
BuOMe  0 89b 75 
12 88bB (1.2) HMPA (3.5) Et2O/THF
f   0 89b 70 
13 88bB (1.2) -- Et2O  0 89b 62 
14 88cA (1.2) -- THF -20 89c 74 
15 88dA (1.2) -- Et2O -20 89d 88 
 
a
Yields were determined based upon isolated products purified by column 
chromatography.
 b







hexyne (1.0 equiv.) and EtMgBr (1.1 equiv.) by heating at reflux for 6 hours.  
d
Starting 
material was present in 10% as determined by the ratio of the average absorption peak 
heights of the olefinic carbons in the 
13
C-NMR spectra of the starting material at 125.8, 
130.3, 140.1, & 142.7 to that of the product at 129.9, 130.5 (2- carbons), & 133.2. 
e
Grignard reagent was added dropwise to a stirred mixture of the diene 73a and Zn(OTf)2 
in the solvent at the temperature indicated (general procedure A). 
f
The Et2O/THF were in 
the ratio of (4:1). 
 
 
Methyl Grignard reagent also gave only the 1,2-adduct 89b in diethyl ether with 3.0 
equiv. of HMPA (Table 2.5, entry 8). Changing the reaction solvent to dichloromethane, 
THF, and methyl 
t
butoxy ether did not change the selectivity (Table 2.5, entries 9-11). 
The use of methyllithium with and without HMPA still gave only the 1,2-adduct (Table 
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2.5, entries 12-13). 
t
Butoxy acetyl magnesium bromide prepared from α-lithiation of 
t
butyl acetate with LDA and transmetallation with MgBr·OEt2 complex gave only the 
1,2-adduct 89c as well (Table 5, entry 14). Allyl Grignard reagent (1.2 equiv.) (88dA) 
also gave only the 1,2-adduct 89d at -20 
°
C in diethyl ether (Table 2.5, entry 15).   





 were briefly examined to probe the effect of 
structural variations in the substrate. Significantly, dienone 90 with a transoid 
arrangement of the ketone and the ,-alkene moieties gave only the 1,2-addition product 
91a upon reaction with EtMgCl (Table 2.6). The addition of 
n
butyl and cyclohexyl 
Grignard reagents also gave only the corresponding 1,2-addition alcohols 91b and 91c, 
respectively. All these alcohols were found to be very unstable in chloroform and they 
quickly dehydrated in the CDCl3 that was being used to run their NMR spectra. As a 




C-NMR of these alcohols were run in C6D6. Dienone 92 
containing a cisoid ,-enone arrangement gave a  mixture of the 1,4-, 1,2- and the 1,6-
addition products 93, 94 and 95 (Table 2.7) respectively in both Et2O and CH2Cl2. The 
1,6-product predominate in Et2O while it was in equal amounts with the 1,2-adduct in 
CH2Cl2. 
The coupling product 96 was obtained as a byproduct when sub-stoichiometric amount of 
cyclohexyl magnesium bromide was added to the dienone 73a, in THF at -20 
°
C. It is the 
result of 1,4-addition of the cyclohexyl Grignard reagent to 73a followed by coupling of 
the intermediate enolate with the starting dienone in the solution (eq. 16).  
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Table 2.6. Addition of Alkyl Grignard Reagents to Monocyclic Dienone 90  
 
a
Yields are based on weight of isolated products from flash chromatography. Product 
quickly undergoes dehydration in CDCl3. 




After these results we turned our attention to the thioldienoates, which are known to have 
similar electronic characteristics with dienones but with reluctant carbonyl carbon 
reactivity toward carbon nucleophiles compared to that of dienones. The treatment of the 
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propyl 2,4-hexadienthioate 97 with ethylmagnesium bromide in Et2O at -20 
o
C resulted in 
a clean 1,4-adduct 98a with good yield (Table 2.8, entry 1). 
n
Butyl and 
isopropylmagnesium bromides gave similar selectivity in high yields (Table 2.8, entry 2-
3). Changing the propyl thiolester to 
t
butyl thiolester 74a did not have any significant 
effect on the selectivity and yield of the reaction (Table 2.8, entries 4-6). Cyclohexyl 
Grignard reagent also gave exlusive 1,4-adduct 99d with the % yield ranging from 
modest to very high (Table 2.8, entry 7). 
t
Butyl magnesium bromide on the other hand 
gave a 80:20 mixture of the 1,4- (i.e, 99e) and the 1,6- adduct (i.e, 101e) in an 80:20  
ratio, respectively (Table 2.8, entry 8) albeit in poor yield. With substrate 97 in Et2O, a 
decreased regioselectivity was obtained but changing the solvent to CH2Cl2 gave a clean 
crude product with improved regioselectivity and increased % yield (Table 2.8, entry 10). 
This is the only ligand that gave 1,6-product and this pattern of selectivity was also 
observed when it was reacted with the dienones (vide supra). Benzyl Grignard reagent 
gave excellent 1,4-selectivities and high yields to both substrates 97 and 74a (Table 8, 
entries 11-12). 1-(2,6-Dichlorobenzyl)magnesium bromide gave a clean 1,4-adduct in 
modest to very high yields (Table 2.8, entry 13). However, addition of allyl, and 
t
butoxyacetyl Grignard reagents to 97 & 74a respectively gave only the starting material 
in each case (Table 2.8, entries 14 & 15) even though the enolate added 1,2- to the 
dienones (vide supra). Both aryl and heteroaryl Grignard reagents added cleanly to either 
97 or 74a in a 1,4-fashion and in good yields (Table 2.8, entries 16-25). The reactions 
were run at room temperature if the Grignard reagents precipitated at low temperatures in 
Et2O. The use of CH2Cl2 as solvent aided with the solubility of the Grignard reagents at 
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low temperatures such as -20 to 0 
°
C. THF was never used alone as a solvent for these 
thioldienoates because it resulted in degradation of the thiolester leading to decrease 
yields. Therefore, whenever THF was required in the preparation of any reagent, an equal 
amount of Et2O was used as co-solvent in the reaction to minimize its effect on product 
yields. Heteroaryls such as 2-thienyl-, 2-furyl-, and 2-(N-methylpyrrolyl)- Grignard 
reagents all transferred with excellent 1,4-selectivities and high yields (Table 8, entries 
22, 24 &25). Also, haloheteroaryl Grignard reagent (2-[5-bromothienyl] magnesium 
bromide) was prepared and transferred smoothly to give 1,4-adduct 99p in high % yield 
and excellent regioselectivity (Table 2.8, entry 23).  
On the other hand the 5-(N-methylindolyl) ligand was very difficult to transfer probably 
due to difficulty in its preparation. After several attempts failed, halogen-metal exchange 
was done with 
n
butyl lithium and 5-iodo-N-methylindole followed by transmetallation 
with MgBr2·OEt2 complex via stirring at room temperature for 2 hours before being used 
for the reaction to give the 1,4-adduct 99n (Table 2.8, entry 21). To explore the scope of 
the starting material, phenyl substituted 2E, 4E-thioldienoate, 102 as well as the 2Z, 4E-
isomer 104 were synthesized and evaluated. The additions of the ethyl- and 
n
butyl 
Grignard reagents to the 2E, 4E-isomer gave clean 1,4-adducts 103a-c in good yields (eq. 
17) but the 
i
propyl Grignard reagent always gave 1,4-adduct with some degraded 























1 97 Et Et2O -20 98a 100:0 68-80 
2 97 
n
Bu Et2O -20 98b 100:0 74 
3 97 
i
Pr Et2O -20 98c 100:0 84 
4
 b
 74a Et Et2O -20 99a 100:0 70 
5 74a 
n
Bu Et2O -20 99b 100:0 67 
6 74a 
i
Pr Et2O -20 99c 100:0 66 
7 74a Cyclohexyl
 
Et2O -20 99d 100:0 55-87 
8 74a 
t
















Et2O  25 99f 100:0 71-86 
12 97 Bn Et2O  25 98f 100:0 86 
13 74a 1-(2,6-dichlorobenzyl) Et2O  25 99g 100:0 51-86 
14 97 Allyl Et2O -20 SM     -- -- 
15 74a 
t
BuOCOCH2 Et2O  25 SM     -- -- 
16 74a Ph Et2O -20 99j 100:0 95 
17
 b
 97 Ph Et2O -20 98j 100:0 90 
18 74a 4-MeOPh CH2Cl2 -20 99k 100:0 82 
19 74a p-Me2NC6H4 Et2O/THF
e
   25 99l 100:0 76-88 
20 74a 1-Naphthyl Et2O  25 99m 100:0 82 
21 74a 5-(N-Methylindolyl) Et2O  25 99n 100:0 73-91 
22 97 2-thienyl Et2O  25 98o 100:0 66 
23 74a 2-[5-bromothienyl] Et2O -20 99p 100:0 51-84 
24 97 2-furyl Et2O  25 98q 100:0 60 
25 74a 2-(N-methylpyrrolyl) Et2O  0 99r 100:0 63 
SM = starting material 
a
Product yields are based upon isolated products purified by column chromatography 
unless otherwise noted. 
b
The Grignard reagent was added dropwise to the substrate 
(general procedure C). 
c
The product distribution was determined from the ratio of the 
average heights of the absorption peaks of the olefinic carbons for the 1,4-adduct at 121.0 
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&138.9 and that of the 1,6-adduct at 127.2 & 129.9 in the 
13
C-NMR spectrum of the 
mixture. 
d
Ratios were determined from the heights of the absorption peaks of the tert-
butyl carbons at δ 27.5 and 27.4 in the 
13
C-NMR spectrum corresponding to the 1,6- and 
1,4- adducts respectively. 
e




The cisoid dienyl thiol ester, 2Z, 4E-isomer 104 similarly underwent exclusive to 1,4-
addition of ethyl magnesium bromide to give 103a cleanly as a crude material albeit in 
modest chemical yield (58%, eq. 18). In a control experiment, an addition of 0.5 
equivalent of EtMgCl to the cisoid isomer 104 gave a mixture of the the cisoid isomer 
104, 1,4-adduct 103a, and the transoid isomer 102, in an NMR ratio of 44:33:22 
respectively (eq. 19). This suggests that isomerization of the cisoid to the transoid dienyl 
thiol ester isomer is possible under this reaction condition. The propyl cinnamyl 
thiolester, 105 prepard by couping of cinnamic acid and propanethiol, also underwent 
clean 1,4-addition when treated with ethyl magnesium chloride to give 106 in excellent 





The lack of 1,4-selectivity in the addition of aryl Grignard reagents to the dienones led us 
to examine the possibility of executing a one-pot tandem 1,4-conjugate addition-
nucleophilic acyl substitution sequence to afford the -substituted enones from the 














 product Yield(%) 
1 Et 
i
Pr 75aC   71 
2 Et 
n
Bu 107   76 
3 1-naphthyl 
n
Bu 108   73 
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The reaction of thiol ester 97 with ethyl or naphthyl Grignard reagents and then 
quenching the resulting enolate with 1.0 equivalents of trifluoroacetic acid to form the 
intermediates 98a and 98m were followed by addition of magnesium cuprates to afford 
the ketones 75aC and 107-108 in modest yields of 71-76% (Table 2.9) suggesting that a 
wide range of alkyl, aryl, and heteroaryl Grignard reagents can be employed in similar 
reactions. The copper-mediated acylsubstitution step was problematic initially as aged 
Grignard reagents did not afford the expected product. However, when a newly opened 
commercially available Grignard reagent was used the desired product was obtained in 
good yield. Clearly, the more reactive lithium centered cuprates could be used, although 
the use of Grignard reagents provides for the possibility of using catalytic quantities of 
Cu(I) salts in the nucleophilic acyl substitution reaction. 
 
The mixed results from the addition of aryl Grignard reagents to the dienones and the 
thiol dienoates lead us to believe a radical reaction pathway could be oprating in the 
conjugate addition of the Grignard reagents to these substrates. However, the reaction of 
dienyl thiol ester 97 with 
t
BuMgCl in the presence of radical traps (i.e., 1,3-
cyclohexadiene, 109 or 1,4-cyclohexadiene, 110)
32a
 gave 98e and 100e cleanly with no 
products arising from addition of 
t
Bu radicals to the diene traps (eq. 21) although the 
experiment with radical trap 110 did show trace amount of benzene by GC-MS analysis 
but because the benezene was also present in the commercial sample that was used. 
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Hence, it could not be ascertained that the benzene was the product of radical trapping. In 
a control experiment, we sought to understand if a long aliphatic chain had any influence 
on the regioselectivity of the 
t
butyl Grignard reagent addition to the dienones. Addition of 
tbutylmagnesium chloride to dienone 73b gave a mixture arising from the 1,2-, 1,4-, and 
1,6-addition of the Grignard reagent in an NMR ratio of 16:53:31 % respectively (eq. 22). 
The 1,4-, and the 1,6-adducts are non-separable and move as a single spot on TLC plate 




 Extensive studies have established that Grignard reagents react by single electron 
transfer mechanisms (SET)
32b
 for easily reduced substrates (e.g., benzophenone, 
azobenzenes) and by polar mechanisms (i.e., carbanions) with substrates that are difficult 
to reduce (e.g., acetone, carbon dioxide), although the latter pathway cannot be 
distinguished from SET pathways involving a “tight” or closely associated radical/radical 
anion pair.
33
 The addition of Grignard reagents to ,-unsaturated ketones frequently 
gives mixtures of products arising from 1,4- and 1,2-addition reactions.
34
 Presently, a 
single kinetic study indicates that the 1,4-addition reaction proceeds via a radical-
mediated pathway for alkyl Grignard reagents and a concerted pathway for PhMgX.
35
 
Consistent with this hypothesis, DFT/M06 and generalized valence bond (GVB) wave 
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function calculations suggest that radical and anionic species (e.g., R, R
–
, MgX and 
RMgX2
–
) are present in solutions of Grignard reagents in addition to the neutral species 
depicted in the Schlenk equilibrium.
36
 
The propensity of radical pathways should reflect the reducing capacity of the 
Grignard reagent and the reduction potentials (i.e., ease of being reduced) of the ,-
unsaturated substrate.
37









 vs. the standard hydrogen electrode (SHE), and pseudo 
first-order rate constants and percent 1,4-addition relative to the total yield for both 1,4- 
and 1,2-addition have been reported for substrates Ab, Bb, and C-D (Figure 5).
35
 
Reduction potentials (i.e., E1/2) vs. the saturated calomel electrode (SCE)  have been 
reported for Aa, Ba, and C-D (Figure 5).
37
 A plot of relative % 1,4-addition vs. E 
(Figure 5A)
38
 shows a correlation coefficient of r = -0.63, while the plot of % 1,4-
addition vs. E1/2 (Figure 5B) shows a correlation coefficient of r = 0.61, which are fairly 
strong correlations and particularly so when considering that the Grignard reagents likely 
to involve a carbanion mechanism are also included in the plot (i.e., PhMgX and 
MeMgX). It should be noted that correlation of E1/2 is nearly the same as E and 
consequently the correlation with E1/2 (single property of substrate) has more explanatory 
power than E (two properties involving substrate and Grignard reagent, Occam’s razor). 
Stabilization energies
33, 39
 for the alkyl radicals derived from the Grignard reagents have 
also been reported and a plot (Figure 5C) of relative % 1,4-addition vs. radical 
stabilization energies (i.e., SE
o
) yields a correlation coefficient of r = 0.42, which is 
121 
 
weaker than either the E or E1/2 plots. The plot of relative % 1,4-addition vs. the 
HOMO-LUMO gap (Figure 6)
37, 40
 shows a good correlation (r = -0.66) with both 
literature and in house calculations done at the B3LYP/6-311g(d,p) level. 
 It is expected that the E, E1/2 and LUMO-HOMO gap plots would correlate, 
since in the molecular orbital model oxidation involves removing an electron from the 
HOMO orbital and reduction involves adding an electron to the LUMO orbital. This is 
consistent with reports that reactions of C, S, N, and O-magnesium nucleophiles with 
aromatic carbonyl and nitro compounds correlate with E.
41
 For the aromatic carbonyl 
and nitro compounds, reactant pairs with E < 2.2 V gave large amounts of radical 
derived products while pairs with E between 2.2-2.8 V show normal polar derived 
products (>65%) and minor amounts of radical derived products (<28%). Examination of 
Figure 5A reveals that pairs of Grignard reagents and substrates with a E  1.6 V are 
more likely to undergo 1,4-addition (60%) than those above E = 1.6 V (10%) and this is 
statistically significant at the level of p = 6x10
-5
 (i.e., the probability that the result arises 
from random chance or statistical noise). The tendency for 1,4-addition appears more 
dependent upon the reduction potential of the substrate than with the energy difference 
between the oxidation and reduction potentials (i.e., E = Eox – E1/2 (red)) of the 
Grignard/enone (enoate) couple (Figure 5). Alkyl substituted ,-enoates (e.g., Aa, E1/2 = 
-2.33 V) do not undergo 1,4-conjugate addition with Grignard reagents even when the E 
values of the substrate/Grignard couple are similar to the enone (E1/2 = -2.08 V for 
Ba)/Grignard couples (i.e., E = 2.33-1.26 V for the enoate vs. E = 2.08-1.01 V for the 
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enone) where the enones do undergo significant 1,4-conjugate addition. The E1/2 of the 
substrate thus appears to be the principal driving force for these Grignard-mediated 
conjugate addition reactions and additional conjugation found in the dienyl ketones and 
thiol esters should lower the E1/2 potentials. This also appears to be the case for ,-
alkenyl thiol ester 105 (eq. 19). Although we do not have values for these substrates, the 
E1/2 potential for 2,6-bis(3-phenyl-2-propen-1-ylidene)cyclohexanone derivatives range 
between -1.03 and -1.46 V, depending upon the substituent on the aromatic rings (e.g., 
NO2 < H < OMe).
42
 
                           
A. E = Eo (SHE) – E1/2 (SCE) 
 







































E  =  Eo - E1/2 
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B. E1/2 vs. SCE 
                  
 
 
C. SEo for R [R = Ph, Me, HCC, Et, iPr, tBu) 
 
Figure 2. 5. A. Plot (r = -0.63) of % 1,4-addition product (relative to 
total yield) vs. E of Eo (Grignard reagent) and E1/2 (reduction 



















































































Bu-). B: Plot (r = 0.61) of % 1,4-addition 
product vs. E1/2 (reduction potential) of substrates A-D. C: Plot (r = 





 in kcal/mol. 
                                      
 
        
 Figure 2.6. Plot (r = -0.66) of % 1,4-addition product (relative to 
total yield) vs. HOMO-LUMO gap energies in e.v.  
 
If radical species are involved in 1,4-conjugate addition, the extent of the reaction 




























E e.v. (ELUMO - EHOMO) 
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poorest correlation. In the present study, MeMgCl (-1.67 kcal/mole for Me), and 
C4H9CCMgCl (-15.57 kcal/mol for HCC) display negative stabilization energies
39
 and 
all undergo chemoselective 1,2-addition reactions with dienone 73a (Table 5), while 
PhMgCl (-10.27 kcal/mole) affords a 1:1 mixture of 1,4:1:2-addition products that can be 
enhanced to an 88:12 ratio favoring 1,4-addition in the presence of 3.0 equivalents of 
HMPA. The addition of HMPA, however, significantly increases the amount of 1,2-
addition products for 2-thienylmagnesum chlorides (Table 5, entry 12). HMPA should 
favor the carbanion pathway by dissociation of the organometallic reagent favoring 
SSIPs
43
 but can also lower the reduction potential of substrates
44
 and its role is unclear 
from these opposing results with phenyl and thienyl Grignard reagents. Calculations also 
suggest that a radical-mediated pathway can arise from steric interactions (e.g., 
t
BuMgX) 
where the C-Mg bond is stretched leading to a R and allyl radical anion (i.e., C-C=C-
OMgX) species that can recombine to form the 1,2- 1,4- and/or 1,6-addition products. 
The formation of the 1,4- and 1,2-addition products can arise from combination within 
the cage, while the 1,6-addition product is a secondary cage product arising from more 
stable R radicals with longer life times.
35
 Significantly, the highest amounts of 1,6-
addition (i.e., 42%, Table 2, entry 4) were obtained by reaction of 
t
BuMgCl with dienone 
73a where a sterically hindered, stable, and long-lived 
t
Bu has time to react at the more 
distant δ-carbon center.  
If the caged R/allyl radical anion pair can combine to form either 1,4- or 1,2-
addition products, why does the former generally predominate? The CH3OCH2 radical is 
126 
 
more stabilized (i.e., SE
o
 = 3.64 kcal/mole) than CH3CH2 (2.11 kcal/mole)
39
 suggesting 
that in the allyl radical anion there is more radical character on the oxymagnesium 
substituted carbon than on the alkenyl substituted carbon (i.e., CH=C-C()-OMgX is a 
more important resonance contributor than CH-C=C-OMgX) indicating a preference for 
1,2-addition. However, the geometry of the transition state and steric hindrance around 
the oxymagnesium substituted carbon atom may not be optimal for 1,2-addition thereby 
favoring formation of the 1,4-addition product.
33
 This influence of steric hindrance in 
substrate and reagent on 1,2-:1,4-:1,6-additions has been observed in the reactions of 
Grignard reagents with substituted benzophenones where radical pathways have been 
invoked.
32, 33
 Significantly, allyl magnesium chloride with anticipated minimal steric 
hindrance affords exclusively the 1,2-addition product with dienone 73a (Table 5, entry 
15). 
 The aryl and heteroaryl Grignard reagents gave mixtures of 1,4- and 1,2-addition 
products with dienone 73a. PhMgCl (SE
o
 = -10.27 kcal/mol) affords a 1:1 mixture of 1,4-
:1:2-addition products that can be enhanced to an 88:12 ratio favoring 1,4-addition in the 
presence of 3.0 equivalents of HMPA, while the p-dimethylanilino reagent gave a 2:1 
ratio of 1,4:1,2-addition products where an electron donating group (EDG) should 
stabilize a radical center but also increase nucleophilicity of a carbanion. The heteroaryl 
Grignard reagents, 2-thienyl- and 2-furylmagnesium chlorides, give mixtures largely 
favoring the 1,2-addition product in ratios of 3:1-1:1 depending upon reaction conditions 
(Table 4), while 1-naphthylmagnesium chloride and 2-(N-methylpyrrolyl)magnesium 
chloride give exclusive 1,4-conjugate addition (Table 4). A radical stability order of 
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phenyl > 2-pyrrolyl > thienyl > 2-furyl is predicted based upon C-H bond dissociation 
energies (i.e., 99, 112.3, 118, and 120 kcal/mole),
45
 although the 1:4:1,2-product ratio 
may more likely reflect orientation for C-C bond formation about the substrate C-atom 
bearing the oxy(chloro)magnesium substituent. In this case, the more bulky 1-
naphthylmagnesium chloride and 2-(N-methylpyrrolyl)magnesium chloride give 
exclusive 1,4-addition, while the less bulky phenyl, 2-thienyl, and 2-furyl Grignard 
reagents give largely 1,2-addition. 
 There is evidence that the alkylmagnesium-ketone carbonyl complex is less 
reactive toward 1,2-addition in the carbanion pathway than the free ketone, while the 
reverse is true for arylmagnesium-ketone complexes. In this scenario, alkylmagnesium 
complexes 111 (Scheme 6, R = alkyl) would exhibit a reduced rate for the carbanion 1,2-
addition pathway thereby favoring the 1,4-addition pathway, while the aryl- (i.e, 111 R = 
aryl) and heteroaryl (i.e., 111 R = heteroaryl) magnesium complexes would show rate 
acceleration for the carbanion 1,2-addition pathway consistent with the observed variable 
1,4:1,2-product ratios (Table 2) often favoring the 1,2-addition pathway (e.g., with 
phenyl, 2-thienyl, and 2-furyl Grignard reagents). A plausible mechanistic scenario is 
depicted in Scheme 2.6.
46
 Grignard-dienyl carbonyl complex 111 either leads to products 
via a polar (i.e., carbanionic character) pathway, develops radical character through 
stretching of the R-Mg bond (i.e., 112) with sterically hindered R-groups or affords 
through single electron transfer (SET) a caged R/allyl radical anion pair 113. In 
principle, all three pathways could afford the 1,2-, 1,4-, and/or 1,6-addition products if a 
solvent-separated Grignard/dienyl carbonyl substrate is included for the polar 1,6-
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addition. Radical pair 113 can combine most easily to form the 1,2- or 1,4-addition 
products and seems in general to favor the 1,4-addition pathway, while the 1,6-product 
can arise as a secondary cage product.
33
 This observation is plausibly rationalized by 
arguing that the transition state (TS) geometry required for 1,4-product formation is 
easier to achieve than the TS-geometry required for 1,2-product formation.
33
 This 
argument is consistent with the greater amounts of 1,2-addition product seen with the 
phenyl, 2-thienyl, 2-furyl and allyl Grignard reagents, while the 1-naphthyl and 2-(N-
methylpyrrolyl) Grignard reagents give exclusively the 1,4-addition products and the p-
dimethylaminophenyl Grignard reagent gives predominantly the 1,4-addition product. 
Radical couplings are generally less sensitive to steric interactions so the crucial factor is 
not the steric bulk around the coupling center as it is the proper alignment or orientation 
geometry for the two radical centers to combine. The 
t
BuMgCl reagent gives more 1,2-
addition product than does the 
n
BuMgCl reagent with dienone 73a (16% vs. 0%) 
suggesting that the greater conformational mobility of the n-butyl group is more 
problematic for achieving the proper geometry in the TS leading to the 1,2-addition 
product, while simple steric bulk about the reactive center appears to account for the fact 
that 
t
BuMgCl gives more 1,6-addition product with the n-propyl thiol ester than with the 
t-butyl thiol ester (31% vs. 20%). The 1,6-addition product is rarely seen and then only 
with stable long lived R species or R-groups that have little conformational mobility 
(e.g., R = Et). The inability to observed radical trap products with 1,3- or 1,4-
cyclohexadiene suggests that if radicals are involved these coupling reactions are 




Scheme 2.6. Plausible mechanism of conjugate addition of Grignard reagents to 
dienones 




Current reports on uncatalyzed (transition-metal free) addition of Grignard reagents to 
dienones and thioldienoates are very limited. Although ,-dienyl Michael acceptors can 
in principle react with Grignard reagents via 1,2-, 1,4-, or 1,6-addition pathways, ,–
,unsaturated ketones display remarkable 1,4-regio- and chemoselectivity in their 
reactions with sterically unhindered alkyl Grignard reagents, while aryl and heteroaryl 
Grignard reagents give mixed results. PhMgCl and p-dimethylaminophenyl magnesium 
bromide give slight to modest 1,4-regioselectivity depending upon reaction conditions, 
while the 1-naphthyl and 2-(N-methylpyrrolyl) Grignard reagents give exclusive 1,4-
addition. The heteroaryl Grignard reagents range from 1:1 to 1:2 in 1,2:1,4-
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regioselectivity, while the 2-furyl reagent affords a 1:2 ratio of 1,4- to 1,2-addition 
products. MeMgCl, allyl magnesium chloride and magnesium ester enolates all give 
tertiary alcohols exclusively via 1,2-addition pathways. 
 While ,–,unsaturated thiol esters display similar reactivity profiles, they 
exhibit broader 1,4-regio- and chemoselectivity. With the exception of 
t
BuMgCl, the ,-
dienyl thiol esters give exclusively 1,4-conjugate addition with alkyl-, aryl-, and 
heteroaryl Grignard reagents. These substrates can be induced to undergo a one-pot 
reaction sequence of 1,4-conjugate addition, enolate protonation, and nucleophilic acyl 
substitution to afford -substituted ketones. The extraordinary 1,4-regio- and 
chemoselectivity observed in these reactions is attributed to radical or radical-like 
pathways or transition states and the observed regioselectivity shows modest correlation 
with E = Eo (RMgX) – E1/2 (dienyl substrate), E1/2 (dienyl substrate), radical stability 
(SE
o
 of R in RMgX), and the LUMO-HOMO gap. In light of the distinct likelihood that 
the aryl Grignard reagents may give products via a concerted or carbanionic pathway and 
the alkyl Grignard reagents via radical pathways, it is significant that meaningful 
correlations are still obtained when both groups of Grignard reagents are analyzed as a 
single set of data points (i.e., Figures 2-3). The reaction of Grignard reagents with ,-
,unsaturated thiol esters represents the most general approach to exceptionally high 
1,4-regio- and chemoselective control in dienyl Michael acceptors and the procedure is 
enhanced further by the ability to carry out a tandem 1,4-conjugate addition/nucleophilic 
acyl substitution to afford -substituted ketones wherein the -substituent may be an 





General:  All NMR spectral were recorded as CDCl3 solutions of the compounds unless 
otherwise stated. 
1
H-NMR chemical shifts are reported as δ values in parts per million 
(ppm) relative to CHCl3 (δ = 7.28 ppm) as internal standard. 
13
C-NMR chemical shifts 
are reported as δ values in parts per million (ppm) and referenced with respect to the 
CDCl3 signal (triplet, centerline δ = 77.0 ppm). Infrared (IR) spectra of liquid compounds 
were recorded as neat liquid films between NaCl plates. Gas chromatography-mass 
spectrometry measurements were performed on a GC coupled to a quadruple detector at 
70 eV. Analytical thin layer chromatography (TLC) was performed on silica gel plates, 
200 mesh with F254 indicator. TLC visualization was achieved with UV light (254 nm), 
10% ethanol solution of phosphomolybdic acid (PMA) stain, and aqueous potassium 
permanganate solution (KMnO4). Products were purified by flash column 
chromatography with 230-400 mesh silica gel unless otherwise stated. Yields are based 
on isolated products purified by flash column chromatography. 
 Anhydrous tetrahydrofuran (THF) and diethyl ether (Et2O) were obtained from sodium 
benzophenone ketyl distillation. Dichloromethane (CH2Cl2) and toluene used for 
reactions were dried over molecular sieves. 
n
BuLi (2.5 M in hexane), MeLi (1.6 M in 
Et2O), and 
t
BuLi (2.0 M in pentane) were available commercially and titrated using sec-




BuMgCl (2.5 M in 
THF/toluene), MeMgCl (3.0 M in Et2O), 
i
PrMgBr (2.0 M in Et2O),  EtMgCl (2.0 M in 
THF), and PhMgCl (2.8 M in Et2O) were available commercially and titrated with 
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menthol and 1,10-phenanthroline monohydrate in THF. Benzyl bromide, 1-
bromonaphthalene, N,N-dimethyl-4-bromoaniline, 4-iodoanisole, 5-iodoindole, furan, 
thiophene, N-methylpyrrole, 1-hexyne, n-propylthiol, and 1,2-dibromoethane were all 
obtained from commercially available source and were used as received without further 
purification. All glassware was flame-dried under high vacuum and purged with argon 
and then cooled under a dry argon atmosphere. Low temperature baths (up to -78 
°
C) 
were prepared in thermoflasks with dry ice- isopropyl alcohol slush bath mixtures or ice-
NaCl (-23 
°
C) mixture. All reactions were conducted under positive dry argon 
atmosphere in anhydrous solvents in flasks fitted with rubber septum. 
Syntheses of starting materials  
Typical procedure 1. Syntheses of the ketodienes: All acyclic α,β,γ,δ-unsaturated 
ketones were prepared from the aldol condensation of crotonaldehyde or cinnamaldehyde 
and the corresponding methyl ketone by employing established literature procedure
47 
as 
follows. To a solution of LDA (1.1 equiv.) in THF at -70 
°
C was added in a dropwise 
fashion over 10 minutes a THF solution of the methylketone (1.0 equiv.). The mixture 
was stirred at -78 
°
C for 90 minutes and then a mixture of crotonaldehyde and 
chlorotrimethylsilane (TMSCl, 1.0 equiv.) in THF was added dropwise to it at -78 
°
C 
before allowing it to warm up to room temperature (rt). The reaction mixture was then 
refluxed for 4 hours after which it was quenched with saturated ammonium chloride and 
extracted with dichloromethane (CH2Cl2). The combined organic phase was washed with 
Na2HPO4(aq) solution and dried over anhydrous MgSO4. It was then filtered and the 
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solvent removed under reduced pressure to obtain crude material which was then purified 
by flash column chromatography (silica gel, 15% Et2O/ 85% hexane). 
Typical procedure 2 Syntheses of thioldienoates: The dienyl thiolesters were 
synthesized from the coupling of sorbic acid and the corresponding alkane thiol by 
employing established literature procedure as follows.
48
 To a dichloromethane (DCM) 
solution of sorbic acid (1.0 equiv.) at 0 
°
C was added the thiol (1.0 equiv.) and stirred for 
5 minutes. A DCM solution of 1,3-dicyclohexylcarbodiimmide (DCC) (1.2 equiv.) and 4-
dimethylaminopyridine (DMAP) (0.1 equiv.) was added and the resulting white 
suspension was stirred and gradually allowed to warm up to rt over 12 h. The precipitate 
was vacuum-filtered over a column of silica gel and rinsed with DCM. The solvent was 
removed under reduced pressure to obtain the crude material which was purified by 
column chromatography and distilled under reduced pressure to afford a liquid product.                                                                             
Method 1: Preparation of aryl Grignard reagents from aryl halides. Aryl Grignard 
reagents that were not commercially available were prepared from their corresponding 
aryl halide by modification of existing literature procedures.
49a-b
 as follows. To flame-
dried magnesium turnings in a flask under argon was added catalytic amount of iodine 
followed by addition of THF/Et2O and the mixture was stirred vigorously at room 
temperature. Then a solution of the aryl halide in THF/Et2O was added drop wise. After 
the addition, the reaction mixture was either refluxed or stirred at room temperature for 
amount of time as specified before being cooled to rt and used in the reaction. 
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Method 2: Preparation of Grignard reagents from heteroaryl compounds. Heteroaryl 
Grignard reagents were prepared from their corresponding heteroaryl compounds by 
employing established literature procedures
50a-b
 as follows: To a flame-dried flask 
containing a stir bar under argon was charged with THF/Et2O followed by the addition of 
the heteroaryl compound (1.0 equiv.) and TMEDA (1.0 equiv.). The mixture was then 
cooled to 0 
°
C and n-BuLi (2.5M in hexanes, 1 equiv.) was added dropwise via syringe. 
After the addition, the mixture was allowed to warm to rt and stirring was continued for 
additional 2hrs at this temperature. In a separate flask, MgBr2 was prepared by stirring 
flame-dried magnesium turnings (1.1 equiv.) with 1,2-dibromoethane (BrCH2CH2Br, 1.0 
equiv.) in Et2O at rt under argon until the evolution of the ethane ceased. The lithium 
reagent was transferred to the MgBr2 flask via cannula under argon and stirred at 0 
°
C for 
30 minutes. It was the cooled to -20 
°
C and used for the respective reaction. 
Method 3: General procedure for the synthesis of Grignard reagents by halogen-
metal exchange: Halogen-metal exchange reaction was used to prepare some Grignard 
reagents from their corresponding aryl iodides by employing modified existing literature 
procedures
51-52
 as follows: A flame-dried flask with a stir bar under argon was charged 
with the aryl iodide and dry THF and cooled to the appropriate temperature followed by 
the addition of 
i
PrMgBr (2.0 M in Et2O). The reaction mixture was stirred at this 
temperature for the time indicated before being used for the respective reactions. 
However, vinyl Grignard reagents were prepared by iodine-lithium exchange reaction 
between vinyl iodide and 
n
butyllithium as follows: A flame-dried flask with a stir bar 




C. To this was added 
n
butyllithium (1.0 equiv.) and stirred at -78 
°
C for 5 minutes after 
which it was warmed to -30 
°
C and a solution of MgBr2 in Et2O (prepared by stirring 1,2-
dibromoethane (1.1 equiv.) with flame-dried magnesium (1.2 equiv.) in Et2O at rt.) was 
added. The resulting mixture was the stirred at -30 
°
C before it was used for the 
respective reactions. 
General Procedure A: Zinc-catalyzed conjugate addition of Grignard reagents to 
dienones and dienyl thiolesters. To a flame-dried flask containing a stir bar and zinc salt 
(0.1 equiv.) (ZnBr2 was flame-dried) under argon was charged with dry diethyl ether (5.0 
mL), followed by addition of the dienone/ dienyl thiolester (1.0 mmol) and stirred for 5 to 
10 minutes. The flask was then cooled to -20 
°
C with ice-NaCl bath and the Grignard 
reagent (1.1 equiv.) was added drop wise to it. After the addition, the reaction mixture 
was allowed to warm to room temperature during overnight stirring. It was then quenched 
with saturated ammonium chloride and extracted three times with diethyl ether. The 
combined organic phase was dried with MgSO4, filtered, and the solvent removed under 
reduced pressure. The crude products were purified by flash column chromatography 
using silica gel and diethyl ether in hexane (10:90). 
General Procedure B: Uncatalyzed conjugate addition of Grignard reagents to 
dienones and dienyl thiolesters. To a flame-dried flask containing a stir bar under argon 
was added dry diethyl ether (5.0 mL) and the Grignard reagent (1.1 equiv.). This was 
cooled to -20 
°
C and diethyl ether solution of the dienone/ dienyl thiolester (1.0 mmol) 
was added drop wise to it via syringe over 5 minutes. After the addition, the reaction 
136 
 
mixture was allowed to warm to room temperature with overnight (although the reaction 
is usually complete after 2 h at -20 
°
C) stirring. It was then quenched with saturated 
aqueous NH4Cl and extracted with diethyl ether. The combined organic phase was dried 
with MgSO4, filtered and the solvent removed under reduced pressure. The crude 
products were purified by flash chromatography using silica gel and 10% Et2O: 90% 
hexane.  
General Procedure C (reversed addition mode): Uncatalyzed conjugate addition of 
Grignard reagents to dienones and dienyl thiolesters. A flame-dried flask containing a 
stir bar under argon was charged with dry diethyl ether (4-5 mL) followed by the 
dienone/ dienyl thiolester (1.0 mmol). The flask was then cooled to -20 
°
C with ice-NaCl 
bath and the Grignard reagent (1.1 equiv.) was added to it at a rate of about a drop every 
three seconds over 5 minutes. After the addition, the reaction mixture was allowed to 
warm to room temperature with overnight (although the reaction is usually complete after 
2 h at -20 
°
C) stirring. This was then quenched with saturated aqueous NH4Cl and 
extracted with diethyl ether (3x), dried with MgSO4, and the solvent removed under 
reduced pressure.  
Synthesis of (4E, 6E)-2-Methylocta-4,6-dien-3-one (73a): Compound was synthesized 
by employing typical procedure 1
47
above and using 
methylisopropylketone (6.00 g, 69.69 mmol, 1 equiv.), LDA (1 equiv.), 
crotonaldehyde (5.37g, 76.66mmol, 1 equiv.), and TMSCl (7.54g, 69.69mmol, 1 equiv.) 




78%): (Rf = 0.35 in 10% ethylacetate in 90% hexane): IR (neat) 3029 (m), 2971 (s), 2935 
(s), 2875 (s), 1687 (s), 1665 (s), 1638 (s), 1597 (s), 1467 (s), 1383 (s), 1351 (m), 1230 




H NMR (500 MHz, CDCl3) δ 0.97 (d, J = 6.9Hz, 
6H), 1.71 (d, J = 4.6Hz, 3H), 2.67 (quin, 6.9Hz, 1H), 5.98-6.09 (m, 3H), 7.02-7.06 (m, 
1H);
 13
C NMR (125 MHz, CDCl3) δ 18.3, 18.6, 38.6, 125.7, 130.2, 139.9, 142.6, 204.0. 
Spectral data were consistent with that reported in the literature.
53  
 
 (2E, 4E)-1-phenylhexa-2,4-dien-1-one (73c): Compound 73c was prepared by 
employing typical procedure
47
1 above using LDA (1.0 equiv.), 
acetophenone (4.80g, 40.00 mmol, 1.0 equiv.), crotonaldehyde (3.08g, 
44.0 mmol, 1.1 equiv.), and TMSCl (4.32g, 40.00 mmol, 1.0 equiv.) in 
THF, the reaction mixture was instead of reflux, stirred at rt for 3 h after it had warmed to 
rt before the work up and column chromatography [silica gel, 15% Et2O/85% hexane (Rf 
= 0.31): Dichloromethane was used to make it soluble before loading to column] to 
obtain a white solid. (Yield = 4.82g, 70% after chromatography). IR (neat) 3060 (m), 
3022 (m), 2996 (m), 2963 (m), 2939 (m), 2910 (m), 1658 (s), 1631 (s), 1587 (s), 1447 




H NMR (500 MHz, CDCl3) δ 1.87 
(d, J = 6.5Hz, 3H), 6.19-6.34 (m, 2H), 6.87 (d, J = 14.7Hz, 1H), 7.37-7.54 (m, 4H), 7.93 
(d, J = 7.8Hz, 2H); 
13
C NMR (125 MHz, CDCl3) δ 18.7, 123.1, 128.1, 128.3, 130.4, 







(4E, 6E)-2-Methyl-7-phenylhepta-4,6-dien-3-one (81a): Compound 81a was 
synthesized by employing typical procedure
47
 1 above and using 
LDA (1.0 equiv.), methylisopropylketone (5.00 g, 58.00 mmol, 1.0 
equiv.), cinnamaldehyde (7.67 g, 58.00 mmol, 1.05 equiv.), and 
TMSCl (6.30g, 58.00 mmol, 1.0 equiv.) in THF, the reaction mixture was allowed to stir 
at rt for 12 h before working up and column to obtain 81a as a cream color low density 
solid (yield = 6.37 g, 55%). Rf = 0.55 in 10% ethylacetate in hexane. IR (neat) 3060 (m), 
3029 (s), 2970 (s), 2933 (s), 2873 (s), 1683 (s), 1660 (s), 1617 (s), 1588 (s), 1467 (s), 




H NMR (500 MHz, CDCl3) δ 1.17 (d, J = 6.9Hz, 6H), 2.87 (sept, J = 6.9Hz, 1H), 6.38 
(d, J = 15.6Hz, 1H), 6.88-6.97 (m, 2H), 7,30-7.43 (m, 4H), 7.47-7.49 (m, 2H); 
13
C NMR 
(125 MHz, CDCl3) δ 18.4, 39.0, 126.7, 127.1, 127.8, 128.7, 129.0, 136.0, 141.1, 142.3, 
203.8. Spectral data were consistent with that reported in the literature.
 56a-c
 
 (2E, 4E)-Dodeca-2,4-dien-6-one (73b): Compound 73b was prepared by employing 
typical procedure
47
 1 above, and using LDA (1.0 equiv.), octan-2-
one (5.00 g, 39.00 mmol, 1.0 equiv.), crotonaldehyde (3.00 g, 
42.90 mmol, 1.1equiv.), and TMSCl (5.20 mL, 41.00 mmol, 1.05 equiv.) in THF to 
obtain 73b after chromatography, a yellow oily liquid which solidifies upon standing in 
the fridge. (Yield = 3.87 g, 55%). IR (neat) 3028 (m), 2931 (s), 2859 (s), 1688 (s), 1639 





NMR (500 MHz, CDCl3) δ 0.82-0.84 (m, 7H), 1.50-1.58 (m, 4H), 1.82 (d, J = 1.8Hz, 







C NMR (125 MHz, CDCl3) δ 13.9, 18.6, 22.3, 24.3, 28.8, 31.5, 40.4, 127.6, 130.2, 
139.9, 142.6, 201.0. Spectral data were consistent with that reported in the literature.
54 
 (1E, 3E)-1-phenylundeca-1,3-dien-5-one (81b): The substrate 81b was prepared by 
employing typical procedure
47
 1 above, using LDA (1.0 
equiv.), octan-2-one (3.00 g, 23.40 mmol, 1.0 equiv.), 
cinnamaldehyde (3.09g, 23.396mmol, 1.0equiv.), and TMSCl (2.542 g, 23.398 mmol, 1.0 
equiv.) in THF. The reaction mixture was stirred at rt for 12 h before work up and 
column chromatography to obtain 81b as a white solid (yield = 2.55 g, 45%; Rf = 0.27 in 
15% Et2O/ hexane): IR (neat) 3060 (m), 3026 (m), 2953 (s), 2932 (s), 2858 (s), 1706 (s), 
1683 (s), 1600 (s), 1451 (s), 1376 (s), 1289 (m), 1235 (m), 1129 (m), 1078 (s), 1013 (s), 




H NMR (500 MHz, CDCl3) δ 0.89-0.92 (m, 3H), 1.30-1.38 (m, 
6H), 1.64-1.70 (m, 2H), 2.61 (t, J = 7.4H, 2H), 6.30 (d, J = 15.6H, 1H), 6.87 (m, 2H), 
7.32-7.40 (m, 4H), 7.49 (d, J = 8.7Hz, 2H); 
13
C NMR (125 MHz, CDCl3) δ 13.0, 22.5, 
24.4, 29.0, 31.6, 40.8, 126.8, 127.2, 128.8, 129.1, 129.7, 136.0,141.1, 142.3, 200.8. 
Spectral data were consistent with that reported in the literature.
 57a-b
 
 (2E, 4E)-1, 5-diphenylpenta-2,4-dien-1-one (81c): Compound 
81c was prepared by employing typical procedure
47
 1 above using 
LDA (1.0 equiv.), acetophenone (4.00 g, 33.29 mmol, 1.0 equiv.), 
cinnamaldehyde (4.40 g, 33.29 mmol, 1.0 equiv.), and TMSCl (3.62 g, 33.29 mmol, 1.0 
equiv.) in THF. The reaction mixture was stirred at rt for 12 h before work up and 
column chromatography (85%hexane:10% Et2O:5%DCM, stains red in PMA) to obtain a 
 
     
140 
 
yellow solid (yield = 3.20 g, 41%): IR (neat) 3028 (m), 1651 (s), 1598 (s), 1583 (s), 1571 





H NMR (500 MHz, CDCl3) δ 7.05 (d, J = 8.2Hz, 2H), 7.12 (d, J = 15.2Hz, 1H), 
7.33-7.41 (m, 3H), 7.50-7.53 (m, 4H), 7.58-7.66 (m, 2H), 8.01 (d, J = 6.9Hz, 2H); 
13
C 
NMR (125 MHz, CDCl3) δ 125.4, 126.9, 127.2, 128.3, 128.5, 128.8, 129.2, 132.6, 136.1, 
138.2, 141.9, 144.8, 190.4. Spectral data were consistent with that reported in the 
literature.
58a-b 
S-(1,1-Dimethylethyl) (2E,4E)-hexa-2,4-dienethioate (74a): Following typical 
procedure 2 using sorbic acid (5.00 g, 44.64 mmol, 1.0 equiv.), and 
2-methylpropan-2-thiol (5.03 mL, 44.64 mmol, 1.0 equiv.) in 
CH2Cl2, 2 was obtained as a colorless liquid after column 
chromatography and distillation under reduced pressure (5.68 g, 75%, Rf = 0.58 in 10% 
Et2O: 90% hexane): IR (neat) 3027 (m), 2999 (m), 2964 (s), 2926 (s), 2863 (m), 2120 (s), 





(500 MHz, CDCl3) δ 1.47 (s, 9H), 1.81 (d, J = 5.5 Hz, 3H), 5.94 (d, J = 15.1 Hz, 1H), 
6.06-6.17 (m, 2H), 7.08 (dd, J = 15.1 Hz, 10.1 Hz, 1H);
 13
C-NMR (125 MHz, CDCl3) δ 
18.7, 29.8, 47.8, 126.9, 129.6, 139.6, 140.2, 190.7; mass spectrum m/z (relative intensity) 
EI 184 (3, M
+
), 128 (10), 113 (20), 96 (8), 95 (100), 67 (44), 65 (11), 57 (18); HRMS 
(EI) calculated for [C10H16OS]
+
 184.0922, found 184.0919. 
 S-Propyl (2E,4E)-hexa-2,4-dienethioate (97): Compound was prepared by employing 
typical procedure
48





equiv.) and propanethiol (4.04 mL, 44.64 mmol, 1.0 equiv.) in CH2Cl2 to  obtain 97 as a 
colorless oil after column chromatography and distillation under reduced pressure (5.85 
g, 77%). 
1
H NMR (500 MHz, CDCl3) δ 0.95 (t, J = 7.3Hz, 3H), 1.56-1.63 (m, 2H), 1.82 
(d, J = 6.0Hz, 3H), 2.88-2.91 (m, 2H), 6.03 (d, J = 15.6Hz, 1H), 6.08-6.20 (m, 2H), 7.14 (dd, J 
= 15.1Hz, 10.1Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 13.2, 18.6, 22.9, 30.4, 126.0, 129.5, 
140.4, 140.6, 189.9. Spectral data was consistent with that reported in the literature.
48a-b  
 (6E)-5-Ethyl-2-methyloct-6-en-3-one (75aA): Following general procedure B using 
diethyl ether (5.0 mL), EtMgCl (1.1 equiv.), and dienone 73a (138 mg, 1 
mmol, 1 equiv.) 75aA was obtained as a yellow oil (139 mg, 87%; Rf = 
0.52 in 10% Et2O: 90% hexane): IR (neat) 2967 (s), 2934 (s), 2877 (s), 




H-NMR (500 MHz, 
CDCl3) δ 0.82 (t, J = 7.4 Hz, 3H), 1.02-1.05 (m, 6H), 1.17-1.26 (m, 1H), 1.31-1.38 (m, 
1H), 1.61 (d, J = 6.5 Hz, 3H), 2.40-2.43 (m, 3H), 2.54 (sept, J = 6.9 Hz, 1H), 5.16 (dd, J 
= 15.2 Hz, 6.4 Hz, 1H), 5.35-5.42 (m 1H); 
13
C-NMR (125 MHz, CDCl3) δ 11.5, 17.8, 
17.9 (2-carbons), 27.8, 40.0, 41.1, 46.1, 125.3, 134.0, 214.1;  mass spectrum m/z (relative 
intensity) EI 168 (5, M
+
), 139 (13), 125 (21), 97 (15), 83 (85), 67 (16), 43 (100), 41 (37); 
HRMS ( EI) calculated for [C11H20O]
+ 168.1514, found 168.1518. 
2-Methyl-5-[(1E)-prop-1-en-1-yl]nonan-3-one (75aB): Following general procedure B 
using Et2O or THF (5.0 mL), n-butylmagnesium chloride (1.2 M in 
THF/toluene, 2.00mL, 1.2 equiv.), and dienone 73a (0.2764 g, 2 mmol) 
75aB was obtained as a yellow oily liquid (314 mg , 90%, Rf = 0.53 in 









H-NMR (500 MHz, CDCl3) δ 0.86 (t, J = 6.9 Hz, 
3H), 1.02-1.05 (m, 6H), 1.18-1.28 (m, 6H), 1.60 (d, J = 6.4 Hz, 3H), 2.39 (d, J = 6.9 Hz,  
2H), 2.48-2.56 (m, 2H), 5.14-5.19 (m, 1H), 5.34-5.41 (m, 1H); 
13
C-NMR (125 MHz, 
CDCl3) δ 14.0,17.8, 17.9 (2-carbon), 22.6, 29.3, 34.8, 38.3, 41.1, 46.5, 125.0, 134.3, 
214.0; mass spectrum m/z (relative intensity) EI 196 (5.0, M
+
), 153 (26), 139 (13), 111 
(27); HRMS (EI) calculated for [C13H24O]
+
 196.1827, found 196.1823. 
S-(1,1-Dimethylethyl)(4E) 3-ethylhex-4-enethioate (76aA): Employing general 
procedure B using diethyl ether (5.0 mL), EtMgCl (1.82 M in Et2O, 
0.66 mL, 1.2 equiv.), and dienyl thiol ester 74a (0.1843 g, 1.0 mmol, 1 
equiv.) 76aA was obtained as a yellow liquid (150 mg, 70%; Rf = 0.66 in 10% Et2O: 90% 
hexane ): IR (neat) 2997 (m), 2964 (s), 2923 (s), 2877 (s), 1680 (s), 1456 (s), 1364 (s), 




H-NMR (500 MHz, CDCl3) δ 0.84-
0.87 (m, 3H), 1.21-1.30 (m, 1H), 1.45 (s, 9H), 1.65 (d, J = 6.0 Hz, 3H), 2.35-2.48 (m, 
3H), 5.16-5.21 (m, 1H), 5.41-5.48 (m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 11.5, 17.8, 
27.5, 29.7, 41.8, 47.8, 50.0,125.8, 133.1,199.6; mass spectrum m/z (relative intensity) EI 
214 (0.08, M
+
), 158 (29), 125 (41), 96 (30), 83 (100), 57 (65), 55 (89); HRMS (EI) 
calculated for [C12H22OS]
+
 214.1391, found 214.1390. 
S-(1,1-Dimethylethyl) 3-[(1E)-prop-1-en-1-yl]heptanethioate (99b): Employing 
general procedure B  using diethyl ether (5.0 mL), 
n
butylMgCl (1.22 M 
in THF/toluene, 0.90 mL, 1.1 equiv.), and dienyl thiol ester 74a  (0.184 
g, 1.0 mmol, 1.0 equiv.) 99b was obtained as an oily liquid (171.1 mg, 









H-NMR (500 MHz, 
CDCl3) δ  0.84-0.87 (m, 3H), 1.15-1.31 (m, 5H), 1.33-1.34 (m, 1H), 1.43 (s, 9H), 1.62 (d, 
J = 6.4 Hz, 3H), 2.32-2.48 (m, 3H), 5.17 (dd, J = 15.2 Hz, 8.3 Hz, 1H), 5.37-5.44 (m, 
1H); 
13
C-NMR (125 MHz, CDCl3) δ 14.0, 17.8, 22.6, 29.2, 29.7, 34.4, 40.2, 47.7, 50.3, 
125.5, 133.4, 199.5; mass spectrum m/z (relative intensity) EI 242 (2, M
+
), 186 (56), 153 
(80), 129 (27), 111 (98); HRMS (EI) calculated for [C14H26OS]
+
 242.1704, found 
242.1701. 
S-(1,1-Dimethylethyl) (4E)-3-(propan-2-yl)hex-4-enethioate (99c): Employing general 
procedure B using diethyl ether (5.0 mL), 
i
PrMgCl (1.25 M in Et2O, 
0.88 mL, 1.1 equiv.), and dienyl thiol ester 74a  (0.1842 g, 1.0 
mmol) 99c was obtained as an oily liquid (150.6 mg, 66%; Rf = 0.69 
in 15% EtOAc: 85% hexane): IR (neat) 2998 (m), 2962 (s), 2874 (s), 1686 (s), 1456 (s), 




H-NMR (500 MHz, 
CDCl3) δ  0.83 (d, J = 6.9 Hz, 3H), 0.86 (d, J = 6.9 Hz, 3H), 1.43 (s, 9H), 1.57-1.61 (m, 
1H), 1.64 (d, J = 6.4 Hz, 3H), 2.33-2.39 (m, 2H), 2.48-2.54 (m, 1H), 5.19-5.24 (m, 1H), 
5.38-5.44 (m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.9, 18.8, 20.4, 29.7, 31.5, 46.4, 
47.6, 47.7, 126.7, 130.7, 199.9; mass spectrum m/z (relative intensity) EI 228 (0.4, M
+
), 




S-(1,1-Dimethylethyl) (4E)-3-cyclohexylhex-4-enethioate (99d): Employing general 
procedure B using diethyl ether (5.0mL), cyclohexyl magnesium chloride 





(0.184 g, 1.0 mmol, 1.0  equiv.) 99d was obtained as a colorless oil  (232.6 mg, 87%; Rf 
= 0.67 in 10% Et2O: 90% hexane): IR (neat) 2925 (s), 2853 (s), 1685 (s), 1613, (m), 1544 




H-NMR (500 MHz, 
CDCl3) δ 0.95-0.81 (m, 2H), 1.20-1.04 (m, 4H), 1.38 (s, 9H), 1.68-1.58 (m, 8H), 2.34-
2.27 (m, 2H), 2.52-2.46 (m, 1H), 5.37-5.30 (m, 1H), 5.18-5.14 (m, 1H); 
13
C-NMR (125 
MHz, CDCl3) δ 17.7, 26.4 (3-carbons), 29.5, 29.6, 30.8, 41.5, 45.9, 47.3, 47.5, 126.3, 
131.3, 199.7; mass spectrum m/z (relative intensity) EI 268 (0.28, M
+
), 212 (29), 179 




S-(1,1-Dimethylethyl) (4E)-3-tert-butylhex-4-enethioate (99e) and S-(1,1-
dimethylethyl)-(3E)-5,6,6-trimethylhept-3-enethioate (101e): Employing general 
procedure B using dichloromethane (7.0mL), 
t
butylMgCl (1.85 M 
in Et2O, 1.19 mL, 1.1 equiv.), and dienyl thiol ester 74a  (0.184 g, 
1.0 mmol, 1.0 equiv.) a mixture of 99e and 101e was obtained as a 
non-separable isomers (365 mg, 60%; Rf = 0.60 in 10% Et2O: 90% 
hexane): IR (neat) 2928 (s), 2931 (s), 2866 (s), 1699 (s), 1443 (s), 
1039 (s), 947 (s) cm
-1
; 1H-NMR (500 MHz, CDCl3) δ 0.84 (s, 9H), 1.42 (d, J = 7.8 Hz, 
3H), 1.44 (s, 9H), 1.88-1.1.94 (m, 1H), 3.12 (d, J = 6.4 Hz, 2H), 5.34-5.54 (m, 2);
 13
C-
NMR (125 MHz, CDCl3) δ 15.2, 27.4, 29.7, 29.8, 32.9, 47.1, 48.4, 121.1, 139.1, 198.8; 
mass spectrum m/z (relative intensity) EI 242 (7, M
+
), 186 (74), 185 (47), 130 (100), 129 
(47); HRMS (EI) calculated for [C14 H25OS]
+
 241.1626, found 241.1627; (6e): 
13
C NMR 





S-(1,1-Dimethylethyl) (4E)-3-benzylhex-4-enethioate (99f): The BnMgBr was prepared 
by employing method 1 using diethyl ether (5 mL), flame-dried 
magnesium turnings (0.051 g, 2.1 mmol), and benzyl bromide (0.223 g, 
1.3 mmol, 1.3 equiv.) at room temperature for 1h before using general 
procedure B, and diethyl ether solution of dienyl thiol ester 74a (0.184 g, 1.0 mmol, 1.0 
equiv.). The crude material was purified by flash column chromatography to obtain 99f 
as an oily liquid (238 mg, 86%; Rf = 0.48 in 10% Et2O: 90% hexane ): IR (neat) 3029 (s), 
2990 (m), 2964 (s), 2920 (s), 1686 (s), 1658 (w), 1496 (m), 1476 (m), 1455 (s), 1074 (s), 




H-NMR (500 MHz, CDCl3) δ  1.44 (s, 9H), 1.60 (d, J = 6.0 Hz, 
3H), 2.36-2.41 (m, 1H), 2.47 (dd, J = 14.2 Hz, 6.0 Hz, 1H), 2.64 (d, J = 7.4 Hz, 2H), 
2.81-2.88 (m, 1H), 5.26-5.31 (m, 1H), 5.34-5.41 (m, 1H), 7.14 (d, J = 7.3 H, 2H), 7.16-
7.2 (m, 1H), 7.25-7.28 (m, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 17.8, 29.7, 41.3, 41.5, 
47.9, 49.1, 126.0, 128.1, 129.3, 132.5, 139.7, 199.4; mass spectrum m/z (relative 
intensity) EI 276 (0.8, M
+
), 220 (56), 145 (92), 144 (95), 129 (63), 91 (98), 57 (100); 
HRMS (EI) calculated for [C17H24OS]
+
 276.1548, found 276.1549. 
S-(1,1-Dimethylethyl) (4E)-3-(2,6-dichlorobenzyl)hex-4-enethioate (99g): The 
Grignard reagent was prepared by employing method 1 using diethyl 
ether (10 mL), flame-dried magnesium turnings (0.0535 g, 2.2 mmol, 1.1 
equiv.), α-bromo-2,6-dichlorotoluene, and two drops of BrCh2CH2Br at 
room temperature for 1 hr before  using general procedure B, and dienyl thiol ester 74a  
(0.369 g, 2.0 mmol, 1.0 equiv.). The crude material was purified by flash column 





to obtain 99g (594 mg, 86%): IR (neat) 2962 (s), 1784 (w), 1681 (s), 1583 (m), 1562 (s), 




H-NMR (500 MHz, 
CDCl3) δ 1.42 (s, 9H), 1.56 (d, J = 5.5 Hz, 3H), 2.45-2.49 (m, 1H), 2.52-2.75 (m, 1H), 
2.91-2.97 (m, 2H), 2.99-3.05 (m, 1H), 5.25-5.38 (m, 2H), 7.04-7.07 (m, 1H), 7.25 (d, J = 
8.3 Hz, 2H);
 13
C-NMR (125 MHz, CDCl3) δ 17.7, 29.7, 36.2, 39.9, 47.9, 49.3, 126.2, 
127.8, 128.1, 131.8, 135.9, 136.1, 199.0; mass spectrum m/z (relative intensity) EI 288 
(15), 255 (38), 213 (43), 159 (55), 129 (30), 57 (100); HRMS (EI) calculated for 
[C17H23OSCl2]
+
 345.0847, found 345.0852.   
S-(1,1-Dimethylethyl) (4E)-3-phenylhex-4-enethioate (99j): Employing general 
procedure B using diethyl ether (5.0 mL), PhMgCl (1.38 M in THF, 0.85 
mL, 1.1 equiv.), and dienyl thiol ester 74a (0.184 g, 1.0 mmol, 1.0 
equiv.) 99j was obtained as an oily liquid (240 mg, 91%; Rf = 0.56 in 
10% Et2O: 90% hexane): IR (neat) 3062 (m), 3030 (s), 2964 (s), 2919 (s), 1719 (s), 1599 




H-NMR (500 MHz, CDCl3) δ 1.42 (s, 
9H), 1.68 (d, J = 6.0 Hz, 3H), 2.77-2.86 (m, 2H), 3.83-3.88 (m, 1H), 5.48-5.55 (m, 1H), 
5.58-5.63 (m, 1H), 7.20-7.33 (m, 5H); 
13
C-NMR (125 MHz, CDCl3) δ 17.9, 29.7, 45.4, 
48.0, 50.5, 125.9, 126.4, 127.5, 128.5, 132.6, 143.1, 198.7;  mass spectrum m/z (relative 
intensity) EI 262 (0.01, M
+
), 206 (97), 173 (40), 144 (86), 131 (100), 129 (66); HRMS 
(EI) calculated for [C16 H22OS]
+
 262.1391, found 262.1400.  
S-(1,1-Dimethylethyl) (4E)-3-(4-methoxyphenyl)hex-4-enethioate (99k): Employing 
general procedure B using dichloromethane (5.0 mL), MeOC6H4MgBr 





room temperature and stirring for 35 minutes), and dienyl thiol ester 74a (0.184 g, 1.0 
mmol, 1.0 equiv.) after purification 99k was obtained as an oily liquid (241 mg, 82%; Rf  
= 0.42, 10% Et2O: 90% hexane): IR (neat) 3030(s), 2998(s), 2962(s), 2836(s), 1681(s), 




H-NMR (500 MHz, CDCl3) δ 1.43 (s, 9H), 1.68 
(d, J = 6.0 Hz, 3H), 2.74-2.84 (m, 2H), 3.80-3.84 (m, 4H), 5.46-5.52 (m, 1H), 5.56-5.61 
(m, 1H), 6.86 (d, J = 8.3 Hz, 2H), 7.13 (d, J = 8.3 Hz, 2H);  
13
C-NMR (125 MHz, CDCl3) 
δ 17.8, 29.6, 44.5, 47.9, 50.6, 55.1, 113.8, 125.4, 128.3, 132.9, 135.1, 158.1, 198.6; mass 
spectrum m/z (relative intensity) EI 292 (9, M
+
), 236 (70), 175 (30), 174 (67), 161 (100), 
159 (34); HRMS (EI) calculated for [C17H24O2S]
+
 292.1497, found 292.1493. 
S-(1,1-Dimethylethyl) (4E)-3-[4-(dimethylamino)phenyl]hex-4-enethioate (99l): The 
p-Me2NC6H4-MgCl (1.5 equiv.) was prepared by following method  1 
using flame-dried magnesium turnings (0.048 g, 2.0 mmol, 2.0 equiv.), 
and p-bromo-N,N-dimethylaniline (0.300 g, 1.50 mmol, 1.5 equiv.), in 
dry THF (3.0 mL). The reaction mixture was heated at reflux for 45 minutes before 
employing general procedure B using diethyl ether (4.0 mL), and dienyl thiol ester 74a 
(0.184 g, 1.0 mmol, 1.0 equiv.). After purification (silica gel deactivated with 
triethylamine ), 99l was obtained as an oil (269 mg, 88%; Rf = 0. 25 in 10% Et2O: 90% 
hexane): IR (neat) 3072 (w), 2962 (s), 2800 (s), 1680 (s), 1614 (s), 1520 (s), 1478 (s), 





(500 MHz, CDCl3) δ 1.44 (s, 9H), 1.64 (d, J = 6.0 Hz, 3H), 2.75 (m, 2H), 2.90 (s, 6H), 
3.74(q, J = 7.4 Hz, 1H), 5.45-5.52 (m, 1H), 5.56-5.61 (m, 1H), 6.72 (d, J = 8.7 Hz, 2H), 
7.09 (d, J = 8.8 Hz, 2H); 
13




50.7, 112.9, 125.1, 127.9, 131.2, 133.2, 149.3, 198.9; mass spectrum m/z (relative 
intensity) EI 305 (56, M
+
), 248 (42), 206 (9), 187 (40), 174 (100), 159 (32), 144 (21), 132 
(15); HRMS (EI) calculated for [C18H27O S N]
+
 305.1813, found 305.1815. 
 S-(1,1-Dimethylethyl) (4E)-3-(naphthalen-1-yl)hex-4-enethioate (99m): Employing 
general procedure B using diethyl ether (4.0 mL), dienyl thiol ester 74a 
(0.184 g, 1.0 mmol, 1.0 equiv.), and naphthyl magnesium bromide (1.2 
mmol, 1.2 equiv.) prepared by following  method 1. The Grignard 
reagent precipitated at -20 
°
C so it was stirred at room temperature while the substrate 
was being added and the precipitate disappeared during the addition. The crude material 
was purified (silica gel, 10% Et2O: 90% hexane; Rf = 0.53) to obtain 99m as an oil (256 
mg, 82%): IR (neat) 3048(s), 2997 (m), 2963 (s), 2918 (s), 2881 (m), 1682 (s), 1598 (m), 




H-NMR (500 MHz, CDCl3) δ 1.47 (s, 9H), 1.73 (d, J = 6.4 H, 3H), 2.99-3.01 (m, 2H), 
4.75-4.80 (m, 1H), 5.59-5.66 (m, 1H), 5.75-5.80 (m, 1H), 7.40 (d, J = 6.9 Hz, 1H), 7.47 
(t, J = 7.8 Hz, 1H), 7.50-7.53 (m, 1H), 7.56-7.59 (m, 1H), 7.77 (d, J = 8.3 Hz, 1H), 7.89 
(d, J = 9.2 Hz, 1H), 8.23 (d, J = 8.3 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.9, 29.6, 
40.0, 48.0, 50.1, 123.3, 123.9, 125.3, 125.4, 126.0, 126.4, 127.0, 128.8, 131.1, 132.0, 
133.9, 139.1, 198.9; mass spectrum m/z (relative intensity) EI 312 (24, M
+
), 256 (61), 195 







S-(1,1-Dimethylethyl) (4E)-3-(1-methyl-1H-indol-5-yl)hex-4-enethioate (99n): The 
Grignard reagent (1.07 equiv.) was prepared from 5-iodoindole by 
following method 2 in diethyl ether (8 mL) at -78 
°
C without the use of 
TMEDA. This was then allowed to warm to room temperature before 
diethyl ether solution of dienyl thiol ester 74a  (0.258 g, 1.4 mmol, 1.0 
equiv.) was added dropwise to it. The crude material was purified (silica gel, 10% Et2O: 
90% hexane; Rf = 0.30) to obtain 99n as an oil (402 mg, 91%): IR (neat) 3102 (m), 3023 
(s), 2961 (s), 2820 (s), 1681 (s), 1573 (m), 1513 (s), 1491 (s), 1450 (s), 1425 (s), 1363 (s), 




H-NMR (500 MHz, CDCl3) δ 
1.47 (s, 9H), 1.71 (d, J = 6.4 Hz, 3H), 2.87-2.97 (m, 2H), 3.79 (s, 3H), 3.98-4.02 (m, 1H), 
5.52-5.58 (m, 1H), 5.68-5.73 (m, 1H), 6.47 (d, J = 2.3 Hz, 1H), 7.05 (d, J = 2.8 Hz, 1H), 
7.12 (dd, J = 8.3 Hz, 1.4 Hz, 1H), 7.29 (d, J = 8.3 Hz, 1H), 7.48 (s, 1H);
 13
C-NMR (125 
MHz, CDCl3) δ 17.9, 29.7, 32.8, 45.5, 47.8, 51.1, 100.7, 109.1, 119.1, 121.4, 125.1, 
128.6, 129.0, 133.5, 134.2, 135.6, 199.0; mass spectrum m/z (relative intensity) EI 315 
(29, M
+
), 258 (31), 197 (45), 184 (100), 182 (41); HRMS (EI) calculated for 
[C19H25OSN]
+
 315.1657, found 315.1652.  
S-(1,1-Dimethylethyl) (4E)-3-(5-bromothiophen-2-yl)hex-4-enethioate (99p): The 
Grignard reagent was prepared by following method 3 using 2, 5-
dibromothiophene (0.5081 g, 2.1 mmol, 1.05 equiv.), and 
n
BuLi (0.84 
mL, 2.1 equiv.) in dry diethyl ether (4.0 mL) at -78 
°
C for 15 minutes 
before addition of MgBr2
.
OEt2 and stirring for 2hr at -78 
°
C.  Then employing general 





equiv.) at  -20 
°
C, the crude material was purified (silica gel, 5% Et2O in 95% hexane; Rf 
= 0.59 in 10% Et2O: 90% hexane) to obtain 99p as a yellow oil (590 mg, 85%): IR (neat) 
3028 (m), 2996 (m), 2964 (s), 2919 (s), 1681 (s), 1476 (m), 1445 (s), 1364 (s), 1216 (s), 




H-NMR (500 MHz, CDCl3) δ 1.45 (s, 9H), 1.70 
(d, J = 6.5 Hz, 3H), 2.75-2.86 (m, 2H), 4.04 (q, J = 7.3 Hz, 1H), 5.49-5.53 (m, 1H), 5.56-
5.63 (m, 1H), 6.58 (dd, J = 2.8 Hz, 0.9 Hz, 1H), 6.87 (d, J = 3.7 H, 1H); 
13
C-NMR (125 
MHz, CDCl3) δ 17.7, 29.7, 40.9, 48.3, 50.5, 109.9, 124.0, 127.3, 129.4, 131.3, 148.7, 
197.8;  mass spectrum m/z (relative intensity) EI 346 (1.1, M+), 292 (90), 290 (90), 230 
(94), 227 (90), 149 (64), 136 (100), 135 (91); HRMS (EI) calculated for [C14H19BrO S2]
+
 
346.0055, found 346.0052. 
S-(1,1-Dimethylethyl) (4E)-3-(1-methyl-1H-pyrrol-2-yl)hex-4-enethioate (99r): 
Employing general procedure B using diethyl ether (4.0 mL), 2-
methylpyrrolyl magnesium bromide (1.2 mmol, 1.2 equiv.) prepared by 
following method 2, and dichloromethane solution of dienyl thiol ester 
74a (0.184 g, 1.0 mmol, 1.0 equiv.) 99r was obtained as an oily liquid (167 mg, 63%; Rf 
= 0.37 in 10% Et2O: 90% hexane): IR (neat) 3102 (m), 2963 (s), 2811 (m), 1681 (s), 
1567 (m), 1543 (m), 1492 (s), 1454 (s), 1364 (s), 1302 (s), 1164 (s), 1089 (s), 1041 (s), 




H-NMR (500 MHz, CDCl3) δ 1.47 (s, 9), 1.66 (d, J = 4.1 
Hz, 3H), 2.80 (dd, J = 9.2 Hz, 1H), 2,88 (dd, J = 14.7 Hz, 6.0 Hz, 1H), 3.55 (s, 3H), 3.87-
3.90 (m, 1H), 5.41-5.43 (m, 2H), 5.91 (d, J = 3.3 Hz, 1H), 6.07 (d, J = 3.7 Hz, 1H), 6.55 
(s, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.6, 29.7, 33.7, 37.0, 48.0, 49.1, 104.8, 106.5, 










 (6E) 2-Methyl-5-(propan-2-yl)oct-6-en-3-one (75aC): Employing general procedure B 
using diethyl ether (5.0 mL), isopropyl magnesium chloride (1.2 M in 
Et2O, 2.00 mL, 1.2 equiv.), and dienone 73a (0.2764 g, 2 mmol) at -20 
°
C 75aC was obtained as a yellow oily liquid (306.2 mg , 84%, Rf = 
0.52 in 10% EtOAc/ 90% hexane): IR (neat) 2965 (s), 2935 (s), 2875 (s), 1713 (s), 1467 




H-NMR (500 MHz, CDCl3) δ 0.84 (d, J = 6.5 Hz, 
3H), 0.87 (d, J = 6.9 Hz, 3H), 1.06 (t, J = 6.7 Hz, 6H), 1.55-1.60 (m, 1H), 1.63 (d, J = 6.4 
Hz, 3H), 2.36-2.46 (m, 3H), 2.57 (quin, J = 6.9 Hz, 1H), 5.19-5.24 (m, 1H), 5.35-5.42 
(m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.9, 18.0, 18.8, 20.5, 31.7, 41.2, 43.7, 44.6, 
126.3, 131.7, 214.4; mass spectrum m/z (relative intensity) EI 182 (4, M
+
), 139 (26), 98 
(39), 97 (64), 71 (94), 55 (56), 43 (100); HRMS (EI) calculated for [C12H22O]
+
 182.1671, 
found 182.1673.  
 (6E) 5-(1,1-Dimethylethyl)-2-methyloct-6-en-3-one (75aD) and (5E) 2,7,8,8-
tetramethylnon-5-en-3-one (77aD): Employing general procedure B using diethyl ether 
(5.0 mL), t-BuMgCl (1.85M in Et2O, 1.14 mL, 2.1 mmol, 
1.05 equiv.), and dienone 73a (0.2764 g, 2 mmol, 1 
equiv.) at -20 
°
C, a colorless oily liquid mixture of 75aD 
and 77aD was obtained as non-separable isomers (287 mg , 73%, Rf = 0.43 in 10% Et2O/ 
90% hexane): IR (neat) 2965 (s), 2873 (s), 1713 (s), 1468 (s), 1366 (s), 1289 (w), 1235 









= 5.1 Hz, 3H), 0.97 (t, J = 7.4 Hz, 3H), 1.54-1.64 (m, 2H), 1.91-1.97 (m, 1H), 2.83 (t, J = 
7.4 Hz, 2H), 3.23 (d, J = 6.9 Hz, 2H), 5.48 (dt, J = 14.2, 6.9 Hz, 1H), 5.57 (dd, J = 15.1 
Hz, 8.7 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.7, 17.8 (2-carbons), 27.4, 32.6, 41.1, 
41.4, 48.9, 126.8, 131.2, 214.3; 77aD: 
1
H-NMR (500 MHz, CDCl3) 0.87 (s, 9H), 0.91-
0.98 (m, 6H), 1.26-1.30 (m, 1H), 1.54-1.64 (m, 2H), 2.29-2.34 (m, 1H), 2.40-2.45 (m, 
1H), 2.67 (dd, J = 14.2, 3.2 Hz, 1H), 2.79-2.83 (m, 1H), 5.21-5.27 (m, 1H), 5.37-5.41 (m, 
1H); 
13
C-NMR (125 MHz, CDCl3) δ 15.3, 18.0, 27.3, 32.7, 39.9, 44.5, 47.1, 121.7, 137.9, 
212.8; mass spectrum m/z (relative intensity) EI 196 (1, M
+
), 140 (24), 97 (36), 71 (100), 
57 (45); HRMS (EI) calculated for [C13H24O]
+
 196.1827, found 196.1825. 
 (6E) 5-Cyclohexyl-2-methyloct-6-en-3-one (75aE): Employing general procedure B 
using diethyl ether (4.0 mL), cyclohexyl magnesium chloride (2.0 M in 
diethyl ether, 0.60 mL, 1.2 mmol, 1.2 equiv.), and dienone 73a  
(0.1382 g, 1.0 mmol, 1.0 equiv.) 75aE was obtained as a colorless 
liquid (160.1 mg, 72%; Rf = 0.47 in 10% Et2O: 90% hexane): IR (neat) 2968 (s), 2926 (s), 





(500 MHz, CDCl3) δ ; 0.88-1.01 (m, 2H), 1.04 (t, J = 6.9 Hz, 6H), 1.08 -1.22 (m, 4H), 
1.60-1.64 (m, 5H), 1.68-1.72 (m, 3H), 2.36-2.39 (m, 1H), 2.42-2.48 (m, 2H), 2.55 (sept, J 
= 6.9 Hz, 1H), 5.17 (ddd, J = 6.4 Hz, 8.7 Hz, 1.4 Hz, 1H), 5.28-5.35 (m, 1H); 
13
C-NMR 
(125 MHz, CDCl3) δ 17.9 (3-carbons), 26.5 (2-carbons), 29.6, 30.9, 41.2, 41.8, 43.5, 
44.1, 125.9, 132.4, 214.5; mass spectrum m/z (relative intensity) EI 222 (38, M
+
), 179 
(58), 137 (36), 136 (86), 97 (62), 95 (87), 81 (86), 71 (100); HRMS (ESI) calculated for 
[C15H27O]
+




 (2E) 4-Ethyldodec-2-en-6-one (75bA): Following general procedure B using diethyl 
ether (5.0 mL),  ethylmagnesium chloride (1.80M in Et2O, 
0.61mL, 1.1 equiv.), and dienone 73b (0.180 g, 1.0 mmol, 1.0 
equiv.) at room temperature, 75bA was obtained as a yellow liquid (163.5 mg, 78%; Rf = 
0.50 in 10% EtOAc: hexane). About 9% of the 1,2-product was also observed by using 
this method. IR (neat) 2960 (s), 2931 (s), 2858 (s), 1715 (s), 1457 (s), 1409 (m), 1378 (s), 




H-NMR (500 MHz, CDCl3) δ 0.83-0.90 (m, 6H), 
1.21-1.32 (m, 8H), 1.35-1.41 (m, 1H), 1.53-1.56 (m, 2H), 1.64 (d, J = 6.4 Hz, 3H), 2.35-
2.39 (m, 4H), 5.16-5.21 (m, 1H), 5.38-5.45 (m, 1H);
 13
C-NMR (125 MHz, CDCl3) δ 11.6, 
14.0, 17.9, 22.5, 23.6, 28.0, 28.9, 31.6, 40.3, 43.5, 48.4, 125.5, 133.9, 210.9; mass 
spectrum m/z (relative intensity) EI 210 (1.3, M
+
), 181 (13), 113 (91), 85 (54), 83 (41), 55 
(67), 43 (100); HRMS (ESI) calculated for [C14H27O]
+
 211.2062, found 211.2061. 
 5-[(1E)-Prop-1-en-1-yl]tridecan-7-one (75bB): Following general procedure B using 
diethyl ether (5.0 mL), n-BuMgCl (1.22 M in THF/toluene, 0.90 mL, 
1.1 equiv.), and dienone 73b (0.180 g, 1.0 mmol, 1.0 equiv.) at room 
temperature, 75bB was obtained as a yellow liquid (226 mg, 95%; Rf 
= 0.58 in 10% Et2O: 90%hexane, stains in KMnO4): IR (neat) 2928 (s), 2858 (s), 1715 




H-NMR (500 MHz, 
CDCl3) δ 0.86-0.90 (m, 6H), 1.20-1.30 (m, 12H), 1.52-1.55 (m, 2H), 1.63 (d, J = 6.4 Hz, 
3H), 2.34-2.37 (m, 4H), 2.45-2.49 (m, 1H), 5.16-5.21 (m, 1H), 5.37-5.43 (m, 1H);
 13
C-
NMR (125 MHz, CDCl3) δ 14.0 (2-carbons), 17.8, 22.5, 22.6, 23.6, 28.9, 29.3, 31.6, 34.9, 







),  181 (15), 113 (100), 85 (33), 69 (27); HRMS (EI) calculated for [C16H30O]
+
 
238.2297, found 238.2303. 
 (2E) 4-(Propan-2-yl)dodec-2-en-6-one (75bC): Employing general procedure B using 
diethyl ether (5.0 mL), 
i
PrMgCl (1.53 M in Et2O, 0.72 mL, 1.1 
equiv.), and dienone 73b (0.180 g, 1.0 mmol, 1.0 equiv.) at room 
temperature, 75bc was obtained as a yellow liquid (182.2 mg, 81%, Rf = 0.47 in 10% 





H-NMR (500 MHz, CDCl3) δ 0.82-0.90 (m, 10H), 1.27-1.31 (m, 6H), 1.52-1.65 
(m, 6H), 2.34-2.42 (m, 4H), 5.19-5.24 (m, 1H), 5.35-5.42 (m, 1H); 
13
C-NMR (125 MHz, 
CDCl3) δ 14.0, 17.9, 18.8, 20.4, 22.5, 23.6, 28.9, 31.6, 31.8, 43.5, 44.9, 46.0, 126.4, 
131.6, 211.2; mass spectrum m/z (relative intensity) EI 224 (5, M
+
) 139 (25), 114 (31), 
113 (99), 111 (26), 97 (83); HRMS (ESI) calculated for [C15H29O]
+
 225.2218, found 
225.2219. 
 (4E) 3-Ethyl-1-phenylhex-4-en-1-one (75cA): Employing general procedure B using 
diethyl ether (5.0 mL), EtMgCl (1.81M in THF, 0.60 mL, 1.1 equiv.) 
and dienone 73c (0.172 g, 1 mmol) dissolved in dry Et2O (made 
soluble by addition of few drops of dry CH2Cl2 until solution became clear; complex 
mixture is obtained if the dienone is not made soluble with CH2Cl2) 75cA was obtained 
after flash chromatography as an oil (184.0 mg, 91%, Rf = 0.42 in 10% Et2O/ 90% 
hexane): IR (neat) 3062 (m), 3028 (m), 2963 (s), 2932 (s), 2877 (s), 2857 (s), 1682 (s), 
1598 (s), 1581 (s), 1449 (s), 1378 (s), 1363 (s), 1330 (s), 1280 (s), 1210 (s), 1181 (s), 









(m, 1H), 1.46-1.54 (m, 1H), 1.63 (d, J = 6.4Hz, 3H), 2.57-2.64 (m, 1H), 2.95 (d, J = 
6.9Hz, 2H), 5.28 (dd, J = 15.2Hz, 8.3Hz, 1H), 5.39-5.46 (m, 1H), 7.46 (t, J = 7.8Hz, 2H), 
7.53-7.57 (m, 1H), 7.95 (d, J = 7.4Hz, 2H); 
13
C NMR (125 MHz, CDCl3) δ 11.6, 17.8, 
27.9, 40.4, 44.1, 125.4, 128.1, 128.5, 132.7, 133.9, 137.5, 199.9. Spectral data were 
consistent with that reported in literature.
59a-b
 
1-Phenyl-3-[(1E)-prop-1-en-1-yl]heptan-1-one (75cB): Employing general procedure 
B using diethyl ether (5.0 mL), n-butylmagnesium bromide (1.22 M in 
THF/toluene, 0.9 mL, 1.1 equiv.) and dienone 73c (0.172 g, 1.0 mmol), 
75cB was obtained as an oily liquid (198 mg, 86%, Rf = 0.44 in 10% 
Et2O: 90% hexane). 75cB was stained in KMnO4: IR (neat) 3062 (m), 3028 (m), 2958 (s), 
2930 (s), 2858 (s), 1683 (s), 1598 (s), 1581 (m), 1449 (s), 1378 (s), 1281 (s), 1214 (s), 




H NMR (500 MHz, CDCl3) δ 0.87-0.91 (m, 3H), 1.22-
1.33 (m, 5H), 1.42-1.47 (m, 1H), 1.62 (dd, J = 6.4Hz, 0.9Hz, 3H), 2.64-2.72 (m, 1H), 
2.94-2.96 (m, 2H), 5.25-5.31 (m, 1H), 5.38-5.45 (m, 1H), 7.45-7.48 (m, 2H), 7.54-7.57 
(m, 1H), 7.95 (d, J = 7.4Hz, 2H); 
13
C NMR (125 MHz, CDCl3) δ 14.0, 17.9, 22.7, 29.4, 
34.9, 38.8, 44.5, 125.2, 128.1, 128.5, 132.7, 134.3, 137.5, 199.9. Spectral data were 
consistent with that reported in literature.
60
 
 (4E) 1-Phenyl-3-(1-methylethyl)hex-4-en-1-one (75cC): Following general procedure 
B  using diethyl ether (5.0 mL), i-PrMgBr (1.25 M in THF, 0.88 mL, 
1.1 equiv.) and dienone 73c (0.720 g, 1.0 mmol), 75cC was obtained as 
a yellow liquid (989 mg, 92%,  Rf = 0.45 in 10% Et2O: 90 hexane): IR 









H-NMR (500 MHz, 
CDCl3) δ 0.90 (d, J = 6.9 Hz, 3H), 0.93 (d, J = 6.9 H, 3H), 1.60 (d, J = 5.9 Hz, 3H), 1.67-
1.74 (m, 1H), 2.54-2.60 (m, 1H), 2.92-3.02 (m, 2H), 5.27-5.39 (m, 2H), 7.46 (t, J = 7.8 
Hz, 2H), 7.53-7.56 (m, 1H), 7.93 (d, J = 7.4 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 
17.9, 18.8, 20.5, 31.7, 41.6, 44.9, 126.4, 128.0, 128.4, 131.5, 132.6, 137.5, 200.1; mass 
spectrum m/z (relative intensity) EI 216 (1.7, M
+
), 173 (12), 105 (100), 96 (21), 77 (36); 
HRMS (ESI) calculated for [C15H21O]
+
 217.1592, found 217.1595 
(6E) 5-Ethyl-2-methyl-7-phenylhept-6-en-3-one (82aA): Following general procedure 
B using diethyl ether (5.0 mL), EtMgBr (1.81 M in THF, 0.66 mL, 
1.2 equiv.), and dienone 81a (0.200 g, 1.0 mmol), 82aA was obtained 
as a yellow oil (216 mg, 94%, Rf = 0.42 in 10% Et2O: 90% hexane): IR (neat) 3082 (m), 
3060 (m), 3027 (s), 2967 (s), 2932 (s), 2875 (s), 1713 (s), 1494 (m), 1464 (s), 1382 (s), 




H-NMR (500 MHz, CDCl3) δ 0.92-
0.95 (m, 3H), 1.07-1.11 (m, 6H), 1.37-1.46 (m, 1H), 1.50-1.58 (m, 1H), 2.53-2.64 (m, 
3H), 2.68-2.75 (m, 1H), 6.02 (dd, J = 16.1 Hz, 8.7 Hz, 1H), 6.41 (d, J = 16.1 Hz, 1H), 
7.207-7.37 (m, 5H);  
13
C-NMR (125 MHz, CDCl3) δ 11.7, 17.9, 18.0, 27.8, 40.2, 41.3, 
45.8, 126.0, 127.0, 128.4, 130.2, 133.2, 137.5, 213.6; mass spectrum  m/z (relative 
intensity) EI 230 (49, M
+
), 187 (61), 145 (71), 129 (47), 117 (65), 91 (79), 71 (100), 43 
(100); HRMS (ESI) calculated for [C16H23O]
+
 231.1749, found 231.1748. 
 2-Methyl-5-[(E) 2-phenylethenyl]nonan-3-one (82aB): Following general procedure 
B using diethyl ether (5.0 mL), 
n
BuMgCl (1.22 M in THF/toluene, 0.90 





was obtained as an oily liquid (225 mg, 87%, Rf = 0.44 in 10% Et2O: 90% hexane): IR 
(neat) 3082 (m), 3060 (s), 3027 (s), 2963 (s), 2930 (s), 2873 (s), 1712 (s), 1599 (m), 1466 




H-NMR (500 MHz, CDCl3) δ 0.90-0.92 (m, 3H), 1.07-1.11 (m, 6H), 
1.31-1.41 (m, 5H), 1.46-1.50 (m, 1H), 2.56-2.62 (m, 3H), 2.76-2.83 (m, 1H), 6.03 (dd, J 
= 15.6 Hz, 8.7 Hz, 1H), 6.41 (d, J = 15.6 Hz, 1H), 7.22 (t, J = 7.4 Hz, 1H), 7.30-7.33 (m, 
2H), 7.37 (d, J = 7.3 Hz, 2H);   
13
C-NMR (125 MHz, CDCl3) δ 14.0, 17.9, 17.9, 22.6, 
29.4, 34.7, 38.6, 41.2, 46.2, 126.0, 126.9, 128.4, 130.0, 133.5, 137.4, 213.5; mass 
spectrum m/z (relative intensity) EI 258 (38, M
+
), 215 (81), 129 (48), 117 (87), 91 (93), 
71 (100), 43 (100); HRMS (ESI) calculated for [C18H27O]
+
 259.2062, found 259.2058 
 (6E) 2-Methyl-7-phenyl-5-(propan-2-yl)hept-6-en-3-one (82aC): Following general 
procedure B using diethyl ether (5.0 mL), 
i
PrMgBr (1.25 M in Et2O, 
0.88 mL, 1.1 equiv.), and dienone 81a (0.200 g, 1.0 mmol, 1.0 
equiv.), 82aC was obtained as a yellow oil (0.200 g, 82%, Rf = 0.308 in 10% Et2O: 90% 
hexane): IR (neat) 3082 (m), 3060 (m), 3027 (s), 2964 (s), 2873 (s), 1712 (s), 1599 (m), 





H-NMR (500 MHz, CDCl3) δ 0.93-0.99 (m, 6H), 1.08 (dd, J = 13.8 Hz, 6.9 
Hz, 6H), 1.72-1.78 (m, 1H), 2.56-2.70 (m, 4H), 6.02-6.08 (m, 1H), 6.39 (d, J = 16.0 Hz, 
1H), 7.20-7.23 (m, 1H), 7.29-7.32 (m, 2H), 7.35 (d, J = 7.3Hz, 2H); 
13
C NMR (125 MHz, 
CDCl3) δ 18.0, 18.0, 19.0, 20.6, 31.8, 41.3, 43.5, 44.8, 126.0, 126.9, 128.4, 131.1, 131.2, 
137.5, 213.7; mass spectrum m/z (relative intensity) EI 244 (39, M
+
), 201 (30), 129 (38), 
117 (54), 91 (46), 71 (100), 43 (100); HRMS (ESI) calculated for [C17H25O]
+
 245.1905, 




 (1E) 3-Mthyl-1-phenylundec-1-en-5-one (82bA): Following general procedure B 
using diethyl ether (5.0 mL), and EtMgBr (0.55 mL, 1.1 mmol, 
1.1 equiv.) at -20 
°
C,  dienone 81b (0.242 g, 1.0 mmol, 1.0 
equiv.) dissolved in CH2Cl2 was added dropwise with stirring. 82bA was obtained after 
flash chromatography (Rf = 0.38 in 10% Et2O: 90% hexane) as a light yellow liquid (234 
mg, 86%; 1,4: 1,2 = 90:10): IR (neat) 3082 (w), 3060 (m), 3027 (s), 2930 (s), 2858 (s), 





(500 MHz, CDCl3) δ 0.86-0.94 ( m, 7H), 1.27 (s, 7H), 1.40 (sept, J = 7.8 Hz, 1H), 1.49-
1.58 (m, 3H), 2.40 (t, J = 7.3 Hz, 2H), 2.52 (d, J = 6.9 Hz, 2H), 2.65-2.71 (m, 1H), 5.99-
6.04 (m, 1H), 6.40 (d, J = 16.1Hz, 1H), 7.20-1.23 (m, 1H), 7.36-7.29 (m, 4H); 
13
C-NMR 
(125 MHz, CDCl3) δ 11.7, 14.0, 22.4, 23.6, 27.9, 28.9, 31.6, 40.5, 43.6, 48.2, 126.0, 
127.0, 128.4, 130.3, 133.1, 137.4, 210.4; mass spectrum m/z (relative intensity) EI 272 
(10, M
+
), 145 (23), 113 (95), 91 (33), 85 (52), 43(100); HRMS (ESI) calculated for 
[C19H29O]
+
 273.2218, found 273.2213.  
 (4E) 3-Ethyl-1,5-diphenylpent-4-en-1-one (82cA): Compound 82cA was synthesized 
by following general procedure B using diethyl ether (5.0 mL), 
EtMgCl (2.0 M in THF, 0.60 mL, 1.1 equiv.), and dienone 81c 
(0.2343 g, 1.0 mmol) dissolved in dry CH2Cl2. After extraction with 
CH2Cl2 the crude material was purified (silica gel) to obtain 82cA as a white solid (238 
mg, 90%). IR (neat) 3060 (m), 3026 (m), 2963 (s), 2929 (s), 2874 (m), 1685 (s), 1597 
(m), 1449 (s), 1266 (m), 1209 (m), 967 (s), 749 (s), 692 (s)cm
-1
;1H NMR (500 MHz, 





1H), 6.22 (d, J = 6.9Hz, 2H), 6.11 (dd, J = 7.4Hz, 8.7H, 1H), 6.43 (d, J = 15.6, 1H), 7.20-
7.23 (m, 1H), 7.29-7.32 (m, 2H), 7.35 (d, J = 7.3Hz, 2H), 7.47-7.50 (m, 2H), 7.56-7.76 
(m, 1H); 
13
C NMR (125 MHz, CDCl3) δ 11.8, 27.9, 40. 7, 44.0, 126.1, 127.0, 128.1, 
128.4, 128.5, 130.3, 132.9, 133.2, 137.4, 137.4, 199.3; mass spectrum m/z (relative 
intensity) EI 264 (10, M
+
), 235 (6), 217 (1), 173 (17), 159 (9), 145 (8), 129 (10), 117 (8), 
106 (11), 105 (100), 91 (17), 77 (39), 51 (7). Spectral data are consistent with that 
reported in the literature.
59a, 61a-b 
 
 4-Methylidene-1-phenyl-3-[(E)-2-phenylethenyl]octan-1-one (82cF): The 2-
hexenylmagnesium bromide (1.1 equiv.) was prepared using an 
established literature procedure
62
 with flame-dried magnesium 
turnings (0.050 g, 2.1 mmol, 2.1 equiv.), a tiny crystal of iodine, a 
THF solution of 2-bromohexene (0.200 g, 1.2 mmol), and  3.0 mL of THF. The reaction 
mixture was heated at 50 
°
C under reflux for 3 hrs and then cooled to room temperature 
before employing general procedure B using a THF solution of dienone 81c (0.2343 g, 
1.0 mmol). Product was extracted with CH2Cl2 and the crude material was purified (silica 
gel, 10% Et2O: 90% hexane, Rf = 0.42 in 10% EtOAc: 90% hexane) to obtain 82cF as an 
oil (267.5 mg, 84%): IR (neat) 3083(s), 3061(s), 3027 (s), 2932 (s), 1686(s), 1639 (s), 




H-NMR (500 MHz, 
CDCl3) δ 0.87-0.92 (m, 3H), 1.28-1.38 (m, 2H), 1.45-1.53 (m, 2H), 1.43 (m, 2H), 2.11-
2.14, (m, 2H), 3.22-3.26 (m, 1H), 3.32-3.37 (m, 1H), 3.63 (q, J = 7.4 Hz, 1H), 4.89 (s, 
2H), 6.13-6.18 (m, 1), 6.43 (d, J = 15.6 Hz, 1H), 7.19-7.22 (m, 1H), 7.30-7.34 (m, 4H), 
7.46-7.49 (m, 2H), 7.56-7.59 (m, 1H), 7.96-7.98 (m, 2H); 
13




14.0, 22.5, 30.0, 34.9, 42.5, 44.2, 109.1, 126.2, 127.1, 128.1, 128.4, 128.6, 130.3, 132.0, 
132.9, 137.3, 151.1, 198.6; mass spectrum m/z (relative intensity) EI 318 (10, M
+
), 198 
(11), 129 (10), 106 (12), 105 (100), 91 (15); HRMS (ESI) calculated for [C23 H27O]
+
 
319.2062, found  319.2051.
  
(6E,8E) 5-(Propan-2-yl)deca-6,8-dien-5-ol (79aB): Employing general procedure B 
using diethyl ether (5.0 mL), n-BuLi (2.83 M in hexane, 0.37 mL, 1.05 
mmol, 1.05 equiv.), and dienone 73a (0.1382 g, 1.0 mmol) at -20 
°
C, 
79aB was obtained after purification as a colorless oily liquid (170.6 
mg, 87%, Rf = 0.23 in 10% Et2O: 90% hexane). 79aB and 75aB were obtained in a ratio 





H-NMR (500 MHz, CDCl3) δ 0.87-0.92 (m, 9H), 1.22-1.33 (m, 4H), 1.35 
(s, 1H), 1.48-1.59 (m, 2H), 1.72-1.77 (m, 4H), 5.54 (d, J = 15.6 Hz, 1H), 5.66-5.73 (m, 
1H), 6.06-6.11 (m, 1H), 6.17-6.22 (m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 14.1, 16.5, 
17.6, 18.1, 23.2, 25.6, 77.3, 128.3, 128.7, 131.2, 135.3; mass spectrum m/z (relative 
intensity) EI 192 (5, M
+
), 153 (100), 97 (51), 95 (36), 93 (28), 57 (72), 43 (81); HRMS 
(EI) calculated for [C13H24O]
+
 196.1827, found 196.1831. 
 (1E,3E) 5-Mthyl-1-phenylundeca-1,3-dien-5-ol (84bA): Compound 84bA was 
obtained as a minor product  in 82bA above. (84bA), Rf = 
0.16 in 10% Et2O: 90% hexane. 
1
H-NMR (500 MHz, CDCl3) 
δ 0.90-0.93 (m, 7H), 1.3 (s, 8H), 1.56-1.65 (m, 4H), 5.82 (d, J 
= 15.2 Hz, 1H), 6.40-6.45 (m, 1H), 6.56 (d, J = 16.1 Hz, 1H), 6.82 (dd, J = 15.6 Hz, 10.5 







NMR (125 MHz, CDCl3) δ 7.9, 14.1, 22.6, 23.5, 29.8, 31.8, 33.7, 40.8, 75.5, 126.2, 
127.3, 128.5, 128.6, 128.7, 131.6, 137.4, 140.1; HRMS (ESI) calculated for [C19H29O]
+
 
273.2218, found 273.2213.  
 (6E) 2-Methyl-5-phenyloct-6-en-3-one (86A): To a flame-dried flask containing a stir 
bar under argon was added 4 mL of diethyl ether and PhMgCl (1.3 M in 
THF, 1.0 mL, 1.3 equiv.) followed by hexamethylphosphoramide 
(HMPA) (0.52 mL, 3.0 equiv.) and the mixture was stirred at room 
temperature for 10 minutes. To this mixture was added a diethyl ether solution of dienone 
73a (0.1382 g, 1.0 mmol) in a drop wise fashion via syringe. After the addition, the 
reaction mixture was allowed to stir at room temperature for 12 hrs before it was 
quenched with saturated aqueous NH4Cl and extracted with diethyl ether. The combined 
organic phase was dried with MgSO4, filtered and the solvent removed in vacuo. The 
crude material was purified by flash column chromatography (silica gel, 10% Et2O: 90% 
hexane; Rf = 0.407) to obtain 86A as a light yellow oil (167.5 mg, 77%): IR (neat) 3084 
(w), 3062(m), 3029 (s), 2970 (s), 2936 (s), 2877 (s), 1713 (s), 1493 (s), 1466 (s), 1453 




H-NMR (500 MHz, CDCl3) δ 0.91 (d, J = 6.9 
Hz, 3H), 0.96 (d, J = 6.9 Hz, 3H), 1.58 (d, J = 6.5 Hz, 3H), 2.43 (sept, J = 6.9 Hz, 1H), 
2.72-2.81 (m, 2H), 3.83 (q, J = 7.4 Hz, 1H), 5.35-5.42 (m, 1H), 5.50-5.55 (m, 1H), 7.10-
7.14 (m, 3H), 7.20-7.73 (m, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 17.7, 17.8, 17.9, 41.2, 
43.6, 46.6, 125.2, 126.2, 127.4, 128.4, 133.5, 143.9, 212.6; mass spectrum m/z (relative 
intensity) EI 216 (3.0, M
+
), 187 (20), 173 (47), 131 (88), 91 (47), 71 (80), 43 (100); 
HRMS (EI) calculated for [C15H20O]
+
 216.1514, found 216.1515.  




 (6E) 2-Methyl-5-(naphthalen-1-yl) oct-6-en-3-one (86B): To a flame-dried magnesium 
chips (2 equiv.) in a round-bottom flask with stir bar under argon was 
charged with 1-bromonaphthalene (0.5383 g, 2.6 mmol, 1.3 equiv.) and a 
crystal of iodine. Dry diethyl ether was added and the mixture stirred 
vigorously at room temperature for 2 hrs. Diethyl ether solution of dienone 73a (0.138 g, 
1.0 mmol) was then added dropwise with vigorous stirring for 12 hrs at room temperature 
after which it was quenched with saturated NH4Cl(aq) and extracted with CH2Cl2. The 
crude material was purified (silica gel) to obtain 86B as a yellow oil (413.2 mg, 75%; Rf 
= 0.38 in 10% EtOAc: 90% hexane ): IR (neat) 3047 (s), 2969 (s), 2934 (s), 1713 (s), 




H-NMR (500 MHz, CDCl3) δ 1.07 (d, J = 6.9 Hz, 3H), 1.11 
(d, J = 7.4 Hz, 3H), 1.68 (d, J = 6.4 Hz, 3H), 2.56-2.64 (m, 1H), 2.92-2.96 (m, 1H), 3.06-
3.11 (m, 1H), 4.60-4.65 (m, 1H), 5.47-5.54 (m, 1H), 5.72-5.76 (m, 1H), 7.39 (d, J = 6.9 
Hz, 1H), 7.43-7.47 (m ,1H), 7.49-7.52 (m, 1H), 7.54-7.57 (m, 1H), 7.75(d, J = 7.8 Hz, 
1H), 7.88 (d, J = 8.3 Hz, 1H), 8.21 (d, J = 8.3 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 
17.9, 38.2, 41.3, 46.4, 123.5, 123.9, 125.3, 125.5, 125.9, 126.0, 126.9, 128.8, 131.2, 
133.0, 133.9, 140.2, 212.8; mass spectrum m/z (relative intensity) EI 266 (57, M
+
), 195 
(71), 180 (68), 166 (68), 165 (95), 153 (38), 71 (80), 43 (100); HRMS (EI) calculated for 
[C19H22O]
+
 266.1671, found 266.1673 
(6E) 2-Methyl-5-(1-methyl-1H-pyrrol-2-yl)oct-6-en-3-one (86C): The N-
methylpyrrolyl magnesium bromide (1.1 equiv.) was prepared by 





B using dienone 73a (0.138 g, 1.0 mmol, 1.0 equiv.) to obtain 86C after purification 
(silica gel) as a colorless liquid (186.4 mg, 85%; Rf = 0.27 in a10% Et2O: 90% hexane): 
IR (neat) 3102 (m), 3021 (m), 2969 (s), 2935 (s), 2812 (w), 1712 (s), 1492 (s), 1467 (s), 




H-NMR (500 MHz, CDCl3) δ 1.11 (m, 6H), 1.65 (d, J = 6.0 Hz, 
3H), 2.57-2.66 (m, 1H), 2.48-2.94 (m, 2H), 2.5797 (s, 3H), 3.95 (q, J = 6.9 Hz, 1H), 5.33-
5.40 (m, 1H), 5.43-5.48 (m, 1H), 5.90 (d, J = 2.8 Hz, 1H), 6.08 (t, J = 3.2 Hz, 1H), 6.55 
(s, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.6, 17.8, 17.8, 33.6, 34.9, 41.3, 45.4, 104.3, 
106.3, 121.2, 125.4, 132.7, 134.4, 212.6. mass spectrum m/z (relative intensity) EI 219 
(67, M
+
), 149 (16), 148 (90), 134 (100), 132 (17), 93 (31), 91 (16); HRMS (EI) calculated 
for [C14H21NO]
+
 219.1623, found 219.1618. 
 (6E) 5-[4-(Dimethylamino)phenyl]-2-methyloct-6-en-3-one (86D): The p-Me2NC6H4-
MgBr (1.5 equiv.) was prepared by modifying an existing literature procedure
63
 using 
flame-dried magnesium turnings (0.096 g, 4.0 mmol), p-bromo-N,N-
dimethylaniline (0.600 g, 3.0 mmol), a tiny crystal of iodine, in 5.0 mL 
of THF. The reaction mixture was heated at reflux for 45 minutes and 
then cooled to room temperature before employing general procedure B 
using 1.5 equivalent of the resulting Grignard reagent, dienone 73a (0.1382 g, 1.0 mmol), 
and dry diethyl ether (4.0 mL) at room temperature to give the crude material which was 
purified (silica gel deactivated with triethylamine) to obtain 86D as an oil (195 mg, 90%): 
(86D) IR (neat) 2968 (s), 2933 (s), 2881 (s), 2801 (s), 1711 (s), 1614 (s), 1520 (s), 1446 









5.5 Hz, 3H), 2.53 (sept, J = 6.9 Hz, 1H), 2.77-2.87 (m, 2H), 2.93 (s, 6H), 3.79-3.84 (m, 
1H), 5.44 (sext, J = 6.4 Hz, 1H), 5.57-5.61 (m, 1H), 6.71 (d, J = 8.7 Hz, 2H), 7.10 ( d, J = 
8.7 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 17.8, 17.9, 40.7, 41.2, 42.8, 46.8, 112.9, 
124.5, 128.0, 132.0, 134.2, 149.2, 213.3; mass spectrum m/z (relative intensity) EI 259 
(75, M
+
), 175 (30), 174 (100), 159 (40), 158 (21), 144 (25), 132 (18); HRMS (EI) 
calculated for [C17H25ON]
+
 259.1936, found 259.1942.   
 (6E) 2-Methyl-5-(thiophen-2-yl)oct-6-en-3-one (86E): The 2-thienyl magnesium 
bromide (1.1 equiv.) was prepared in diethyl ether employing method 2, before applying 
general procedure B using dienone 73a (0.138 g, 1.0 mmol, 1.0 equiv.) 
10% Et2O: 90% hexane) to obtain  86E after purification (silica gel) as 
an oily liquid (155.6 mg, 70%; Rf = 0.45 in 10% Et2O: 3% CH2Cl2: 87% 
hexane): IR (neat) 3107 (w), 3072 (w), 3025 (w), 2970 (s), 2934 (s), 2876 (s), 1713 (s), 





H-NMR (500 MHz, CDCl3) δ 1.05 (d, J = 6.9 Hz, 3H), 1.08 (d, J = 6.9 Hz, 3H), 1.68 
(d, J = 4.6 Hz, 3H), 2.55 (sept, J = 6.9 Hz, 1H), 2.84-2.93 (m, 2H), 4.18-4.22 (m, 1H), 
5.51-5.61 (m, 2H), 6.81-6.82 (m, 1H), 6.92-6.93 (m, 1H), 7.14-7.15 (m, 1H);  
13
C-NMR 
(125 MHz, CDCl3) δ 17.9, 17.9, 17.95, 37.0, 41.34 47.5, 123.3, 123.5, 126.1, 126.6, 
133.0, 148.0, 212.2; mass spectrum m/z (relative intensity) EI 222 (5, M
+
), 180 (20), 179 
(100), 151 (48), 145 (15), 135 (10); HRMS (EI) calculated for [C13 H18OS]
+
 222.1078, 
found 222.1081.   
(6E) 5-(Furan-2-yl)-2-methyloct-6-en-3-one (86F):The 2-furyl magnesium bromide 
(2.4 mmol, 1.1 equiv.) was prepared in diethyl ether by employing 
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method 2 before applying general procedure B using dienone 73a (0.276 g, 2.0 mmol, 
1.0 equiv.) to give a crude material which was purified (silica gel, 15% Et2O: 85% 
hexane) to obtain 86F as an oily liquid (354 mg, 72%; Rf = 0.38 in 10% Et2O: 90% 
hexane ): IR (neat) 3118 (w), 3029 (m), 2971 (s), 2935 (s), 2877 (s), 1713 (s), 1582 (m), 




H NMR (500 MHz, CDCl3) δ 1.05-1.09 (m, 6H), 1.67 (d, J = 4.6 Hz, 3H), 2.56 (sept, J = 
6.9 Hz. 1H), 2.76 (dd, J = 16.5 Hz, 7.4 Hz, 1H), 2.89-2.94 (m, 1H), 3.97 (4.01 (m, 1H), 
5.51-5.54 (m, 2H), 6.01 (d, J = 3.2 Hz, 1H), 6.28 (dd, J = 3.2 Hz, 1.9 Hz, 1H), 7.31-7.32 
(m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.8, 17.9, 37.5, 41.3, 44.2, 104.8, 110.1, 126.8, 
130.5, 141.1, 156.8, 212.3; mass spectrum m/z (relative intensity) EI 206 (21, M
+
), 163 
(60), 121  (50), 91 (33), 71 (57), 43 (100); HRMS (EI) calculated for [C13H17O2]
+
 
205.1229, found 205.1227.   
 (4E,6E) 2-Methyl-3-phenylocta-4,6-dien-3-ol (87A): Compound 87A was obtained as 
a minor product  in 86A above (23.2 mg, 10.7%, Rf = 0.24 in 10% 
Et2O: 90% hexane): IR (neat) 3464 (br), 3059 (m), 3028 (m), 2971 (s), 
2933 (s), 2875 (s), 1687 (s), 1623 (m), 1448 (s), 1380 (s), 1273 (s), 




H-NMR (500 MHz, CDCl3) δ 0.80 (d, J = 6.4 
Hz, 3H), 0.93 (d, J = 6.9 Hz, 3H), 1.60 (s, 1H), 1.77 (d, J = 6.9 Hz, 4H), 2.21 (sept, J 
=6.9 Hz, 1H), 5.67-5.74 (m, 1H), 6.00 (d, J = 15.6 Hz, 1H), 6.11 (t, J = 15.2 Hz, 1H), 
6.26-6.31 (m, 1H), 7.24 (t, J = 7.4 Hz, 1H), 7.34 (t, J = 7.8 Hz, 2H), 7.44 (d, J = 7.3 Hz, 
2H);  
13




128.8, 129.4, 131.0, 135.9, 145.9; HRMS (EI) calculated for [C15H20O]
+
 216.1514, found 
216.1515.    
2-Methyl-3-(thiophen-2-yl)octa-4,6-dien-3-ol (87E): Compound (87E), the 1,2-product 
was obtained as byproduct from 86E above (Rf = 0.19 in 10% EtOAc: 
90% hexane): IR (neat) 3478 (br), 3106 (w), 3072 (m), 3019 (s), 2965 
(s), 2934 (s), 2876 (s), 1706 (m), 1659 (m), 1467 (s), 1448 (s), 1291 (s), 
1235 (s), 1170 (s), 1043 (s), 991 (s), 698 (s) cm
-1
; 1H-NMR (500 MHz, CDCl3) δ 0.9118-
0.9870 (m, 6H), 1.79 (d, J = 6.4 Hz, 3H), 2.07 (s, 1H), 2.16-2.22 (m, 1H), 5.73-5.79 (m, 
1H), 5.96 (d, J = 15.1 Hz, 1H), 6.14-6.18 (m, 1H), 6.34-6.39 (m, 1H), 6.93-6.98 (m, 2H), 
7.22 (dd, J = 5.1 Hz, 0.9 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.0, 17.6, 18.1, 39.5, 
78.4, 123.4, 123.9, 126.5, 129.4, 130.0, 130.7, 133.7, 151.4: HRMS (EI) calculated for 
[C13 H18OS]
+
 222.1078, found 222.1084. 
 (4E,6E) 3-(Furan-2-yl)-2-methylocta-4,6-dien-3-ol (87F): Compound 87F was 
obtained as a byproduct  of 86F above. (Rf = 0.33 in 15% Et2O: 85% 
hexane): IR (neat) 3589 (s), 3569 (s), 3468 (br), 3020 (s), 2965 (s), 2935 
(s), 2877 (s), 1658 (m), 1501 (m), 1466 (s), 1450 (s), 1385 (s), 1342 (s), 




H-NMR (500 MHz, CDCl3) δ 0.86 (d, J = 6.9 Hz, 3H), 
0.91 (d, J = 6.9 Hz, 3H), 1.78 (dd, J = 6.4 Hz, 1.4 Hz, 3H), 2.02 (s, 1H), 2.28 (sept, J = 
6.9 Hz, 1H), 5.70-5.78 (m, 1H), 5.89 (d, J = 15.2 Hz, 1H), 6.11-6.17 (m, 1H), 6.20-6.23 
(m, 1H), 6.32-6.37 (m, 2H), 7.37-7.38 (m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 16.7, 
17.3, 18.1, 106.0, 110.0, 129.8, 130.0, 130.8, 131.3, 141.5, 158.1; HRMS (EI) calculated 
for [C13H18O2]
+





(2E,4E) 6-(Propan-2-yl)dodeca-2,4-dien-7-yn-6-ol (89a): The 1-hexynyl magnesium 
bromide was prepared by modifying an existing literature procedure
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employing  dry diethyl ether (8.0 mL), 1-hexyne ( 0.411 g, 5.0 mmol, 1 
equiv.), and ethylmagnesium chloride in THF (1.81 M, 2.80 mL, 1.0 
equiv.) and then heating the mixture at reflux under argon for 6 h. The 
resulting Grignard reagent (1.1 mmol) was used with  a diethyl ether solution of dienone 
73a (0.1382 g, 1.0 mmol, 1.0 equiv.) in general procedure B to obtain after purification 
89a as a yellow oily liquid (204 mg, 93%, Rf = 0.30 in 10% EtOAc: 90% hexane): IR 
(neat) 3446 (br), 2933 (s), 2733 (w), 2214 (s), 1694 (s), 1634 (s), 1596 (m), 1467 (s), 




H-NMR (500 MHz, CDCl3) δ 0.9091-0.9430 
(m, 6H), 1.03 (d, J = 6.4 Hz, 3H), 1.41-1.56 (m, 4H), 1.76-1.87 (m, 4H), 2.03 (s, 1H), 
2.25-2.28 (m, 2H), 5.57 (d, J = 15.1 Hz, 1H), 5.72-5.79 (m, 1H), 6.06-6.11 (m, 1H), 6.47 
(dd, J = 10.5 Hz, 4.6 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 13.5, 17.2, 17.8, 18.1, 
18.3, 21.9, 30.8, 38.5, 75.1, 80.1, 87.0, 130.3, 130.5, 130.7, 133.2; mass spectrum m/z 
(relative intensity) EI 220 (0.01, M
+
), 202 (100), 131 (89), 130 (30), 129 (41), 128 (34), 
77 (28); HRMS (EI) calculated for [C15H24O]
+
 220.1827, found 220.1830.   
(4E,6E) 2,3-Dimethylocta-4,6-dien-3-ol (89b): Employing general procedure B and 
using diethyl ether (5.0 mL), MeMgBr (3.0 M in THF, 0.44 mL, 1.3 
equiv.), and dienone 73a (0.1382 g, 1.0 mmol) at -20 
°
C  89b was 
obtained after purification (silica gel) as a light yellow oily liquid with a pleasant smell, 
(127.6 mg , 83%, Rf = 0.19 in 10% EtOAc: 90% hexane): IR (neat) 3435 (br), 3020 (m), 









H NMR (500 MHz, CDCl3) δ 0.89-0.91 (m, 6H), 1.25 (s, 3H), 1.48 
(s, 1H), 1.71 (sept, J = 6.9Hz, 1H), 1.76 (d, J = 5.5Hz, 3H), 5.62-5.71 (m, 2H), 6.03-6.09 
(m, 1H), 6.17-6.22 (m, 1H); 
13
C NMR (125 MHz, CDCl3) δ 17.0, 17.4, 17.9, 24.9, 38.0, 
75.0, 128.0, 128.5, 131.1, 136.5. Spectral data were consistent with that reported in the 
literature.
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 1,1-Dimethylethyl-(4E,6E) 3-hydroxy-3-(propan-2-yl)octa-4,6-dienoate (89c): To an 
LDA (1.3 equiv.) in THF at -78 
°
C under argon was added tetramethyl 
ethylenediamine (TMEDA) (0.390 mL, 1.3 equiv.) and the mixture was 
stirred for 10 minutes. The tert-butyl acetate (0.3020 g, 2.6 mmol, 1.3 
equiv.) in THF was added dropwise to this mixture and then allowed to stir for 2 hours at 
this temperature. In a separate flask, MgBr2 was prepared by stirring flame-dried Mg 
turnings (100 mg, 4.2 mmol, 2.1equiv.) with 1,2-dibromoethane (0.526 g, 2.80 mmol, 1.4 
equiv.) in Et2O under argon at room temperature. The enolate was then transferred to the 
MgBr2 in diethyl ether at room temperature. The mixture was clear initially but then 
formed precipitate in the course of stirring over 30 minutes. The dienone 73a (0.2764 g, 
2.0 mmol, 1.0 equiv.) in THF was then added dropwise to this mixture at room 
temperature. After work-up, the crude material was purified (silica gel) to obtain 89c as a 
slightly yellowish oil (377. 2 mg, 74.1%; Rf = 0.30 in 10% EtOAc: 90% hexane): IR 
(neat) 3488 (br), 2972 (s), 2935 (s), 2879 (s), 1707 (s), 1637 (w), 1596 (m), 1456 (s), 




H-NMR (500 MHz, CDCl3) δ 0.89-
0.91 (m, 7H), 1.13(d, J = 6.9Hz, 1H), 1.43 (s, 9H), 1.75 (d, J = 6.5 Hz, 4H), 2.48 (d, J = 




1H), 6.17-6.24 (m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 16.7, 17.4, 18.1, 28.1, 37.5, 42.8, 
75.6, 81.6, 129.0, 129.9, 130.9, 133.1, 172.5; mass spectrum m/z (relative intensity) EI 
254 (0.02, M
+
), 155 (78), 137 (27), 95 (100), 57 (33), 43 (21); HRMS (EI) calculated for 
[C15H26O3]
+
 254.1882, found 254.1891. 
 (5E,7E) 4-(Propan-2-yl)nona-1,5,7-trien-4-ol (89d): Employing general procedure B 
using diethyl ether (5.0 mL), allylmagnesium bromide  (1.0M in Et2O, 
1.2 mL, 1.2 equiv.), and dienone 73a (0.1382 g, 1.0 mmol) at -20
 °
C, 
89d was obtained after purification as a colorless oily liquid with a pleasant smell (158.4 
mg, 88%; Rf = 0.34 in 10% Et2O: 90% hexane): IR (neat) 3589 (m), 3569 (m), 3554 (m), 
3485 (br), 3077 (m), 3018 (s), 2964 (s), 2879 (s), 1639 (m), 1468 (s), 1438 (s), 1381 (s), 




H-NMR (500 MHz, CDCl3) δ 0.91(t, 
J = 6.9 Hz, 6H), 1.62 (s, 1H), 1.77 (d, J = 6.9 Hz, 3H), 2.26-2.31 (m, 1H), 2.38-2.42 (m, 
1H), 5.12-5.16 (m, 2H), 5.58 (d, J = 15.1 Hz, 1H), 5.67-5.82 (m, 2H), 6.06-6.12 (m, 2H), 
6.20 (dd, J = 10.6 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 16.5, 17.6, 18.1, 36.9, 43.4, 
76.2, 119.1, 128.7, 129.5, 131.1, 133.9, 134.2; mass spectrum m/z (relative intensity) EI 
180 (0.2, M
+
), 139 (93), 97 (23), 95 (100), 67 (50), 43 (96); HRMS (EI) calculated for 
[C12H20O]
+
 180.1514, found 180.1512.   
 3-[(1E)-Prop-1-en-1-yl]cyclohex-2-en-1-one (90): Compound 90 is a known compound 
that was prepared by employing an existing literature procedure.
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Compound 90 was obtained as a light yellow oil with pleasant cinnamon 
smell with 80% (2.591 g ) yield in a 3.0 g scale synthesis from 3-







(500 MHz, CDCl3) δ 1.78 (d, J = 5.5 Hz, 3H), 1.90-1.92 (m, 2H), 2.27-2.29 (m, 2H), 
2.34-2.36 (m, 2H), 5.74 (s, 1H), 6.07-6.18 (m, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 18.8, 
22.3, 25.0, 37.6, 126.2, 132.7, 133.8, 157.5, 200.4.   
1-Ethyl-3-[(1E)-prop-1-en-1-yl]cyclohex-2-en-1-ol (91a): Compound 91a was prepared 
by employing general procedure B using CH2Cl2 (5 mL), EtMgCl (1.92 
M in THF, 0.58 mL, 1.1 mmol, 1.1 equiv.), and dienone 90 (0.136 g, 1.0 
mmol) at -20 
°
C for 2 hrs. The crude material was purified (silica gel 
neutralized with Et3N, 15% EtOAc: 85% hexane) to obtain 91a as a yellow oil (154.4 mg, 
95%, Rf = 0.26 in 20% EtOAc: 80% hexane). The product is very prone to dehydration 
and thus became cloudy soon after it was dissolved in CDCl3 for NMR. The cloudiness 
clears up as two layers form with water from the dehydration forming a layer on top. The 
NMR was however, taken in C6D6 without decomposition: IR (neat) 3371 (br), 3026 (w), 





H-NMR (500 MHz, Benzene-D6) δ 0.95 (t, J = 7.6 Hz, 3H), 1.43-1.58 (m, 4H), 
1.62-1.68 (m, 5H), 1.70 (s, 1H), 1.81-1.87 (m, 1H), 2.02-2.08 (m, 1H), 5.49 (s, 1H), 5.52-
5.59 (m, 1H), 6.03 (d, J = 15.6 Hz, 1H);
 13
C-NMR (125 MHz, Benzene-D6) δ 7.9, 18.1, 
19.1, 24.9, 35.1, 70.0, 123.6, 131.8, 134.7, 137.2; mass spectrum m/z (relative intensity) 
EI 166 (10, M
+
), 149 (37), 138 (42), 137 (100), 91 (28); HRMS (EI) calculated for 
[C11H18O]
+
 166.1358, found 166.1352.   
1-Butyl-3-[(1E)-prop-1-en-1-yl]cyclohex-2-en-1-ol (91b): Compound 91b was prepared 
by employing general procedure B using CH2Cl2 (5 mL), n-BuMgCl 





g, 1.0 mmol) at -20 
°
C for 2 hrs. The crude material was purified (silica gel neutralized 
with Et3N, 15% EtOAc: 85% hexane) to obtain 91b as a yellow liquid (303 mg, 78%, Rf 
= 0.32 in 20% EtOAc: 80% hexane). The product is very prone to dehydration and thus 
became cloudy soon after it was dissolved in CDCl3 for NMR. The cloudiness clears up 
as two layers form with water from the dehydration forming a layer on top. The NMR 
was however, taken in C6D6 without decomposition: IR (neat) 3370 (br), 3026 (s), 2933 





MHz, CDCl3) δ 0.89-0.93 (m, 3H), 1.26-1.34 (m, 3H), 1.36-1.45 (m, 2H), 1.46-1.58 (m, 
4H), 1.65-1.70 (m, 3H), 1.73 (s, 1H), 1.83-1.89 (m, 1H), 2.04-2.09 (m, 1H), 5.51 (s, 1H), 
5.53-5.60 (m, 2H), 6.05 (d, J = 15.6 Hz, 1H);
 13
C-NMR (125 MHz, BENZENE-D6) δ 
14.2, 18.1, 19.2, 23.6, 24.9, 26.0, 35.7, 42.6, 69.9, 123.6, 132.2, 134.7, 137.0; 
13
C-NMR 
(125 MHz, CDCl3) δ 14.0, 18.1, 18.9, 23.2, 24.6, 25.7, 35.3, 42.1, 70.3, 124.2, 131.0, 
133.9, 137.5; mass spectrum m/z (relative intensity) EI 194 (4, M
+
), 138 (19), 137 (100), 
79 (6); HRMS (EI) calculated for [C13H22O]
+
 194.1671, found 194.1665.   
3-[(1E)-Prop-1-en-1-yl]-1,1'-bi(cyclohexan)-2-en-1-ol (91c): Compound 91c was 
prepared by employing general procedure B using CH2Cl2 (5 mL), 
cyclohexylmagnesium chloride (1.82 M in Et2O, 0.62 mL, 1.1 mmol, 1.1 
equiv.), and dienone 90 (0.136 g, 1.0 mmol) at -20 
°
C for 2 hrs. The crude 
material was purified (silica gel neutralized with Et3N, 15% EtOAc: 85% hexane) to 
obtain 91c as a yellow oil (171.9 mg, 78%, Rf = 0.40 in 20% EtOAc: 80% hexane): The 
product is very prone to dehydration and thus became cloudy soon after it was dissolved 




dehydration forming a layer on top. The NMR was however, taken in C6D6 without 
decomposition: IR (neat) 3435 (br), 3025 (s), 2849 (s), 2728 (w), 1662 (s), 1624 (m), 





MHz, CDCl3) δ 0.95-1.08 (m, 2H), 1.17-1.26 (m, 3H), 1.52-1.62 (m, 4H), 1.65-1.69 (m, 
5H), 1.70-1.79 (m, 6H), 5.45 (s, 1H), 5.65-5.72 (m, 1H), 6.03 (d, J = 15.6 Hz, 1Hz);
 13
C-
NMR (125 MHz, CDCl3) δ 182.1, 18.6, 24.7, 26.5, 26.6, 26.7, 27.7, 31.3, 72.2, 124.2, 
130.7, 134.0, 138.4; mass spectrum m/z (relative intensity) EI 220 (12, M
+
), 203 (92), 202 
(18), 138 (93), 137 (100), 110 (37); HRMS (EI) calculated for [C15H24O]
+
 220.1827, 
found 220.1826.   
 (2E) 2-[(2E)-But-2-en-1-ylidene]cyclohexanone (92): This compound was prepared 
using a modified existing literature procedure
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 as follows. To a flame-
dried flask under argon was charged with THF (50 mL) followed by 
HMDS (3.389 g, 21.0 mmol, 1.05 equiv.) and the mixture cooled to 0 
o
C. 
n-BuLi (1.70 M in hexanes, 11.88 mL, 20.2 mmol, 1.1 equiv.) was then added dropwise 
via syringe and the mixture was stirred at 0 
°
C for 90 minutes. The mixture was then 
cooled to -78 
°
C and THF solution of the cyclohexanone (1.962 g, 20 mmol, 1.0 equiv.) 
was added dropwise to it over 5 minutes. After the addition, it was allowed to stir for 60 
minutes before THF solution of crotonaldehyde (1.402 g, 20 mmol, 1 equiv.) was added 
dropwise to it. The reaction mixture was then allowed to stir for at least an hour before 
quenching with saturated NH4Cl solution and then extracting (3x) with diethyl ether. The 
combined organic phase was dried with MgSO4, filtered and the solvent removed under 




HCl was added. The reaction mixture was stirred over 12 hrs after which the methanol 
was removed under reduced pressure. It was then diluted with water and extracted (3x) 
with diethyl ether. The combined organic phase was then dried with MgSO4, filtered and 
the solvent removed under reduced pressure. The crude material was purified by flash 
chromatography with 15% EtOAc/85% hexane (1.202 g; 40%; Rf = 0.34) to obtain 92 as 
a colorless solid.
 1
H-NMR (500 MHz, CDCl3) δ 1.70-1.76 (m, 2H), 1.79-1.87 (m, 5H), 
2.38-2.43 (m, 2H), 2.56-58 (m, 2H), 6.10-6.19 (m, 1H), 6.26-6.30 (m, 1H), 7.02 (d, J = 
11.5 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 19.1, 23.0, 23.3, 26.5, 39.9, 126.6, 132.6, 
135.6, 139.9, 201.0. 
2-[(4E)-Hex-4-en-3-yl]cyclohexanone (93) and 2-[(1E)-3-Methylpent-1-en-1-
yl]cyclohexanone (95):  Employing general procedure B using CH2Cl2 (5 mL), EtMgCl 
(1.92 M in THF, 0.79 mL, 1.53 mmol, 1.1 equiv.), and dienone 92 (0.2084 
g, 1.39 mmol) a mixture of 93 and 95 was obtained as non-separable 
isomers (144.2 mg, 80%, Rf = 0.29 in 10% EtOAc/ 90% hexane): IR (neat) 





NMR (500 MHz, CDCl3) δ 0.80-0.84 (m,
 
6H), 1.09-1.17 (m, 1H), 1.20-
1.28 (m, 1H), 1.32-1.40 (m, 1H), 1.42-1.51 (m, 1H), 1.56-1.62 (m, 1H), 1.64 (dd, J = 6.0 
Hz, 1.4Hz, 6H), 1.67 (dd, J = 6.4 Hz, 1.8 Hz, 4H), 1.69-1.93 (m, 7H), 2.17-2.40 (m, 8H), 
5.03-5.08 (m, 1H), 5.26-5.31 (m, 1H), 5.35-5.47 (m, 2H), (93): 
13
C-NMR (125 MHz, 
CDCl3) δ 11.9, 17.9, 23.6, 25.7, 28.0, 30.8, 41.8, 43.5, 54.9, 126.9, 132.3, 213.7; (95):
 
13
C-NMR (125 MHz, CDCl3): 12.1, 17.9, 24.0, 24.3, 27.5, 29.6, 42.0, 44.0, 55.2, 126.0, 
132.6, 212.6; mass spectrum m/z (relative intensity) EI 180 (19, M
+




98 (37), 83 (19), 55 (61); HRMS (EI) calculated for [C12H20O]
+
 180.1514, found 
180.1520. 
 (2E) 2-[(2E)-But-2-en-1-ylidene]-1-ethylcyclohexanol (94): (Rf = 0.15 in 10% EtOAc: 
90% hexane): IR (neat) 3439 (br), 3027 (m), 2927 (s), 2858 (s), 1711 (m), 





MHz, CDCl3) δ 0.82 (t, J = 7.3 Hz, 3H), 1.28-1.35 (m, 2H), 1.40-1.46 (m, 
1H), 1.52-1.59 (m, 3H), 1.70-1.88 (m, 7H), 2.76 (d, J = 13.8 Hz, 1H), 5.73-5.78 (m, 1H), 
6.13 (d, J = 10.6 Hz, 1H), 6.32-6.37 (m, 1H);
 13
C-NMR (125 MHz, CDCl3) δ 7.3, 18.4, 
23.5, 26.6, 27.2, 30.1, 41.2, 75.3, 120.4, 127.0, 128.7, 143.0; mass spectrum m/z (relative 
intensity) EI 180 (31, M
+
), 152 (26), 151 (100), 133(24), 81 (47), 67 (30); HRMS (EI) 
calculated for [C12H20O]
+
 180.1514, found 180.1518. 
 S-Propyl (2E,4E)-hexa-2,4-dienethioate (97): Compound was prepared by employing 
the typical procedure using sorbic acid (5. 00 g, 44.64 mmol, 1.0 
equiv.) and propanethiol (4.04 mL, 44.64 mmol, 1.0 equiv.) in 
CH2Cl2 to  obtain 97 as a colorless oil after column chromatography and distillation 
under reduced pressure (5.85 g, 77%). 
1
H NMR (500 MHz, CDCl3) δ 0.95 (t, J = 7.3Hz, 
3H), 1.56-1.63 (m, 2H), 1.82 (d, J = 6.0Hz, 3H), 2.88-2.91 (m, 2H), 6.03 (d, J = 15.6Hz, 
1H), 6.08-6.20 (m, 2H), 7.14 (dd, J = 15.1Hz, 10.1Hz, 1H); 13C NMR (125 MHz, CDCl3) 
δ 13.2, 18.6, 22.9, 30.4, 126.0, 129.5, 140.4, 140.6, 189.9. Spectral data was consistent 







S-Propyl (4E)-3-ethylhex-4-enethioate (98a): Employing general procedure A and 
using diethyl ether (4.0 mL), EtMgCl (1.82 M in Et2O, 0.66 mL, 1.2 
equiv.), and dienyl thiol ester 97 (0.170 g, 1.0 mmol) 98a was 
obtained as a yellow liquid (138 mg, 69%, Rf = 0.63 in 10% Et2O: 90% hexane): IR 





NMR (500 MHz, CDCl3) δ 0.85 (t, J = 7.8 Hz, 3H), 0.96 (t, J = 7.4 Hz, 3H), 1.26 (sept, J 
= 7.3 Hz, 1H), 1.38-1.47 (m, 1H), 1.58 (sext, J = 7.4 H, 2H), 1.64 (d, J = 6.4 Hz, 3H), 
2.40 (m, 3H), 2.82-2.85 (m, 2H), 5.19 (dd, J = 15.1 Hz, 8.3 Hz, 1H),  5.40-5.47 (m, 1H);
 
13
C-NMR (125 MHz, CDCl3) δ 11.4, 13.2, 17.8, 23.0, 27.5, 30.7, 41.7, 49.6, 125.9, 
133.0, 198.7; mass spectrum m/z (relative intensity) EI 200 (2, M
+
), 150 (33), 124 (56), 




S-Propyl 3-[(1E)-prop-1-en-1-yl]heptanethioate (98b): Employing general procedure 
B using diethyl ether (5.0 mL), n-BuMgCl (1.51 M in THF/toluene, 
0.73 mL, 1.1 equiv.), and dienyl thiol ester 97 (0.170 g, 1.0 mmol, 1.0 
equiv.) 98b was obtained as an oily liquid (169 mg, 74%; Rf = 0.61 in 
10% Et2O: 90% hexane): IR (neat) 2959 (s), 2931 (s), 2853 (s), 1692 (s), 1458 (s), 1039 




H-NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.9 Hz, 3H), 0.97 (t, J = 7.4 
Hz, 3H), 1.18-1.38 (m, 6H), 1.56-1.66 (m, 5H), 2.49-2.56 (m, 3H), 2.84-2.87 (m, 2H), 
5.20 (dd, J = 15.1 Hz, 6.4 Hz, 1H), 5.41-5.47 (m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 





spectrum m/z (relative intensity) EI 228 (4, M
+
), 153 (42), 152 (47), 124 (31), 111 (100), 
82 (42), 69 (96); HRMS (EI) calculated for [C13H24OS]
+
 228.15479, found 228.15513. 
S-Propyl (4E) 3-(propan-2-yl)hex-4-enethioate (98c): Employing general procedure B 
using diethyl ether (5.0 mL), i-PrMgCl (1.25 M in Et2O, 0.80 mL, 
1.0 equiv.), and dienyl thiol ester 97 (0.1703 g, 1.0 mmol, 1.0 equiv.) 
98c was obtained as a light yellow oil (179.3 mg, 84%; Rf = 0.61 in 10% Et2O: 90% 





H-NMR (500 MHz, CDCl3) δ  0.84 (d, J = 6.9 Hz, 3H), 0.87 (d, J = 6.5 H, 3H), 
0.96 (m, 3H), 1.54-1.65 (m, 6H), 2.37-2.43 (m, 1H), 2.47-2.52 (m, 1H), 2.61 (dd, J = 
14.2 Hz, 5.5Hz, 1H), 2.79-2.88 (m, 2H), 5.23 (ddd, J = 6.4 Hz, 8.7 Hz, 1.4 Hz, 1H),  
5.38-5.45 (m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 13.3, 17.9, 18.6, 20.4, 23.0, 30.7, 
31.5, 46.2, 47.3, 126.9, 130.6, 199.0; mass spectrum m/z (relative intensity) EI 214 (5, 
M
+
), 139 (40), 138 (92), 111 (51), 110 (80), 97 (100), 69 (70), 55 (84); HRMS (EI) 
calculated for [C12H22OS]
+
 214.13914, found 214.13877. 
 S-Propyl-(4E) 3-(1,1-dimethylethyl)-hex-4-enethioate (99e): Employing general 
procedure B using dichloromethane (7.0 mL), t-BuMgCl (1.85 M in 
Et2O, 1.19 mL, 1.1 equiv.), and dienyl thiol ester 74a (0.3430 g, 2.0 
mmol, 1.0 equiv.) at -20 
°
C for 2 hours. The crude material was 
purified (silica gel, 10% Et2O: 90% hexane; Rf = 0.60) to obtain a mixture of 99e and 
101e as non-separable  regioisomers (365 mg, 80%): IR (neat) 2928 (s), 2931 (s), 2866 
(s), 1699 (s), 1443 (s), 1039 (s), 947 (s) cm
-1
; Major (99e): 
1
H-NMR (500 MHz, CDCl3) 





1.97 (m, 1H), 2.83 (t, J = 7.4 Hz, 2H), 3.23 (d, J = 6.9 Hz, 2H), 5.48 (dt, J = 14.2, 6.9 Hz, 
1H), 5.57 (dd, J = 15.1, 8.7 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) δ 13.3, 15.2, 22.9, 
27.5, 30.7, 32.9, 47.1, 47.7, 120.8, 139.6, 198.3; mass spectrum m/z (relative intensity) EI 
228 (0.52, M
+
), 172 (80), 97 (93), 96 (92), 69 (97), 68 (99), 57 (100); HRMS (EI) 
calculated for [C13H24OS]
+
 228.1548, found 228.1548.  
S-Propyl-(4E)-3-(thiophen-2-yl)hex-4-enethioate (98o): The thienylmagnesium 
bromide (1.4 equiv.) was prepared from 2-bromothiophene by 
following method 1 in diethyl ether at room temperature before 
employing general procedure B using diethyl ether (4.0 mL), and 
dienyl thiol ester 97 (0.170 g, 1.0 mmol, 1.0 equiv.). The crude material was purified 
(silica gel, 10% Et2O: 90% hexane; Rf  = 0.55 in 10% EtOAc: 90% hexane) to obtain 98o 
as an oily liquid (198 mg, 78%): IR (neat) 3106 (w), 3070 (m), 3028 (m), 2964 (s), 2931 




H-NMR (500 MHz, 
CDCl3) δ 0.95 (t, J = 7.4 Hz, 3H), 1.54-1.62 (m, 2H), 1.69 (d, J = 4.2 Hz, 3H), 2.84-2.88 
(m, 2H), 2.92-3.02 (m, 2H), 4.16-4.20 (m, 1H), 5.59-5.60 (m, 2H), 6.83 (d, J = 3.7 Hz, 
1H), 6.93-6.95 (m, 1H), 7.17 (d, J = 5.0 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 13.2, 
17.7, 22.9, 30.8, 40.6, 50.8, 123.6 (2-carbons), 126.7, 126.8, 132.1, 146.9, 197.4; mass 
spectrum m/z (relative intensity) EI 254 (21, M
+
), 178 (17), 151 (41), 150 (100), 137 
(100), 135 (65), 97 (48); HRMS (EI) calculated for [C13H18OS2]
+





S-Propyl (4E)-3-(furan-2-yl)hex-4-enethioate (98q): The 2-furylmagnesium bromide 
(1.2 mmol, 1.2 equiv.) was prepared by following method 2 in diethyl 
ether at 0 
°
C before employing general procedure B using 
dichloromethane (3.0 mL), and dienyl thiol ester 97  (0.170 g, 1.0 
mmol, 1.0 equiv.) at -20 
°
C for 2 hrs.  The crude material was purified (silica gel, 10% 
Et2O: 90% hexane; Rf = 0.50) to obtain 98q as an oily liquid (143 mg, 60%): IR (neat) 
3026 (m), 2965 (s), 2933 (s), 2875 (s), 1693 (s), 1614 (s), 1542 (s), 1505 (s), 1454 (s), 




H-NMR (500 MHz, 
CDCl3) δ 0.96 (t, J = 7.3 Hz, 3H), 1.56-1.61 (m, 2H), 1.69 (d, J = 5.5 Hz, 3H), 2.83-2.88 
(m, 3H), 2.99-3.03 (m, 1H), 3.97 (q, J = 7.3Hz, 1H), 5.49-5.62 (m, 2H), 6.04 (d, J = 3.2 
Hz, 1H), 6.28-6.29 (m, 1H), 7.33-7.34 (m, 1H);
 13
C-NMR (125 MHz, CDCl3) δ 13.2, 
17.8, 22.9, 30.8, 39.1, 47.8, 105.1, 110.1, 127.5, 129.6, 141.4, 155.9, 197.4; mass 
spectrum m/z (relative intensity) EI 238 (14, M
+
), 135 (21), 134 (100), 121 (97), 93 (37), 
91 (49), 77 (34); HRMS (EI) calculated for [C13H18O2S]
+
 238.1028, found 238.1028.  
S-Propyl (3E) 5,6,6-trimethylhept-3-enethioate: (100e) was obtained as a minor 
product of 98e above: 
1
H-NMR (500 MHz, CDCl3) 0.87 (s, 9H), 
0.91-0.98 (m, 6H), 1.26-1.30 (m, 1H), 1.54-1.64 (m, 2H), 2.29-2.34 
(m, 1H), 2.40-2.45 (m, 1H), 2.67 (dd, J = 14.2 Hz, 3.2 Hz, 1H), 2.79-
2.83 (m, 1H), 5.21-5.27 (m, 1H), 5.37-5.41 (m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 13.2, 
17.8, 23.0, 27.5, 30.7, 32.9, 45.1, 50.5, 127.5, 130.1, 199.2; mass spectrum m/z (relative 
intensity) EI 228 (0.28, M
+





(97). (98e /100e = 79:21), 98e: HRMS (EI) calculated for [C13H24OS]
+
 228.1548, found 
228.1548. 
S-Propyl (2E,4E) 5-phenylpenta-2,4-dienethioate (102): This compound was prepared 
in 4 steps from bromoacetyl bromide by using modified existing 
literature procedures
69
 as described below. To a dry CH2Cl2 (90 
mL) solution of bromoacetyl bromide (10 mL, 114.44 mmol, 1 
equiv.), and anhydrous K2CO3 (1.0 equiv.), under argon at 0 
°
C was added dropwise with 
stirring, a CH2Cl2 solution of propanethiol (10.4 mL, 114.44 mmol, 1.0 equiv.in 10 mL 
CH2Cl2). After the gas evolution has subsided, the suspension was allowed to stir over 12 
hrs and then diluted with water and the organic phase washed several times with water. It 
was then dried with MgSO4, filtered and the CH2Cl2 removed under reduced pressure to 
obtain clear oily liquid (propyl-α-bromothioacetate) which was used for the next step 
without further purification (16.865 g, 75%). 1:1 mixture of the propyl-α-
bromothioacetate (10.0 g, 50.737 mmol) and triphenylphosphine (13.31 g, 50.745 mmol) 
in toluene was kept at 70 
°
C for 2h in a reflux set up during which white precipitate 
formed. After cooling to room temperature, the mixture was gravity filtered and washed 
with toluene and then the solid air-dried in the hood. The product was boiled with Et2O 
and vacuum filtered after cooling to obtain pure product (21.5109 g, 92%). The product 
was dissolved in EtOAc- CH2Cl2 mixture (3:1, 280 mL) and 84 mL of conc. NaOH (50 
g/50 mL H2O) was added. The mixture was stirred at room temperature until the phases 
have become clear. The organic phase was separated and dried with MgSO4, filtered and 




The ylide (6.214 g, 16.42 mmol) was suspended in dry THF under argon at rt and a 
solution of the cinnamaldehyde (2.17 g, 16.42 mmol, 1 equiv.) in THF was added quickly 
in a dropwise manner. After stirring at room temperature for 12 hrs, the solvent was 
removed and hexane/Et2O mixture (96%:4%) was added and kept in the fridge to aid the 
precipitation of the triphenylphosphine oxide. It was then filtered over a short column of 
silica and eluted with hexane/Et2O mixture (96%:4%) to obtain a crude (3.6634 g, 96%) 
which was purified by flash column chromatography (column was packed and run with 
10% Et2O: 90% hexane before switching to 15% Et2O: 85% hexane later) to obtain 102 
as a light yellow to colorless solid (2E, 4E isomer, Rf = 0.53 in 15% Et2O: 85% hexane). 
The 102: 104 ratio was about 90:10. 102: IR (neat) 3028 (m), 2964 (s), 2930 (s), 2872 
(m), 1655 (s), 1612 (s), 1599 (s), 1590 (s), 1449 (m), 1286 (m), 1218 (m), 1154 (m), 1026 




H NMR (500 MHz, CDCl3) δ 1.03 (t, J = 7.3 
Hz, 3H), 1.62 (sext, J = 7.3 Hz, 2H), 2.99 (t, J = 7.3 Hz, 2H),6.29 (d, J = 15.1 H, 1H), 
6.83 (dd, J = 15.6 Hz, 11.0 Hz, 1H), 6.95 (d, J = 15.6 Hz, 1H), 7.31-7.42 (m, 4H), 7.47 
(d, J = 7.8 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 13.3, 22.9, 30.6, 126.0, 127.1, 128.2, 
128.7, 129.1, 135.9, 140.1, 141.6, 189.6; mass spectrum m/z (relative intensity) EI 232 
(10, M
+
), 158 (20), 157 (100), 129 (36), 128 (62), 127 (23); HRMS (EI) calculated for 
[C14H16OS]
+
 232.0922, found 232.0925.  
S-Propyl (4E) 3-ethyl-5-phenylpent-4-enethioate (103a): Employing general 
procedure B using dichloromethane (5.0 mL), EtMgCl (0.66 mL, 
1.2 mmol, 1.2 equiv.), and dienyl thiol ester 102 (0.233 g, 1.0 
mmol, 1.0 equiv.) at -20 
°




Et2O: 90% hexane; Rf = 0.52 ) to obtain 103a as a pale yellow oil (220 mg, 84%): IR 
(neat) 3081(m), 3059 (m), 3026 (s), 2936 (s), 2930 (s), 2873(s), 1687 (s), 1493 (s), 1451 




H-NMR (500 MHz, CDCl3) δ 0.94-0.98 (m, 
6H), 1.41-1.50 (m, 1H), 1.56-1.65 (m, 3H), 2.64-2.73 (m, 3H), 2.86-2.89 (m, 2H), 6.01-
6.06- (m, 1H), 6.44 (d, J = 15.6 Hz, 1H), 7.22-7.26 (m, 1H), 7.31-7.35 (m, 2H), 7.39 (d, J 
= 7.3 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 11.5, 13.2, 22.9, 27.5, 30.7, 42.0, 49.3, 
126.1, 127.0, 128.4, 130.7, 132.1, 137.3, 198.2; mass spectrum m/z (relative intensity) EI 
262 (18, M
+
), 187 (41), 186 (55), 158 (99), 145 (99), 129 (100), 117 (88), 116 (54); 
HRMS (EI) calculated for [C16H22O S]
+
 262.1391, found 262.1403.  
S-Propyl 3-[(E) 2-phenylethenyl]heptanethioate (103b): Employing general procedure 
B using dichloromethane (5.0 mL), n-BuMgCl (1.3M in 
THF/toluene, 0.85 mL, 1.1 mmol, 1.1 equiv.), and dienyl thiol 
ester 102 (233 mg, 1.0 mmol, 1.0 equiv.) at -20 
°
C for 2 hours. 
The crude material was purified (silica gel, 10% Et2O: 90% hexane; Rf = 0.53) to obtain 
103b as a light yellow oil (220 mg, 75%): IR (neat) 3082 (m), 3060 (m), 3027 (s), 2929 





H-NMR (500 MHz, CDCl3) δ 0.88-0.95 (m, 6H), 1.28-1.42 (m, 4H), 1.50-1.60 (m, 
4H), 2.61-2.71 (m, 2H), 2.73-2.79 (m, 1H), 2.83-2.87 (m, 2H), 6.01 (dd, J = 16.1 Hz, 8.7 
Hz, 1H), 6.40 (d, J = 16.6 Hz, 1H), 7.20-7.37 (m, 5H); 
13
C-NMR (125 MHz, CDCl3) δ 
13.2, 14.0, 22.6, 22.9, 29.3, 30.8, 34.5, 40.5, 49.8, 126.1, 127.1, 128.4, 130.5, 132.6, 
137.4, 198.4; mass spectrum m/z (relative intensity) EI 290 (9, M
+




144 (95), 129 (87), 117 (100); HRMS (ESI) calculated for [C18H27OS]
+
 291.1783, found 
291.1775.  
S-Propyl (4E) 5-phenyl-3-(propan-2-yl)pent-4-enethioate (103c): Employing general 
procedure B using diethyl ether (4.0 mL), 
i
PrMgCl (1.1 mmol, 1.1 
equiv.), and dichloromethane solution of  dienyl thiol ester 102 
(0.233 g, 1.0 mmol, 1.0 equiv.) at -20 
°
C for 2 hours. The crude material was purified 
(silica gel, 10% Et2O: 90% hexane, Rf = 0.53) to obtain 103c as a yellow oil (152 mg, 
55%): IR (neat) 3083 (w), 3061 (w), 3027 (m), 2962 (s), 2873 (s), 1692 (s), 1597 (s), 





(500 MHz, CDCl3) δ 0. 90-0.97 (m, 9H), 1.51-1.58 (m, 2H), 1.73-1.80 (m, 1H), 2.63-2.68 
(m, 2H), 2.73-2.77 (m, 1H), 2.82-2.85 (m, 2H), 6.04 (dd, J = 15.6 Hz, 8.7 Hz, 1H), 6.39 
(d, J = 16.1 Hz, 1H), 7.20-7.23 (m, 1H), 7.29-7.32 (m, 2H), 7.36 (d, J = 7.4 Hz, 2H); 
13
C-
NMR (125 MHz, CDCl3) δ 13.2, 18.9, 20.6, 22.9, 30.8, 31.8, 46.7, 47.2, 126.2, 127.0, 
128.4, 130.2, 131.6, 137.5, 198.7; mass spectrum m/z (relative intensity) EI 276 (5, M
+
), 
200 (38), 172 (47), 159 (46), 129 (100), 117 (71), 91 (37), 43 (70); HRMS (ESI) 
calculated for [C17H25OS]
+
 277.1626, found 277.1618.  
S-Propyl (2Z,4E)-5-phenylpenta-2,4-dienethioate (104): Compound 104 was a minor 
product in 102 above as a light yellow oil (Rf = 0.625 in 15% 
Et2O: 85% hexane): IR (neat) 3062 (m), 3028 (m), 2965 (s), 2931 
(s), 2874 (s), 1667 (s), 1613 (s), 1583 (s), 1495 (m), 1452 (s), 









Hz, 2H), 6.01 (d, J = 11.0 Hz, 1H), 6.52 (t, J = 11.6 Hz, 1H), 6.88 (d, J = 15.6 Hz, 1H), 
7.31-7.38 (m, 3H), 7.55 (d, J = 7.4 Hz, 2H), 8.16 (ddd, J = 16.1 Hz, 11.0 Hz, 0.9 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 13.4, 23.0, 31.0, 123.7, 125.6, 127.5, 128.7, 129.1, 136.2, 
140.8, 142.7, 189.5; HRMS (EI) calculated for [C14H16OS]
+
 232.0922, found 232.0925.  
S-Propyl (2E) 3-phenylprop-2-enethioate (105): Compound 105 was prepared by 
employing the typical procedure 2 
48
 using cinnamic acid (5. 00 g, 
33.75 mmol, 1.0 equiv.) and propanethiol (3.05 mL, 33.75 mmol, 
1.0 equiv.) in CH2Cl2 to  obtain a colorless liquid after column chromatography (5.01 g, 
72%): IR (neat) 3061 (m), 3029 (m), 2965 (s), 2931 (s), 2873 (s), 1673 (s), 1617 (s), 1451 




H-NMR (500 MHz, CDCl3) δ 1.04 
(t, J = 7.3 Hz, 3H), 1.65-1.74 (m, 2H), 3.02 (d, J = 7.3 Hz, 2H), 6.74 (d, J = 15.6 Hz, 1H), 
7.39-7.41 (m, 3H), 7.54-7.56 (m, 2H), 7.63 (d, J = 15.6 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) 
δ 13.3, 22.9, 30.8, 125.1, 128.3, 128.8, 130.4, 134.1, 140.1, 189.8; mass spectrum m/z 
(relative intensity) EI 206 (4, M
+
), 257 (28), 131 (100), 103 (29), 77 (27); HRMS (EI) 
calculated for [C12H14OS]
+
 206.07654, found 206.07654. 
S-Propyl 3-phenylpentanethioate (106): Employing general procedure B using diethyl 
ether (5.0 mL), EtMgCl (2.20M, 0.5 mL, 1.1 mmol, 1.1 equiv.), 
and enyl thiol ester 105 (0.206 g, 1.0 mmol, 1.0 equiv.) at -20 
°
C 
for 2 hours. The crude material was purified (silica gel) to obtain 
106 as a yellow oil (213 mg, 90%, Rf = 0.36 in 10% Et2O: 90% hexane): IR (neat) 3085 
(m), 3063 (m), 3029 (m), 2965 (s), 2931 (s), 2875 (s), 1688 (S), 1379 (m), 1455 (s), 1117 








H-NMR (500 MHz, CDCl3) δ 0.81 (t, J = 7.3 Hz, 3H), 0.92 (t, J = 7.4 Hz, 3H), 1.50-1.58 
(m, 2H), 1.60-1.68 (m, 1H), 1.71-1.80 (m, 1H), 2.79-2.91 (m, 4H), 3.07-3.13 (m, 1H), 7.18-
7.23 (m, 3H), 7.29-7.32 (m, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 11.8, 13.2, 22.8, 28.8, 
30.7, 44.4, 50.8, 126.4, 127.5, 128.3, 143.4, 198.4; mass spectrum m/z (relative intensity) 
EI 236 (51, M
+
), 161 (64), 132 (94), 120 (50), 119 (100), 91 (98); HRMS (EI) calculated 
for [C14H20OS]
+
 236.12349, found 236.12316.  
 (8E) 7-Ethyldec-8-en-5-one (107): Following general procedure B using diethyl ether 
(5.0 mL), EtMgCl (2.0 M in Et2O, 0.60 mL, 1.2 equiv.), and dienyl 
thiol ester 97 (0.171 g, 1.0 mmol, 1.0 equiv.), and stirring at -20 
°
C for 
90 minutes. Trifluoroacetic acid (0.09 mL, 1.1 equiv.) was then added in one portion and 
the mixture allowed stirring for 10 minutes. In a separate flask containing flame-dried 
lithium chloride (84.7 mg, 2.0 equiv.), and copper (I) cyanide (0.107 g, 1.2 equiv.) under 
argon was charged with THF (6 mL), and stirred at room temperature to dissolve the 




BuMgCl (1.60 M in Et2O, 1.5 mL, 2.4 equiv.) 
was added dropwise. After stirring at -78 
°
C for 30 minutes, it was cannulated to the first 
flask containing the thiolester intermediate. This reaction mixture was allowed to stir at -
78 
°
C to gradually warm to room temperature during overnight stirring. It was then 
quenched with saturated NH4Cl(aq) and extracted with Et2O (3x). The combined organic 
layer was dried with MgSO4, filtered and the solvent removed under reduced pressure. 
The crude material was purified (silica gel) to obtain 107 as a light yellow oily liquid 
(138.3 mg, 76%; Rf = 0.44 in 10% Et2O: 90% hexane): IR (neat) 2961 (s), 2933(s), 2875 








CDCl3) δ 0.83 (t, J = 7.3 Hz, 3H), 0.89 (t, J = 7.6 Hz, 3H), 1.2-1.41 (m, 5H), 1.49-1.55 
(m, 2H), 1.62 (d, J = 6.4 Hz, 3H), 2.34-2.41 (m, 4H), 5.15-5.19 (m, 1H), 5.37-5.43 (m, 
1H); 
13
C-NMR (125 MHz, CDCl3) δ 11.5, 13.8, 17.8, 22.3, 25.7, 27.9, 40.3, 43.2, 48.4, 
125.4, 133.8, 210.8; mass spectrum m/z (relative intensity) EI 182 (1, M
+
), 153 (18), 85 
(100), 83 (37), 57 (95); HRMS (EI) calculated for [C12H22O]
+
 182.1671, found 182.1670.  
 (8E) 7-(Naphthalen-1-yl)dec-8-en-5-one (108): Following general procedure B using 
diethyl ether (5.0 mL), naphthylmagnesium bromide (2.1 mmol, 1.1 
equiv.), and dienyl thiol ester 97  (0.327 g, 1.92 mmol, 1.0 equiv.), 
and stirring at room temperature for 90 minutes. It was then cooled to 
-78 
°
C and trifluoroacetic acid (0.09 mL, 1.1 equiv.) was added in one portion and the 
mixture allowed stirring for 10 minutes. In a separate flask containing flame-dried 
lithium chloride (0.163 g, 2.0 equiv.), and copper (I) cyanide (0.206 g, 1.2 equiv.) under 
argon was charged with THF (8 mL), and stirred at room temperature to dissolve the 
CuCN. This was then cooled to -78 
°
C and n-BuMgCl (1.60 M in Et2O, 2.87 mL, 2.4 
equiv.) was added dropwise. After stirring at -78 
°
C for 30 minutes, it was cannulated to 
the first flask containing the thiolester intermediate. This reaction mixture was allowed to 
stir at -78 
°
C to gradually warm to room temperature during overnight stirring. It was then 
quenched with saturated NH4Cl(aq) and stirred for 10 minutes. The mixture was extracted 
(3x) with diethyl ether and the combined organic phase was dried with MgSO4. It was 
filetered and the solvent removed under reduced pressure. The crude material was 
purified (silica gel) to obtain 108 as a yellow oil. (393 mg, 73%, Rf = 0.26 in 10% Et2O: 




(S), 1398 (s), 1378 (s), 969 (s), 779 (s);
 1
H NMR (500 MHz, CDCl3) δ 0.91 (t, J = 7.46 
Hz, 3H), 1.28-1.33 (m, 2H), 1.54-1.60 (m, 2H), 1.70 (d, J = 6.45 Hz, 3H), 2.41-2.44 (m, 
2H), 2.92 (dd, J = 16.5 Hz, 5.5 Hz, 1H), 3.03 (dd, J = 16.5 H, 8.7 Hz, 1H), 4.81 (q, J = 
6.9 Hz, 1H), 5.49-5.57 (m, 1H), 5.73-5.78 (m, 1H), 7.39 (d, J = 6.4, 1H), 7.45-7.48 (m, 
1H), 7.50-7.53 (m, 1H), 7.55-7.59 (m, 1H), 7.76 (d, J = 8.3 Hz, 1H), 7.89 (d, J = 7.4 Hz, 
1H), 8.23 (d, J = 8.7 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 13.8, 17.9, 22.2, 25.6, 38.3, 
43.2, 48.5, 123.4, 123.9, 125.3, 125.4, 125.9 (2-carbons), 126.9, 128.8, 131.2, 133.0, 
134.0, 140.0, 209.4; mass spectrum m/z (relative intensity) EI 280 (33, M
+
), 195 (53), 181 
(85), 180 (70), 166 (56), 165 (100), 185 (96), 57 (92); HRMS (EI) calculated for 
[C20H24O]
+
 280.1827, found 280.1836. 
 (6E)-5-cyclohexyl-2-methyloct-6-en-3-one (75aE): The cyclohexylMgCl (1.5 equiv.) 
was prepared by following method 1, using cyclohexyl magnesium 
bromide (2.0M in diethyl ether, 0.60mL, 1.2mmol, 1.2 equiv.), and 
employing general procedure B and using (4E, 6E)-2-methyloctadien-
3-one (0.1382g, 1.0mmol, 1.0 equiv.), in diethyl ether. The titled compound (75aE) was 
purified by flash column chromatography (silica gel, 10% Et2O: 90% hexane) to obtain 
colorless liquid  
 (yield = 0.1601g, 72%, Rf = 0.47 in 10% Et2O: 90% hexane). IR (neat) 2968 (s), 2926 





NMR (500 MHz, CDCl3) δ ; 0.88-1.01 (m, 2H), 1.04 (t, J = 6.9Hz, 6H), 1.08 -1.22 (m, 
4H), 1.60-1.64 (m, 5H), 1.68-1.72 (m, 3H), 2.36-2.39 (m, 1H), 2.42-2.48 (m, 2H), 2.55 






NMR (125 MHz, CDCl3) δ 17.9 (3-carbons), 26.5 (2-carbons), 29.6, 30.9, 41.2, 41.8, 
43.5, 44.1, 125.9, 132.4, 214.5; mass spectrum m/z (relative intensity) EI 222 (38, M
+
), 
180 (10), 179 (58), 161 (13), 152 (5), 151 (29), 139 (12), 137 (36), 136 (86), 135 (6), 121 
(11), 109 (19), 108 (6), 107 (24), 98 (5), 97 (62), 96 (8), 95 (87), 94 (15), 93 (10), 91 (7), 
83 (23), 82 (10), 81 (86), 79 (20), 77 (8), 72 (12), 71 (100), 70 (9), 69 (50), 68 (27), 67 
(52), 65 (6), 56 (5), 55 (95), 54 (6), 53 (16), 44 (7), 43 (100), 42 (9), 41 (83), 40 (5); 
HRMS (ESI) calculated for [C15H27O]
+
:223.2062, found 223.2061.  
 (8E)-2-Methyl-5-[(E)-1-propenyl]-6-[1-isobutanoyl]-7-cyclohexyldec-8-en-3-one 
(96): The dimer, 96 was obtained as a byproduct of the reaction above and 
was purified to give white solid (yield = 0.127g, 19%, Rf = 0.25 in 10% 
Et2O: 90% hexane). IR (neat) 2969 (s), 2925 (s), 2875 (m), 2852 (s), 1701 




H NMR (500 MHz, CDCl3) 
δ 0.82 (d, J = 6.9Hz, 3H), 1.90 (d, J = 6.4H, 3H), 1.01-1.09 (m, 15H), 1.60-1.68 (m, 6H), 
2.26-2.30 (m, 1H), 2.47-2.48 (m, 1H), 2.52-2.57 (m, 1H), 2.59-2.66 (m, 1H), 2.93-2.96 
(m, 1H), 3.15(d, J = 4.1Hz, 2H), 5.11-5.16 (m, 1H), 5.33-5.40 (m, 1H), 5.50-5.51 (m, 
2H); 
13
C NMR (125 MHz, CDCl3) δ 13.5, 16.9, 18.0, 18.1(2-carbons), 26.6, 27.9, 32.7, 
36.5, 40.0, 40.4, 42.3, 44.1, 48.1, 56.4, 121.2, 127.9, 129.3, 138.9, 212.6, 216.7; HRMS 
(EI) calculated for [C24H40O2]
+





(2E)-4-tert-butyldodec-2-en-6-one (111); & (4E)-2,2,3-trimethyltridec-4-en-7-one 
(112): Employing general procedure B and using tert-
butylmagnesium chloride (1.85M in Et2O, 0.59mL, 1.1 equiv.) in 
dichloromethane and (2E, 4E)-dodeca-2,4-dien-6-one (0.180g, 1.0 
mmol, 1.0 equiv.), at -20 
°
C, the 1,4-, and the 1,6-products were 
obtained after work-up and chromatography, as a yellow liquid (182 mg, 81%, Rf = 0.44 
in 10% Et2O/90% hexane: the two regioisomers move as a single spot on TLC plate): 
1
H 
NMR (500 MHz, CDCl3) δ 0.86-0.90 (m, 6H), 1.20-1.30 (m, 12H), 1.52-1.55 (m, 2H), 
1.63 (d, J = 6.4Hz, 3H), 2.34-2.37 (m, 4H), 2.45-2.49 (m, 1H), 5.16-5.21 (m, 1H), 5.37-
5.43 (m, 1H);
 13
C NMR (125 MHz, CDCl3) δ 14.0, 15.4, 17.9, 22.5, 23.5, 23.6, 27.4, 
27.5, 28.9, 31.6 (2-carbons), 32.7, 32.8, 42.0, 43.6, 43.7, 47.0, 47.2, 49.2, 121.6, 127.0, 
131.1, 138.4, 209.8, 211.4; 1,4-product: mass spectrum m/z (relative intensity) EI 238 
(0.9, M
+
), 182 (14), 125 (5), 114 (10), 113 (100), 97 (15), 95 (8), 85 (26), 83 (6), 69 (16), 
68 (7), 67 (8), 57 (46), 55 (13), 43 (41), 41 (25); 1,6-product: mass spectrum m/z 
(relative intensity) EI 238 (0.04, M
+
), 182 (13), 114 (8), 113 (100), 97 (11), 95 (6), 85 
(24), 83 (5), 57 (39), 55 (10), 43 (48), 41 (22); HRMS (EI) calculated for [C16H30O]
+
: 
238.2297, found 238.2299. 
1,2-product {(2E,4E)-6-tert-butyldodeca-2,4-dien-6-ol} (113): Rf = 0.31 in 10% Et2O: 
90% hexane). IR; 
1
H NMR (500 MHz, CDCl3) δ 0.86-0.90 (m, 6H), 






2.34-2.37 (m, 4H), 2.45-2.49 (m, 1H), 5.16-5.21 (m, 1H), 5.37-5.43 (m, 1H);
 13
C NMR 
(125 MHz, CDCl3) δ 14.1, 18.1, 22.7, 23.8, 25.4, 30.0, 31.9, 34.6, 38.1, 79.2, 128.0, 
129.1, 131.2, 134.5.  
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REGIO- AND STEREOSELECTIVE COPPER (I)-MEDIATED ALLYLIC 
ALKYLATIONS OF α,β-EPOXY-γ,δ-UNSATURATED CARBONYL 
COMPOUNDS (ENONES AND ENOATES) 
 
3.1 Introduction 
Copper-catalyzed allylic substitutions have become important methods for creating 
asymmetric carbon-carbon(C-C) and carbon-heteroatom (C-X) bonds. Several allylic 
substrates have been explored with copper salts and organometallic reagents; notable 











 Besides copper (I) salts, metals such as Pd, W, Mo, Ir, Ni, Rh, Zn, and Ru 
have also been employed in allylic substitution reactions, with Pd and Cu exhibiting 
considerable success.
5
 Vinyloxiranes are a unique class of allylic electrophiles in the 
sense that, their SN2′ reactions involve ring opening of the epoxide where the leaving 
group is retained in the final product to produce allylic alcohols. These products can 
readily be stereoselectively transformed into allylic leaving groups
6
 (tosyl, acetoxy, 
phosphate, silyloxy, etc.) to enable sequential chain elongation or stereoselective 
bisallylic alkylation resulting in vicinal C-C stereogenic centers.  
Moreover, α, β-epoxy γ, δ-unsaturated carbonyls (enones and enoates) form a class of 
their own within the vinyloxirane system because they combine the reactivity of allylic 
substrates and epoxides with that of carbonyl functionality to enable them undergo a 
plethora of synthetic transformations available only to few chemical substrates. 
Specifically, epoxyenones possess three reactive carbons that are susceptible to 
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nucleophilic attack. They can undergo 1,2-addition (SN2 type) reactions at both, the 
epoxy carbon in the allylic position to form β-substituted α-hydroxyenone and at the 
carbonyl carbon to form allylic epoxy alcohol. Also, 1,4-addition reaction can be effected 
with soft nucleophiles at the olefinic carbon to obtain δ-substituted α-hydroxy enones. 
Although, in most instances the goal is to develop a methodology to achieve each of these 
transformations selectively, these α-hydroxy unsaturated carbonyls (enones and enoates) 
form a class of compounds with interesting chemical and biological properties.
7
 While 
reports on allylic substitutions with carbon nucleophiles on α,β-epoxy-γ,δ-unsaturated 
carbonyls are non-existent, that of transition metal-mediated substitutions on 
vinyloxiranes in general with various nucleophiles are relatively common.  
 
Scheme 3.1. BF3·OEt2 promoted intramolecular 7-endo selective Friedel-Crafts type 
cyclisation of γ,δ-epoxyenoate derivative 
 
Past research works have focused on transformations of the γ,δ-epoxyenones and enoates 
cousins of these vinyloxiranes. These include the BF3·OEt2 promoted intramolecular 7-
endo selective Friedel-Crafts type cyclisation of γ,δ-epoxyenoate derivatives (1)
8 
reported 
by Kawahara and co-workers (Scheme 3.1).  In this cyclization, the presence of the π-
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orbitals of the adjacent vinyl group was used to direct the preference for 7-endo over the 
6-exo cyclization to form hydroxy ester 2 which was converted to the δ-lactone 3 in 56% 
overall yield. Mioskowski and coworkers have also ring opened similar substrates with 
oxygen nucleophiles catalyzed by BF3·OEt2 in their effort to synthesize (-)-Muricatacin,
9, 
10 
an antitumor agent (Scheme 3.2).  
 
Scheme 3.2. BF3·OEt2 Catalyzed opening of γ,δ-epoxyenoate derivative with oxygen 
nucleophiles 
 
The γ,δ-epoxyenoate 4 was treated with 3,4-dimethoxybenzylalcohol (DMPMOH) in the 
presence of BF3·OEt2 in CH2Cl2 and then converted to the γ-hydroxyenoate 5 in 65% 
yield. After hydrogenation of allylic alcohol 5 in the presence of a P-2 nickel catalyst,
11
 
the intermediate was lactonized with p-toluenesulfonic acid in bezene and then 




The intramolecular version of this ring-closure reaction with nitrogen and oxygen 
nucleophiles has also been reported
12
 with Rh complexes to obtain pyrrolidine/piperidine 
and tetrahydrofuran/ tetrahydropyran derivatives, respectively in high yields and 
stereoselectivities (eqs. 1&2). It was observed that only the trans epoxides of the 
substrates could cyclize under the set conditions. The cis versions were inert under the 
same reaction conditions and an attempt to increase the temperature or prolong the 
reaction times only lead to decomposed starting materials. The mechanism of the reaction 
is not well understood.  
Our group in the past reported
13
 zinc-catalyzed stereoselective Michael Initiated Ring 
Closure (MIRC) of these γ,δ-epoxyenones and -enoates to produce cyclopropanes from 
good to very good chemical yields and up to excellent regio and stereoselectivities. It was 
observed that the protocol in both stoichiometric and catalytic in ZnBr2 were effective in 
achieving conjugate addition-epoxide opening to form the substituted cyclopropane 
product in chemical yields and stereoselectivities. While the protocol worked well for 
epoxyenoates, epoxyenones, and epoxyenesulfones in Et2O and THF, it was observed 
that that the stereochemistry was completely reversed for the products from the 
epoxyenesulfones when the reactions were carried out in toluene as solvent (Scheme 3.3). 
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Scheme 3.3. Zinc-catalyzed Michael Initiated Ring Closure (MIRC) of γ,δ-
epoxyenones and -enoates 
 
Scheme 3.4. Organocuprate-mediated allylic substitutions of (Z)- and (E)-ethyl-2-
chloro-3-octenoates 
 
Organocuprate-mediated allylic substitutions have also been employed to prepare γ-
substituted α,β-enoates from both (Z)- and (E)-ethyl-2-chloro-3-octenoate ( 20 & 21) in 
high yields and excellent regio- and stereoselectivities (i.e, E:Z).
14
 While the regio- and 
stereoselectivities of the Z- isomer were found to be general (Scheme 3.4) that of the E-
isomer were observed to be dependent on the solvent, the nature of the cuprate reagent, 




), and the type of the transferable ligand.  
Despite extensive studies on the γ,δ-epoxyenones and enoates, reports on the α,β-
epoxyenones and α,β-epoxyenoate counterparts are rare, especially substitutions  with 
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carbon nucleophiles do not exist.  Some of the earlier works on these α,β-epoxyenones 
substrates included the investigations by Murphy and coworkers of the radical-induced 
fragmentation pattern of aromatic α,β-epoxyenones
 
to form conjugated aldehydes and 
benzaldehyde (eq. 3).
15 
The n-butanethiyl radical used as the nucleophile in the reaction 
was generated in situ from the reaction of butanethiol with azobisisobutyronitrile (AIBN). 
The mechanism of the reaction was proposed to involve the addition of the thiyl radical 
to the epoxide 15 followed by the breaking of the C-O bond to form the oxyradical 19 
and fragmentation adjacent to the carbonyl group yielded benzaldehyde 16 and 
conjugated aldehyde 17 (Scheme 3.5). 
 
 
Scheme 3.5. Proposed mechanism for radical-induced fragmentation of a,b-
epoxyenones 
 
While the creation of an asymmetric C-C bond is a fundamental operation in modern 
organic synthesis, the generation of non-functionalized carbon-carbon stereogenic center 




Traditionally, functional groups are used to introduce stereogenic centers near or at a 
functional group (eq. 4) and vinyloxiranes are well suited for generating vicinal 
stereogenic centers via bis-allylic substitution reactions (eq. 5) near or away from the 
main functional group. Thus, our group previously employed this strategy to create 
vicinal disubstituted γ,δ-enoates from ethyl-4-chloro-5-acetoxy-2,3-hexenoate (25) to 
achieve excellent diastereoselectivity and high chemical yield via sequential or one-pot 
tandem organocuprate-mediate bisallylic substitution methodologies (eq. 4).
16
 In a later 
work, it was discovered that a stoichiometric 
n
Bu2Zn/CuCN combination in THF was 
effective in executing the first SN2′ substitution on epoxyenoate 27 while 
n
BuCu(CN)MgCl was employed for the second SN2′ substitution on the acetoxy 
derivative of the intermediate alcohol in a bis-allylic substitution sequence that produced 
the syn-selective  α,β-disubstituted enoate 28 in good yield (eq. 5).
17
 In the same work, 
the possibility of creating an alkene unit with vicinal syn disubstitution remote of the 
terminal functional group was explored with trans-1-(tert-butyldimethylsilyloxy)-2,3-
epoxy-4-hexene (29). In the event, it was revealed that the  vicinal syn disubstituted 
alkene 30 could be obtained with catalytic 
n
Bu2Zn/CuCN and stoichiometric RCu(CN)Li 
via phosphate intermediate in three-step sequence to achieve excellent SN2′ 




In an ongoing tradition of our program, we sought to create vicinal C-C stereogenic 
centers away from a terminal functional group such as a carbonyl moiety (eq. 6) 
employing sequential or tandem stereoselective organocuprate-mediated protocols that 
have been developed in our laboratory. Herein, we report our findings on organocuprate-
mediated ring opening of γ,δ-epoxyenones and enoates. 
 
3.2 Results and Discussions 
Although epoxidation of both linear and cyclic 2,4-diunsaturated carbonyl compounds to 
form α, β-epoxy-γ,δ-unsaturated carbonyls (enones and enoates) has been well 
investigated  with procedures developed to afford excellent setereo- and enantioselective 
control, the allylic openings of these functionalized vinyloxiranes with carbon 
nucleophiles have not been well explored. This inspired our choice of these substrates for 
the current investigations. 
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All cuprate reagents were prepared at -78 
°
C or -55 
°
C and the substrates were added 
dropwise as solutions of the reaction solvents at the reaction temperatures indicated. 
Reaction mixtures were stirred at the indicated temperatures for at least 3h before being 
quenched with saturated ammonium chloride or phosphate buffer of pH 7. Initially, the 
reactions were quenched with saturated aqueous NH4Cl solution. However, the products 
from the reactions with the enones decomposed soon after work up. This led to the 
reasoning that the α-hydroxyketone product formed might not be stable under the mildly 
acidic NH4Cl condition. Hence phosphate buffer was used in place of NH4Cl for the 
subsequent reactions. Cuprates from organolithium and Grignard reagents were examined 
with the substrates. In the initial reactions, stoichiometric amounts of copper (I) cyanide 
was used with either one or two equivalents of the organometallic reagents (Table 1 vide 
infra). Thus, the in situ prepared reacting species were lithium alkylcyanocuprates, 
lithium dialkylcuprates, magnesium alkylcyanocuprate chloride, and magnesium 
dialkylcuprate chloride. These reactions were carried out initially in THF, and diethyl 
ether, but later switched to dichloromethane (Table 2) because regio and 







Table 3.1. Copper (I) Cyanide-mediated Allylations on Ethyl-α,β-epoxyenoate with 
Grignard Reagents in THF. 
 




















  60:40 
3 EtMgCl(2.0) CuBr·SMe2(1.0) THF 32a 35   58:42 
4 EtMgCl(2.0) CuBr·SMe2(1.0) CH2Cl2 32a 75   63:37 
5 EtMgCl(1.05) CuBr·SMe2(0.2) CH2Cl2 32a 76   80:20 
6 EtMgCl(1.05) CuBr·SMe2(0.1) CH2Cl2 32a 72   61:39 
7 EtMgCl(1.05) CuBr·SMe2(0.05) CH2Cl2 32a 74   50:50 
8 EtMgCl(1.05) CuBr·SMe2(0.2) THF 32a 73   50:50 
9 EtMgCl(1.05) CuBr·SMe2(1.0) CH2Cl2 32a 70   75:25 
 
All reactions were quenched with saturated NH
4
Cl solution at room temperature. Yields are based upon isolated 
product after flush column chromatography. a Products consist of column inseparable diastereomers. b ratio based on 
the height of the 13CNMR signal of the olefinic carbons. 
A few reactions were carried out in diethyl ether on the substrate but these gave complex 
mixtures and so the use of diethyl ether as a solvent was discontinued. The general 
observation was that, the monoalkylcyanocuprates yielded complex mixtures irrespective 
of the solvent used. After several trials with the dialkylcuprates, it became clear that the 
dialkylcuprates gave better SN2′ alkylations than their monoalkylcyanocuprate 
counterparts. However, the lithium dialkylcuprates gave either addition product at the 
carbonyl carbon or SN2 product at the epoxide carbon. The Grignard cuprates gave 
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primarily SN2′ products; hence subsequent reactions were carried out with the magnesium 
cuprate reagents. 
Table 3.2. Catalytic copper (I)-mediated alkylations of α, β- epoxyenone 
 
entry RM(equiv.) Cu(I)X(equiv.) solvent temp.(
°



















PrMgCl(1.0) CuCN(1.0)/2LiCl THF -78 34c 52:48d 61 
4 
n
BuMgCl(1.0) CuCN(1.0)/2LiCl THF -78 34b 70:30d 69 
5 EtMgCl(1.1) CuCN(1.0)/2LiCl THF -55 34a 50:50d 73 
6 
n





BuMgCl(1.0) CuBr·SMe2(0.2) CH2Cl2 -78 34b 100:0 65 
8 
i
PrMgCl(1.0) CuBr·SMe2(0.05) CH2Cl2 -55 34c 100:0 71 
9 
i
PrMgCl(1.0) CuBr·SMe2(0.1) CH2Cl2 -55 34c 100:0 73 
10 
i
PrMgCl(1.0) CuBr·SMe2(0.2) CH2Cl2 -55 34c 100:0 78 
11 EtMgCl(1.1) CuBr·SMe2(0.1) CH2Cl2 -78 34a 100:0 27
c
 
12 EtMgCl(1.1) CuBr·SMe2(0.1) CH2Cl2 -55 34a 100:0 58 
13 EtMgCl(1.1) CuBr·SMe2(0.2) CH2Cl2 -78 34a 100:0 50 
14 EtMgCl(1.1) CuBr·SMe2(1.0) CH2Cl2 -78 34a 100:0 45 
15 MeMgBr(1.0) CuBr·SMe2(0.1) CH2Cl2 -55 34d 100:0 56 
16 MeMgBr(1.0) CuBr·SMe2(0.2) CH2Cl2 -55 34d 100:0 50 
17 MeLi (1.5) CuBr·SMe2(1.0) CH2Cl2 -55 34d 100:0 40 
18 
c







CuBr·SMe2(0.2) CH2Cl2 -55 34f 100:0 60 
 
All reactions were quenched with phosphate buffer of pH 7.0 at the same temperature of the reaction. aYield based on 
mass of isolated product obtained after flush chromatography unless otherwise stated.  bYield based on mass of crude 
material obtained. cAbout 30% of starting material was present. dE: Z ratios were determined from the average of the 
ratios of the heights of the peaks due to the α-hydroxy carbon and that of the peaks due to the carbonyl carbons of the 
two isomers in the 13CNMR spectrum. eReaction was quenched with NH4Cl(aq) and the combined organic layer was 




In THF, the CuCN was dissolved with two equivalents of LiCl, and Table 3.1 shows the 
results from this reaction (vide supra). Two equivalents of Grignard reagents reacted with 
1:1 cis/trans mixture of the substrate 31 in the presence of one equivalent of CuCN and 
two equivalents of LiCl to give a column non-separable mixture of three diastereomers of 
the product 32. The diastereomers could be contributed by the fact that the starting 
epoxyenoate 31 was about 1:1 ratio of both the cis/trans epoxy isomers. The identity of 
the individual isomers could not be made due to inability to separate them as all the 
isomers have the same Rf value on TLC plate. The reaction works fairly well with this 
α,β-epoxyenoate 31 and the products formed are stable. The 
i
Pr group gave the highest 
yield of 90% (Table 3.1, entry 2). When the copper salt was changed to CuBr·SMe2 two 
non-separable diastereomers were obtained (Table 3.1, entries 3-9) and by exploring 
solvent effect and amount of the copper salt we could improve the selectivity to only 
80:20 (Table 3.1, entry 5). However, this selectivity was not consistent as it depended on 
the cis/trans composition of the starting material started with.  
Next, we turned our attention to α,β-epoxy-γ,δ-unsaturated ketone (33). This starting 
material and its analogues 15 and 37 were prepared from their corresponding dienones 
(eq. 7) by employing a modified existing literature procedure as described in detail in the 
experimental. The reaction of this epoxyenone 33 with Grignard reagents in the absence 
of Cu
I
 salt in THF gave only the 1,2-addition products 35b-c arising from the attack at 
the carbonyl carbon  (Table 3.2, entries 1-2) in about 62 to 68%  crude yield. However, 
i
PrMgCl in the presence of CuCN in THF gave about 1:1 ratio of the E/Z isomeric 
mixture of SN2′ products 34c was formed in 61% yield (Table 3.2, entry 3). With the 
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same solvent and copper salt, 
n
butylmagnesium chloride gave 70:30 ratio of the E/Z 
mixture in 69% yield (entry 4). Increasing the temperature to -55 
°
C only decreased the 
selectivity to (50:50) when EtMgCl was used with the CuCN/LiCl combination (entry 5).  
 
 
Table 3.3. Copper (I)-Catalyzed Alkylations on α,β- Epoxyenone with Allyl and Aryl 
Grignard Reagents. 
 










1 AllylMgCl -78 34g 100:0 86 
2 PhMgBr -78 34h 100:0 67 
3 4-Me2NPhMgBr -60 34i 100:0 75 
4 4-MeOPhMgBr -78 34j 100:0 76 
5 NaphthylMgBr -78 34k 100:0 77 
a Ratios are based on signal of alpha carbon in the NMR spectra of the crude material. bIsolated product after flash column 
chromatography. 
After several trials with different solvent systems and temperatures in an attempt to 
improve the E/Z ratio, the copper salt was changed from CuCN/2LiCl system to 





combination gave excellent selectivity for the E isomer (entry 6) albeit in poor yield. The 
poor yield was due in part to incomplete reaction as result of the low temperature (-78 
°
C) 
and also the result of complex emulsion stemming from the phosphate buffer used for 
quenching the reaction. The emulsion made the extraction of the product very difficult, 
thus losing some of product in the process. To overcome this problem, catalytic amount 
of the CuBr·SMe2 (20 mol%) was used which gave satisfactory yields (65%) with 
excellent E selectivity (entries 7). To further improve on the yield, the temperature was 
increased to -55 
°
C and the CuBr·SMe2 reduced to 5 mol% resulting in 71% chemical 
yield (entry 8). It was observed that though 5.0 mol% of the CuBr·SMe2 worked as well 
(entry 8), 20 mol% gave a much cleaner product as judged by the NMR spectrum of the 
crude material. The observation was that the isopropyl ligands gave the best results 
(entries 8-10) in terms of yields and the cleanliness of the crude NMR spectra (>95% 
clean). EtMgCl with 10 mol% of CuBr·SMe2 at -78 
°
C still had starting material after 
four hours (entry 11) leading to only 27 % yield. After experimenting with temperature 
and amount of the copper salt, the yield for 34a could only be improved to 58% (entries 
12-14). The methyl ligands gave lower yields (entries 15-17) due to the difficulty in their 
extraction from the emulsions. Cyclohexylmagnesium chloride on the other hand gave 
higher yield with 20 mol% of the CuBr·SMe2 (entry 18). The improved yield is due in 
part by the fact that the reaction was quenched initially with NH4Cl(aq) and after 
extraction with diethyl ether, the combined organic layer washed once with the phosphate 





BuMgCl also gave modest yield and excellent stereoselectivity with 
the epoxyenone 33 (entry 19). 
The allyl and phenyl Grignard reagents with 20 mol% of the Cu
I
 salt after 4 h gave only 
complex mixtures comprising starting material and products. Several trials with different 
amounts of the Grignard reagents, and the Cu
I
 salt at different temperatures revealed that 
stoichiometric amounts of the Cu
I
 salt and two equivalents of the allyl magnesium 
chloride could give a clean product in over 86% after column chromatography (Table 3.3, 
entry 1). All the aryl Grignard reagents examined followed similar reactivity pattern to 
give good yields and excellent stereoselectivities (Table 3.3, entries 2-5).   
To explore the substrate scope of this protocol, we turned to the aromatic analogue 15 of 
the substrate. Initial experiments with both stoichiometric and catalytic amounts of 
CuBr·SMe2 in CH2Cl2 and THF gave complex mixtures (Table 3.4, entries 1-2) including 
both SN2 and SN2′ products. After several trials, it was found that two equivalents of the 
Grignard reagent were required with stoichiometric amounts of the copper salt in THF at 
-55 
°







Table 3.4. Finding optimum conditions for the allylic alkylations of the aromatic 
substrate 
 


































PrMgCl (1.1) 0.2 THF -78 36c 100 30 
4 
i
PrMgCl (1.1) 1 THF -55 36c 100 71 
5 
i
PrMgCl (2.0) 1 THF -55 36c 100 75 
6 EtMgCl (1.1) 1 THF -55 36b 55 -- 
7 
t
BuMgCl (1.1) 1 THF -78 36e 25 -- 
8 
t
BuMgCl (1.1) 1 THF -55 36e 50 -- 
9 
n
BuMgCl (1.1) 1 THF -55 36d 60 -- 
10 
n
BuMgCl (1.1) 0.5 THF -55 36d 65 -- 
11 
n
BuMgCl (1.1) 1 Et2O -55 36d 80 -- 
12 
n
BuMgCl (1.1) 0.5 Et2O -55 36d 55 -- 
 
a Calculation was based on the ratio of the height of carbonyl peak of the product in 13C-NMR to that of the starting 
material. b            Product mixture contained both SN2 and SN2′ products.  
Surprisingly, one equivalent of isopropylmagnesium chloride with stoichiometric copper 
salt could also achieve complete conversion at -55 
°
C after 3 hours (entry 3). In an 
attempt to reduce the amount of the organometallic reagents, half the amount of the 
copper salts were used with one equivalents of the Grignard reagents but the reactions 
were not complete after 3 hours (entries 10 and 12). Running the reactions at -55 
°
C still 
had starting material after 3h (entries 5-12).  
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Having found the optimum conditions, we set out to transfer both alkyl and aryl ligands 
shown in Table 3.5 (vide infra). Ethylmagnesium chloride gave excellent yield and 







and N,N-dimethylanilinyl ligands (Table 3.5, entries 1-8).  
Comparing these results with those in Table 3.2, it can be inferred that the 
stereoselectivity is controlled by the type of copper salt used and the accompanying 
lithium chloride. Copper cyanide with LiCl in THF gave a mixture of both E/Z 
stereoisomers. However, CuBr·SMe2 in THF gave only the E isomer.    
It was observed that the δ-substituted α-hydroxyenone formed would oxidize to the 
diketone 39 at rt or 4 
°
C in the crude mixture (Scheme 3.6). However, if the crude was 
purified by chromatography immediately after work-up then the hydroxyenone was stable 
and would not convert to the diketone even at rt. The mechanism of the oxidation is not 
understood yet but it appears the oxidation might be catalyzed by residual amounts of the 
copper salt used in the reaction and a plausible mechanism might involve a radical 
pathway similar to that shown in Scheme 5 (vide supra) for the radical-induced 
fragmentation of the aromatic α,β-epoxyenones
 
to form conjugated aldehydes and 
benzaldehyde. Here the addition of nucleophilic alklyl group to 15 or 33 might lead to an 
intermediate which undergoes translocation of the double bond and cleavage of the C-O 
bond of the epoxide to form δ-substituted oxy radical. The oxy radical may fragment in 
several ways but cleavage of the C-H bond would lead to the δ-substituted conjugated 
enedione 39 and a hydrogen atom.  
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BuMgCl in the 
presence of CuCN (1.0 equiv.) in THF at -78 
°
C, a clean aryl ketone 42 was isolated in 
high yield (eq. 9). This aryl ketone is clearly a fragmentation product from 1,2-addition 
of the Grignard reagents on the carbonyl carbon. The plausible reaction mechanism is 
shown in Scheme 3.7 (vide infra) where a nucleophilic attack of the Grignard reagent on 
the carbonyl carbon leads to the oxymagnesium chloride of the allylic epoxide 43. The 
formation of the C=O bond and the cleavage of the C-C bond adjacent to the epoxide 
leads to the aryl ketone 42 and the magnesium enolate 44 which tautomerizes to the 
aldehyde 45. 
To further explore the scope of the substrate the epoxy enone 37 was prepared from the 
corresponding dienone with phenyl group at the tail end of the chain.  Substrate 37 
underwent SN2′ substitution smoothly with ethylmagnesium chloride and 20 mol% of 
CuBr·SMe2 in CH2Cl2 in 3 hours to give 70% of the E-isomer (eq. 10).  
The next step was to convert the α-hydroxyketone to phosphate or acetoxy group to 








Table 3.5. Alkylations of the aromatic epoxyenone 
 
entry RMgX (equiv.) product E:Z Yield 
(%) 
1 CH3MgBr (2.1) 36a 100:0 76 
2 EtMgCl (2.1) 36b 100:0 93 
3 
i
PrMgCl (1.1) 36c 100:0 71 
4 
i
PrMgCl (2.0) 36c 100:0 75 
5 
n
BuMgCl (2.0) 36d 100:0 58-84 
6 
t
BuMgBr (2.0) 36e 100:0 78 
7 PhMgBr (2.0) 36f 100:0 74 
8 Me2NPhMgBr (2.0) 36g 100:0 84 
 
Yields are based on product isolated after flush column chromatography on silica gel and ethyl acetate and hexane 
mixtures as solvents. 
 
 





Copper (I) Cyanide-induced fragmentation 
 
 








The intermediates α-acyloxy δ-substituted enones 46 & 47 have been prepared by 
addition of one equivalent of acetic anhydride to the reaction and stirring for 30 minutes 
at -55 
°
C prior to quenching with the aqueous NH4Cl (eq. 10). The α-chloro δ-substituted 
enones 48 & 49 have also been prepared from the corresponding alcohols (eq. 11). 
Unfortunately, this protocol gave poor yield and diastereoselectivity of 48 & 49 ranging 
from 50:50 to 57:43 mixture of its diastereomers. 
The origin of the E:Z selectivity can be explained by considering the Corey-Boaz model 
for the anti-selectivity of cuprate catalyzed allylic substitution reactions based on the 
frontier molecular orbital theory as illustrated in Figure 1 (vide infra). The copper (I) has 
d
10
 orbitals that interact with the olefins π* orbital and weakly interact with the σ* orbital 
of carbon-leaving group bond (C-X). Due to the anti-attack of the cuprate on the 
vinyloxiranes, both the cuprate and the epoxy leaving group would have to be anti-
periplanar in the transition state. Considering the transition state conformations of the 
substrate-cuprate complex, two distinct conformations (50 &51) can be adopted that 







between two hydrogen atoms as compared to a hydrogen and a methane group A
1,3
(C-H) 
strain in conformation 51. Thus the anti-attack of the cuprate in conformation 50 will 
dominate in the transition state and lead to the E isomer 52 (bonds in red are in trans 
arrangement) while that in 51 will be least favored and lead to the Z-isomer 53 (bonds in 




Figure 3.1.Corey-Boaz model for orbital overlap of d(Cu) and an allylic system.
1
 
Scheme 3. 8. Mechanistic rationale for stereoselectivity in the CuBr·SMe2-mediated 
addition 
 
In the case of the CuCN/LiCl mediated reaction, the lithium counter ion to the cuprate 
could also chelates the carbonyl oxygen in both transition state conformations 54 & 55 
(Scheme 9). This chelation of the lithium ion in conformation 55 is a favorable 
interaction that can override the A
1,3
(C-H) strain that exist and thereby stabilizing 




Scheme 3.9. Mechanistic rationale for stereoselectivity in the CuCN/LiCl-mediated 
addition  
  
To prove that the presence of lithium ions in the reaction medium contribute to the 
formation of the z-isomer, control reactions were conducted without lithium chloride 
(Table 6). Thus, reaction conditions were CuCN (1.0 equiv.), Grignard reagent (2.0 
equiv.), THF, and -78 
°
C for 3.5 to 4 hours. In the event, only the E-isomer of the SN2′ 
product was produced in each case (Table 3.6, entries 1-2), thus indicating that the 
proposed model is consistent with the observed results.     





 product yield (%) E:Z (%)  
1 33 
i
Pr 34c 80 100:0 
2 15 
n




Stereoselective organocuprate-mediated allylic alkylations of α,β-epoxy-γ,δ-enones and 
α,β-epoxy-γ,δ-enoates have been achieved with high yield. The protocol is catalytic in 
Cu
I
 salt for alkyl Grignard reagents in dichloromethane as solvent but requires 
stoichiometric amount of Cu
I
 in THF or CH2Cl2 at -55 
°
C for 3.5-4 hrs to go to 
completion. The α-hydroxyenone intermediate formed after the allylic substitution could 
oxidize to the diketone if the reaction was allowed to warm to rt over 12 hr stirring. 
However, this could be prevented if the reaction was quenched at -55 
°
C and the crude 
material purified by chromatography soon after the work-up. The mechanism for this 
concomitant oxidation is not understood and needs more investigation.  
The preliminary results suggest that the E/Z selectivity is dependent on the kind of copper 
salt used. While CuCN/LiCl combination gives a mixture of E/Z isomeric product, 
CuBr·SMe2 gives exclusively the E product thus suggesting that the lithium ion may be 
playing a role in the stereoselectivity. The exclusive formation of the E-isomer in the 
lithium-free reaction supports the proposed model to explain the stereoselectivity. 
 
3.4 Experimental 
General:  All NMR spectra were recorded as CDCl3 solutions of the compounds unless 
otherwise stated. 
1
H-NMR chemical shifts are reported as δ values in parts per million 
(ppm) relative to CHCl3 (δ = 7.28 ppm) as internal standard. 
13
C-NMR chemical shifts 
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are reported as δ values in parts per million (ppm) and referenced with respect to the 
CDCl3 signal (triplet, centerline δ = 77.0 ppm). Infrared (IR) spectra of liquid compounds 
were recorded as neat liquid films between NaCl plates. Gas chromatography-mass 
spectrometry measurements were performed on a GC coupled to a quadrupole detector at 
70 eV. Analytical thin layer chromatography (TLC) was performed on silica gel plates, 
200 mesh with F254 indicator. TLC visualization was achieved with UV light (254 nm), 
10% ethanol solution of phosphomolybdic acid (PMA) stain, and aqueous potassium 
permanganate solution (KMnO4). Products were purified by flash column 
chromatography with 230-400 mesh silica gel unless otherwise stated. Yields are based 
on isolated products purified by flash column chromatography. 
 Anhydrous tetrahydrofuran (THF) and diethyl ether (Et2O) were obtained from sodium 
benzophenone ketyl distillation. Dichloromethane (CH2Cl2) and toluene used for 
reactions were dried over molecular sieves. 
n
BuLi (2.5 M in hexane), MeLi (1.6 M in 
Et2O), and 
t
BuLi (2.0 M in pentane) were available commercially and titrated using sec-




BuMgCl (2.5 M in 
THF/toluene), MeMgCl (3.0 M in Et2O), 
i
PrMgBr (2.0 M in Et2O),  EtMgCl (2.0 M in 
THF), and PhMgCl (2.8 M in Et2O) were available commercially and titrated with 
menthol and 1,10-phenanthroline monohydrate in THF. Benzyl bromide, 1-
bromonaphthalene, N,N-dimethyl-4-bromoaniline, 4-iodoanisole, 5-iodoindole, furan, 
thiophene, N-methylpyrrole, 1-hexyne, n-propylthiol, and 1,2-dibromoethane were all 
obtained from commercially available sources and were used as received without further 
purification. All glassware was flame-dried under high vacuum and purged with argon 
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and then cooled under a dry argon atmosphere. Low temperature baths (up to -78 
°
C) 
were prepared in thermoflasks with dry ice- isopropyl alcohol slush bath mixtures or ice-
NaCl (-23 
°
C) mixture. All reactions were conducted under positive dry argon 
atmosphere in anhydrous solvents in flasks fitted with a rubber septum. 
 
Syntheses of the starting materials 
Typical procedure 1 for the syntheses of the ketodienes: The starting materials were 
synthesized by following existing literature procedures
18
 as follow. To a solution of LDA 
in THF at -70 
°
C was added in a dropwise fashion over 10 minutes a THF solution of the 
ketone (1 equiv.). The mixture was stirred at -78 
°
C for 90 minutes and then a mixture of 
crotonaldehyde and chlorotrimethylsilane (TMSCl) in THF was added dropwise at -78 
°
C 
before allowing it to warm up to room temperature (rt). The reaction mixture was then 
refluxed for 4h after which it was quenched with saturated ammonium chloride (NH4Cl) 
and extracted with dichloromethane (CH2Cl2). The combined organic phase was washed 
with Na2HPO4 solution and dried over MgSO4. It was then filtered and the solvent 
removed in vacuo to obtain a product which was then purified by flash column 





Synthesis of (4E, 6E)-2-Methylocta-4,6-dien-3-one (56): Compound was synthesized 
by employing typical procedure 1 above and using 
methylisopropylketone (6.00 g, 69.69 mmol, 1.0 , LDA (1.0 , 
crotonaldehyde (5.37 g, 76.66 mmol, 1.0 , and TMSCl (7.54 g, 69.69 
mmol, 1.0  in THF to obtain after flash chromatography, a yellow oily liquid (yield= 5.91 
g,  61-78%): (Rf = 0.35 in 10% ethylacetate in 90% hexane). Both 
1
H NMR and 
13
C 
NMR were consisted with those reported in literature. IR (neat) 3029 (m), 2971 (s), 2935 
(s), 2875 (s), 1687 (s), 1665 (s), 1638 (s), 1597 (s), 1467 (s), 1383 (s), 1351 (m), 1230 




H NMR (500 MHz, CDCl3) δ 0.97 (d, J = 6.9Hz, 
6H), 1.71 (d, J = 4.6Hz, 3H), 2.67 (quint., 6.9Hz, 1H), 5.98-6.09 (m, 3H), 7.02-7.06 (m, 
1H);
 13
C NMR (125 MHz, CDCl3) δ 18.3, 18.6, 38.6, 125.7, 130.2, 139.9, 142.6, 204.0 
 (2E, 4E)-1-phenylhexa-2,4-dien-1-one (57): Employing typical procedure 1 above and 
using LDA (1.0 equiv.), acetophenone (4.80 g, 40.00 mmol, 1.0 , 
crotonaldehyde (3.08 g, 44.0 mmol, 1.1 equiv.), and TMSCl (4.32 g, 
40.00 mmol, 1.0  in THF, the reaction mixture was instead of reflux, stirred at rt for 3h 
after it had warmed to rt before the work up and column chromatography [silica gel, 15% 
Et2O/85% hexane (Rf = 0.31): used dichloromethane to make it soluble before loading to 
column] to obtain a white solid. (Yield = 4.82 g, 70% after chromatography): IR (neat) 
3060 (m), 3022 (m), 2996 (m), 2963 (m), 2939 (m), 2910 (m), 1658 (s), 1631 (s), 1587 




H NMR (500 MHz, 





(m, 4H), 7.93 (d, J = 7.8Hz, 2H); 
13
C NMR (125 MHz, CDCl3) δ 18.7, 123.1, 128.1, 
128.3, 130.4, 132.3, 138.1, 140.9, 145.0, 190.6 
 (4E, 6E)-2-Methyl-7-phenylhepta-4,6-dien-3-one (58): Employing typical procedure 1 
above and using LDA (1.0 equiv.), methylisopropylketone (5.00 g, 
58.00 mmol, 1.0 equiv.), cinnamaldehyde (7.67 g, 58.00 mmol, 1.05 , 
and TMSCl (6.30g, 58.00 mmol, 1.0  in THF, the reaction mixture 
was allowed to stir at rt for 12 hrs before working up and column to obtain a cream color 
low density solid (yield = 6.37g, 55%; Rf = 0.55 in 10% ethylacetate in hexane): IR (neat) 
3060 (m), 3029 (s), 2970 (s), 2933 (s), 2873 (s), 1683 (s), 1660 (s), 1617 (s), 1588 (s), 





H NMR (500 MHz, CDCl3) δ 1.17 (d, J = 6.9Hz, 6H), 2.87 (sept, J = 6.9Hz, 
1H), 6.38 (d, J = 15.6Hz, 1H), 6.88-6.97 (m, 2H), 7,30-7.43 (m, 4H), 7.47-7.49 (m, 2H); 
13
C NMR (125 MHz, CDCl3) δ 18.4, 39.0, 126.7, 127.1, 127.8, 128.7, 129.0, 136.0, 
141.1, 142.3, 203.8 
 Procedure for the synthesis of ethyl 3-[(1E)-prop-1-en-1-yl]oxirane-2-carboxylate 
(31):  This compound was prepared in one pot by employing the 
Darzen condensation of ethyl-α-bromoacetate and crotonaldehyde
19
 as 
follows. To a flame-dried round-bottom flask under argon was added 
dry THF (70 mL) and   diisopropylamine (DIPA) (6.352 g, 62.78 mmol, 1.1 equiv.). The 
mixture was cooled to 0 
°
C and nBuLi (2.12 M in hexanes, 27.4 mL, 58.21 mmol, 1.02 





allowed to stir for 30 minutes at 0 
°
C before it was cooled to -78 
°
C and a THF solution of 
the ethyl- α-bromoacetate (9.53 g, 57.07 mmol, 1.0 equiv.) was added dropwise to it. 
After stirring for additional 30 min at -78 
°
C, a THF solution of crotonaldehyde (4.0 g, 
57.07 mmol, 1.0 equiv) was added dropwise. The reaction mixture was then stirred at -78 
°
C for another 2h. The cooling bath was then remove and after 15 minutes, the mixture 
was quenched with saturated NH4Cl(aq) solution. The mixture was extracted with CH2Cl2 
and the combined organic layer dried with anhydrous MgSO4. After the filtration and the 
solvent removal, the crude was purified by flash chromatography on silica with 10% 
EtOAc: 90% hexanes to obtain a fruity smell yellow oil which consist of 1:1 mixture of 
the cis and trans isomers: IR (neat) 2984 (s), 2942 (s), 1747 (s), 1673 (m), 1452 (s), 1377 
(s), 1286 (s), 1197 (s), 1037 (s), 968 (s); 
1
H-NMR (500 MHz, CDCl3) δ 1.25-1.29 (m, 
6H), 1.72 (d, J = 6.5, 6H), 3.31 (s, 1H), 3.50 (d, J = 8.5 Hz, 1H), 5.56 (dd, J = 9.0 Hz, 4.5 
Hz, 1H), 3.61 (dd, J = 4.5 Hz, 1.5 Hz, 1H), 4.17-4.27 (m, 4H), 5.15 (dd, J = 16.0 Hz, 8.3 
Hz, 1H), 5.38 (dd, J = 15.2 Hz, 9.0 Hz, 1H), 5.97-6.09 (m, 2H); 
13
C-NMR (125 MHz, 
CDCl3) δ 13.9, 14.0, 17.7, 17.9, 54.1, 54.5, 57.4, 57.9, 61.3, 61.4, 123.4, 126.2, 133.9, 
135.5, 167.8, 168.6; 
General procedure 1 for the syntheses of the α,β-epoxy-γ,δ-unsaturated ketones: The 
products were prepared from their corresponding dienones by employing an existing 
literature procedure
20
 as follows. A flame-dried flask under argon was charged with dry 
THF and cooled to -78 
°
C followed by the addition of tert-butylhydroperoxide (TBHP) 
(5.7-6.0 M in decane on MS, 1.5 equiv.) and then either ethyl or n-butyllithium (1.2  in a 





which THF solution of the dienone was added dropwise to it. The reaction mixture was 
kept at -20 
°
C (refrigerated) for 20h. At the end of this period, solid Na2SO3 
(0.164g/mmol of substrate) was added in one portion and stirred at rt for 15 minutes 
before being diluted with saturated NH4Cl(aq) and then extracted with Et2O (3x). The 
combined ethereal layer was washed once with brine and dried with anhydrous Na2SO4, 
filtered and the solvent removed under reduced pressure.  
General procedure 2i for CuCN-mediated allylic opening of the α,β-epoxy-γ,δ-
unsaturated ketones: To a flame-dried LiCl (2.0 equiv.) in a round-bottom flask under 
argon was added CuCN (1.0 equiv.) and 4.0 mL of dry THF. The mixture was stirred at rt 
to dissolve the CuCN. This was then cooled to -78 
°
C and the Grignard reagent (1.0 
equiv.) was added dropwise. The mixture was allowed to stir at this temperature for 30 
minutes after which a THF solution of the α,β-epoxy-γ,δ-unsaturated ketone (1.0 equiv.) 
was added dropwise to it via syringe. The resulting mixture was stirred at -78 
°
C for 4h 
before quenching with phosphate buffer (pH = 7.0) at this temperature.  After allowing it 
to warm to rt, it was extracted with Et2O and the combined ethereal phase dried with 
anhydrous MgSO4. It was then filtered and the solvent removed under reduced pressure. 
The crude product was purified by flash chromatography with 10% EtOAc: 90% hexane 
to obtain colorless oil.  
General procedure 2ii for lithium chloride-free CuCN-mediated allylic opening of 
the α,β-epoxy-γ,δ-unsaturated ketones: To a flame-dried round-bottom flask under 
argon was added CuCN (45 mg, 0.5 mmol, 1.0 equiv.) and 6.0 mL of dry THF and the 
mixture stirred at rt for 5 minute. This was then cooled to -78 
°
C and the Grignard reagent 
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(1.0 mmol, 2.0 equiv.) was added dropwise. The mixture was allowed to stir at this 
temperature for 10 minutes and then taken out of the -78 
°
C bath and kept stirring until 
the turbid reaction mixture became clear after which it was taken back to the -78 
°
C bath 
and stirred for additional 30 minutes. A THF solution of the α,β-epoxy-γ,δ-unsaturated 
ketone (0.5 mmol, 1.0 equiv.) was added dropwise to it via syringe. The resulting mixture 
was stirred at -78 
°
C for 3.5 h before quenching with NH4Cl(aq.) and extracted with Et2O 
(3x). The combined organic phase was washed once with phosphate buffer (pH = 7.0) 
and then dried with anhydrous MgSO4. It was then filtered and the solvent removed 
under reduced pressure. The crude product was purified by flash chromatography with 
10% EtOAc: 90% hexane to obtain colorless oil.  
General procedure 3 for CuBr·SMe2-mediated/catalyzed addition of Grignard 
reagents to the α,β-epoxy-γ,δ-unsaturated ketones: To a flame-dried flask under argon 
was added CuBr·SMe2 (1.0 equiv. or 20 mol %), dry CH2Cl2 (3.0-6.0 mL) and stirred at rt 
to dissolve it. The flask was then cooled between -55 
°
C and -78 
°
C and the Grignard 
reagent was added dropwise to it via syringe. The reaction mixture was allowed to stir at 
this temperature for between 30 to 45 min to form the cuprate before CH2Cl2 solution of 
the epoxyenone was added dropwise via syringe to it. After the addition, it was allowed 
to stir for at least 3h additional time before quenching with NH4Cl(aq) and extracted with 
Et2O (3x) and the combined organic phase washed once with water and once with 
phosphate buffer (pH = 7.0). It was dried with anhydrous MgSO4, filtered and the solvent 
removed under reduced pressure to obtain the crude product.  
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General procedure 4 for CuBr·SMe2-mediated opening of phenyl{3-[(1E)-prop-1-en-
1-yl]oxiran-2-yl}methanone: To a flame-dried flask containing stir-bar under argon was 
added CuBr·SMe2 (1.0 equiv.) followed by the addition of dry THF (5.0 mL). The 
mixture was stirred at rt for 10 minutes and then cooled to -78 
°
C before the Grignard 
reagent (2.0 equiv.) was added dropwise to it via syringe. After stirring for about 20 
minutes, the suspension was warmed briefly at 0 
°
C where the CuBr·SMe2 dissolved. The 
mixture was then cooled to -78 
°
C and kept it there for additional 45 minutes before THF 
solution of the phenyl{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}methanone (1.0 equiv.) was 
added dropwise via syringe. After the addition, it was then stirred for at least 3 h at this 
temperature before quenching with NH4Cl(aq)  and stirred for 3 minutes, then extracted 
with Et2O (3x). The combined organic phase was washed once with phosphate buffer (pH 
= 7.0), dried, filtered and the solvent remove under reduced pressure. 
Method 1: General procedure for the synthesis of Grignard reagents from halogen-
metal exchange: Halogen-metal exchange reaction was employed to prepare some 
Grignard reagents from their corresponding aryl iodides by following existing literature 
procedures as follows. A flame-dried flask with a stir bar under argon was charged with 
the aryl iodide and dry THF and cooled to the appropriate temperature followed by the 
addition of 
i
PrMgBr (2.0 M in Et2O). The reaction mixture was stirred at this temperature 
for the time indicated before being used for the respective reactions.  
Method 2: Preparation of aryl Grignard reagents from aryl halides. Aryl Grignard 
reagents that were not commercially available were prepared from the corresponding aryl 
halide by modification of existing literature procedure as follows. To flame-dried 
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magnesium turnings in a flask under argon was added catalytic amount of iodine 
followed by addition of THF/Et2O and the mixture was stirred vigorously at room 
temperature. Then a solution of the aryl halide in THF/Et2O was added drop wise. After 
the addition, the reaction mixture was either refluxed or stirred at room temperature for a 
specified amount of time before being cooled to rt and used in the reaction.  
phenyl{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}methanone (15): Following general 
procedure 1 above and using (2E,4E)-1-phenylhexa-2,4-dien-1-one (1.0 
g, 5.8 mmol), TBHP (1.5 equiv.), and ethyllithium (6.96 mmol, 1.2 
equiv.), the crude product was purified by flash chromatography (silica, 20% Et2O: 80% 
hexane) and crystallized by dissolving it in 5 or 10% Et2O in petroleum ether and 
allowing the crystals to form in the refrigerator to obtain white crystals (yield = 0.961 g, 
88%, Rf = 0.48, 20% EtOAc: 80% hexane): 
1
H-NMR (500 MHz, CDCl3) δ 1.81 (d, J = 
6.5 Hz, 3H), 3.54 (d, J = 8.5 Hz, 1H), 4.19 (d, J = 2.0 Hz, 1H), 5.36 (ddd, J = 6.5 Hz, 8.5 
Hz, 1.5 Hz, 1H), 6.05-6.12 (m , 1H), 7.52 (t, J = 8.0 Hz, 2H), 7.64 (t, J = 7.5 Hz, 1H), 
8.02 (d, J = 8.5, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 18.0, 58.8, 59.6, 126.7, 128.2, 
128.8, 133.8, 134.3, 135.5, 194.0.  
2-methyl-1-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}propan-1-one (33): Following general 
procedure 1 above, using (4E,6E)-2-methylocta-4,6-dien-3-one (3.0 g, 
21.71 mmol), TBHP (5.0M in decane, 6.51mL, 1.5 equiv.), and n-
butyllithium (2.12M in hexanes, 12.24 mL, 26.05 mmol, 1.2 equiv.), the crude product 
was purified by flash chromatography (silica, 15% Et2O: 85% hexane) to obtain light 





(s), 2937 (s), 2877 (s), 1723 (s), 1700 (s), 1674 (m), 1470 (s), 1415 (m), 1384 (m), 1038 
(m), 965 (s), 877 (m); 
1
H-NMR (500 MHz, CDCl3) δ 1.08 (qd, J = 6.5 Hz, 3.0 Hz, 6H), 
1.73 (d, J = 6.5 Hz, 3H), 2.71 (quint.d, J = 7.0 Hz, 2.5 Hz, 1H), 3.34 (dd, J = 8.0 Hz, 2.0 
Hz, 1H), 3.43 (t, J = 2.5 Hz, 1H), 5.15-5.20 (m, 1H), 5.99 (sext. d, J = 7.0 Hz, 2.5 Hz, 
1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.1, 17.8, 17.9, 36.4, 58.4, 59.5, 126.6, 133.8, 
209.6.  
2-methyl-1-{3-[(E)-2-phenylethenyl]oxiran-2-yl}propan-1-one (37): Following 
general procedure 1 for the syntheses of the α,β-epoxy-γ,δ-
unsaturated ketones above, compound 37 was prepared using dienone 
58 (0.6 g, 3.0 mmol), TBHP (5.0M in decane, 0.78 mL, 1.3 equiv.), and Etyllithium (1.5 
M in THF, 2.6 mL, 3.9 mmol, 1.3 equiv.), the crude product was purified by flash 
chromatography (silica, 15% Et2O: 85% hexane) to obtain light yellow oil. (Yield = 0.47 
g (72%), Rf = 0.27 in 15% Et2O/85% hexane): IR (neat) 3449 (m), 3030 (m), 2973 (s), 
2935 (s), 2875 (m), 1719 (s), 1677 (m), 1589 (m), 1467 (s), 1222 (m), 1051 (m), 966 (s); 
1
H-NMR (500 MHz, CDCl3) δ 1.22 (t, J = 7.5 Hz, 6H), 2.85 (quin, J = 6.5 Hz, 1H), 3.65 
(s, 1H), 3.67 (s, 1H), 5.97 (dd, J = 16.0 Hz, 8.0 Hz, 1H), 6.91 (d, J = 16.0 Hz, 1H), 7.35 
(t, J = 8.0 Hz, 1H), 7.40 (t, J = 7.5 Hz, 2H), 7.45 (d, J = 8.0 Hz, 2H); 
13
C-NMR (125 







 Procedure for uncatalyzed addition of isopropylmagnesium chloride to form 2,4-
dimethyl-3-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}pentan-3-ol (35c): To a flame-dried 
flame under argon was added dichloromethane (3.0 mL) followed by 
isopropylmagnesium chloride (1.10 M in THF, 0.50 mL, 0.55 mmol, 1.1 
equiv.). The mixture was allowed to stir at -78 
°
C for 30 min before CH2Cl2 solution of 
the 2-methyl-1-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}propan-1-one (77 mg, 0.5 mmol) 
was added dropwise to it. After stirring at -78 
°
C for an additional 4h, it was quenched 
with phosphate buffer and extracted with Et2O (3x). The combined organic layer was 
dried with MgSO4, filtered and the solvent removed under reduced pressure. (Yield = 
72.0 mg, 62%). 
13
C-NMR (125 MHz, CDCl3) δ 16.5, 17.1, 17.2, 17.4, 17.9, 32.0, 34.6, 
54.2, 61.4, 73.7, 127.7, 132.2;  
2-methyl-3-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}heptan-3-ol (35b): To a flame-dried 
flame under argon was added dichloromethane (3.0mL) followed by 
n
butylmagnesium chloride (1.70M in THF, 0.30 mL, 0.5 mmol, 1.0 
equiv.). The mixture was allowed to stir at -78 
°
C for 30 min before 
CH2Cl2 solution of the epoxyenone 33 (77 mg, 0.5 mmol) was added dropwise to it. After 
stirring at -78 
°
C for an additional 4h, it was quenched with phosphate buffer and 
extracted with Et2O (3x). The combined organic layer was dried with MgSO4, filtered 
and the solvent removed under reduced pressure ( yield = 72.2 mg, 68%; Rf = 0.48 in 
20% EtOAc/80% hex):
 
IR (neat) 3484 (br), 2963 (s), 2936 (s), 2875 (m), 1710 (w), 1670 
(w), 1467 (w), 1382 (w), 1019(w);
 1
H-NMR (500 MHz, CDCl3) δ 0.88-0.95 (m, 9H), 





2.84 (d, J = 2.3 Hz, 1H), 3.39 (dd, J = 8.3 Hz, 2.3 Hz, 1H), 5.22 (dd, J = 15.6 Hz, 8.3 Hz, 
1H), 5.95 ( sext., J = 6.9 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 14.0, 16.7, 17.2, 17.9, 
23.3, 25.1, 33.3, 37.0, 55.4, 63.5, 72.7, 127.7, 132.2.  
 (5Z)-4-hydroxy-2,7-dimethylundec-5-en-3-one (34b): Following general procedure 2i 
and using  
n
BuMgCl(1.0 equiv.), 2-methyl-1-{3-[(1E)-prop-1-en-1-
yl]oxiran-2-yl}propan-1-one (1.0 equiv.), at -78 
°
C for 4 hours before 
quenching. The crude product was purified by flash chromatography 
with 10% EtOAc: 90% hexane to obtain colorless oil: (Yield = 138 mg, 65%; Rf = 0.29 in 
10% EtOAc/ 90% hexane); 
1
H-NMR (500 MHz, CDCl3) δ 0.90 (t, J = 7.1 Hz, 3H), 1.03 
(d, J = 6.9 Hz, 3H), 1.09 (d, J = 5.0 Hz, 3H), 1.13 (d, J = 6.9 Hz, 3H), 1.20-1.28 (m, 6H), 
2.65-2.67 (m, 1H), 2.84-2.90 (m, 1H), 3.78 (d, J = 4.6 Hz, 1H), 5.00 (dd, J = 9.6 Hz, 3.0 
Hz, 1H), 5.12 (t, J = 10.1 Hz, 1H), 5.58 (t, J = 10.1 Hz, 1H); 
13
C-NMR (125 MHz, 
CDCl3) δ 17.8, 19.2, 21.1, 22.8, 29.8, 32.4, 35.7, 36.8, 72.1, 123.8, 143.4, 214.3;  
 (5Z)-4-hydroxy-2,7,8-trimethylnon-5-en-3-one (34c): Following general procedure 2i 
and using  
i
PrMgCl(1.0 equiv.), 2-methyl-1-{3-[(1E)-prop-1-en-1-
yl]oxiran-2-yl}propan-1-one (1.0 equiv.), at -78 
°
C for 4hrs before 
quenching. The crude product was purified by flash chromatography 
with 10% EtOAc: 90% hexane to obtain colorless oil (Yield = 61 mg, 61%; Rf = 0.33 in 
15% EtOAc/ 85% hexane): 
1
H-NMR (500 MHz, CDCl3) δ 0.90 (d, J = 6.9 Hz, 3H), 0.92 
(d, J = 6.9 Hz, 3H), 1.00 (d, J = 6.9 Hz, 3H), 1.07 (d, J = 6.4 Hz, 3H), 1.11 (d, J = 6.9 Hz, 
3H), 1.52-1.58 (m, 1H), 2.42-2.45 (m, 1H), 2.83-2.91 (m, 1H), 3.75 (s, 1H), 4.99 (d, J = 
9.6 Hz, 1H), 5.14 (t, J = 10.6 Hz, 1H), 5.67 (t, J = 10.6 Hz, 1H);
 13





CDCl3) δ 17.8, 18.3, 19.2, 19.8, 20.3, 33.2, 35.6, 38.6, 71.9, 124.1, 142.0, 214.4; HRMS 
(EI) calculated for [C12H22O2]
+
 198.1620, found 198.1619.  
 (5Z)-4-hydroxy-2,7-dimethylnon-5-en-3-one (34a): Following general procedure 2i 
using  CuCN (45.0 mg, 0.5 mmol, 1.0 equiv.), LiCl (42 mg, 1.0 mmol, 
2.0 equiv.), EtMgCl(1.67 M, 0.35 mL, 0.55 mmol, 1.1 equiv.), and the 
epoxyenone 33 (77.1 mg, 0.5 mmol, 1.0 equiv) in THF at -55 
°
C for 4 
hour before quenching. The crude product was purified by flash chromatography with 
10% EtOAc: 90% hexane to obtain yellow oil (yield = 67.3 mg, 73%; Rf = 0.42 in 20% 
EtOAc/80% hexane): 
1
H-NMR (500 MHz, CDCl3) δ 0.90 (t, J = 7.5 Hz, 3H), 1.01 (d, J = 
7.0 Hz, 3H), 1.07 (d, J = 7.0 Hz, 3H), 1.09 (d, J = 4.5 Hz, 3H), 1.39-1.42 (m, 1H), 1.73 
(d, J = 7.0 Hz, 1H), 2.56-2.60 (m, 1H), 2.83-2.92 (m, 1H), 3.80 (s, 1H), 4.99 (d, J = 7.5 
Hz, 1H), 5.12 (t, J = 10.0 Hz, 1H), 5.55 (t, J = 10.0 Hz, 1H);
 13
C-NMR (125 MHz, 
CDCl3) δ 11.6, 17.7, 20.7, 29.8, 34.0, 35.6, 72.0, 124.1, 143.0, 214.0; (EI) calculated for 
[C11H20O2]
+
 184.1463, found 184.1461.  
 (5E)-4-hydroxy-2,7-dimethylnon-5-en-3-one (34a): Following general procedure 3 
above and using  CuBr·SMe2 (10.3 mg, 0.050 mmol, 10 mol %), 
EtMgCl (1.67 M in THF, 0.33 mL, 0.55 mmol, 1.1 equiv.), and 2-
methyl-1-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}propan-1-one (77.0 mg, 0.5 mmol) in 3.0 
mL CH2Cl2 to obtain light yellow oil after flash chromatography. (Yield = 71.8 mg, 78%; 
Rf = 0.42 in 20% EtOAc/80% hexane): 
1
H-NMR (500 MHz, CDCl3) δ 0.86 (t, J = 7.5Hz, 
3H), 1.00 (d, J = 6.0 Hz, 3H), 1.09 (d, J = 7.0 Hz, 3H), 1.14 (d, J = 6.5 Hz, 3H), 1.32-





4.67 (d, J = 7.5 Hz, 1H), 5.31 (dd, J = 15.5 Hz, 8.0 Hz, 1H), 5.81 (dd, J = 15.0 Hz, 8.0 
Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 11.7, 17.7, 19.1, 19.8, 29.4, 35.7, 38.3, 77.2, 
124.5, 142.9, 214.1; HRMS (EI) calculated for [C11H20O2]
+
 184.1463, found 184.1461.  
 (5E)-4-hydroxy-2,7-dimethylundec-5-en-3-one (34b): Following general  procedure 3 
above using  CuBr·SMe2 (41.0 mg, 0.20 mmol, 20 mol %), 
n
ButylMgCl (1.61 M in THF, 0.33 mL, 0.53 mmol, 1.06 equiv.), and 
2-methyl-1-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}propan-1-one (0.1542 
g, 1.0 mmol), to obtain light yellow oil after flash chromatography. (Yield = 0.138 g 
(65%), Rf = 0.29 in 10% EtOAc/ 90% hexane ): IR (neat) 3449 (br), 2963 (s), 2934 (s), 
2875 (m), 1719 (s), 1908 (m), 1687 (m), 1459 (m), 1379 (w), 971 (m); 
1
H-NMR (500 
MHz, CDCl3) δ 0.89 (t, J = 7.0 Hz, 3H), 1.02 (d, J = 7.0 Hz, 3H), 1.10 (d, J = 7.0 Hz, 
3H), 1.15 (d, J = 7.0 Hz, 3H), 1.24-1.34 (m, 6H), 2.18 (quint. J = 7.0 Hz, 1H), 2.92 (sept. 
J = 7.0 Hz, 1H), 3.80 (s, 1H), 4.67 (d, J = 8.0 Hz, 1H), 5.30 (dd, J = 15.0 Hz, 8.0 Hz, 
1H), 5.82 (dd, J = 15 Hz, 8.0 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 14.1, 17.8, 19.2, 
20.3, 22.7, 29.6, 35.7, 36.4, 36.7, 77.2, 124.3, 143.2, 214.2  
 (5E)-2,7-dimethylundec-5-ene-3,4-dione (39a): Following general  procedure 3 above 
using CuBr·SMe2 (41.0 mg, 0.20 mmol, 0.2 equiv.), 
n
ButylMgCl 
(1.61M in THF, 0.33 mL, 0.53 mmol, 1.06 equiv), and epoxyenone 
33 (0.154 g, 1.0 mmol), the reaction mixture was allowed to warm to 
rt during 12 h stirring.  After work-up, the crude material was purified by flash 
chromatography to obtain light yellow oil (Yield = 130 mg, 62%): 
1
H-NMR (500 MHz, 





1.33 (m, 4H), 1.38-1.44 (m, 2H); 2.39 (quint. J = 6.9 Hz, 1H), 3.36-3.42 (m, 1H), 6.60 (d, 
J = 16.1 Hz, 1H), 7.00 (dd, J = 16.0 Hz, 7.8 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 
13.9, 17.3 (2-carbons), 19.1, 22.7, 29.4, 34.6, 35.6, 37.4, 122.3, 159.5, 189.6, 205.1.  
 (5E)-4-hydroxy-2,7,8-trimethylnon-5-en-3-one (34c): Following general  procedure 3 
above and using  CuBr·SMe2 (40.6 mg, 0.20 mmol, 20 mol %), 
i
PrMgCl 
(1.10M in THF, 0.95 mL, 0.55 mmol, 1.05 equiv.), and 2-methyl-1-{3-
[(1E)-prop-1-en-1-yl]oxiran-2-yl}propan-1-one (154.2 mg, 1.0 mmol, 1.0 equiv.) in 6.0 
mL of CH2Cl2 to obtain light yellow oil after flash chromatography (Yield = 155 mg, 
78%, Rf = 0.33 in 15% EtOAc/ 85% hexane): IR (neat) 3467 (br), 2965 (s), 2876 (s), 
1717 (s), 1686 (w), 1459 (s), 1450 (m), 1386 (m), 1100 (m), 1016 (s); 
1
H-NMR (500 
MHz, CDCl3) δ 0.86 (t, J = 6.0 Hz, 6H), 0.99 (d, J = 6.5 Hz, 3H), 1.09 (d, J = 7.0 Hz, 
3H), 1.14 (d, J = 7.0 Hz, 3H), 1.56 (sext. J = 6.5 Hz, 1H), 2.01 (sext. J = 6.5 Hz, 1H), 
2.91 (sept. J = 7.0 Hz, 1H), 3.65 (s, 1H), 4.67 (d, J = 8.0 Hz, 1H), 5.29 (dd, J = 15.0 Hz, 
8.0 Hz, 1H), 5.84 (dd, J = 15.0 Hz, 8.0 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.1, 
17.7, 19.1, 19.7, 19.9, 32.9, 35.7, 43.0, 77.2, 125.2, 141.5, 214.1; HRMS (EI) calculated 
for [C12H22O2]
+
 198.1620, found 198.1619. 
 (5E)-4-hydroxy-2,7-dimethyloct-5-en-3-one (34d): Following general procedure 3 
above and using  CuBr·SMe2 (40.6 mg, 0.20 mmol, 20 mol %), MeMgCl 
(2.10 M in Et2O, 0.251 mL, 0.525 mmol, 1.06 equiv.), and 2-methyl-1-
{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}propan-1-one (154.2 mg, 1.0 mmol, 1.0  in 6.0 mL 
of CH2Cl2 to obtain light yellow oil after flash chromatography. (Yield = 95 mg, 56%; Rf 
= 0.27 in 15% EtOAc/ 85% hexane): 
1





6H), 1.09 (d, J = 6.0 Hz, 3H), 1.14 (d, J = 6.0 Hz, 3H), 2.37 (quint., J = 7.5 Hz, 1H), 
2.84-2.94 (m, 1H), 4.67 (d, J = 9.0 Hz, 1H), 5.31 (ddd, J = 15.0 Hz, 6.0 Hz, 3.0 Hz, 1H), 
5.93 (dd, J = 15.0 Hz, 6.0 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.8, 19.1, 21.9 (2-
carbons), 30.9, 35.8, 77.1, 123.2, 143.9, 214.1.  
 (5E)-4-hydroxy-2,7,8,8-tetramethylnon-5-en-3-one (34f): Following general  
procedure 3 above and using  CuBr·SMe2 (41.2 mg, 0.20 mmol, 20 mol 
%), 
t
BuMgCl (1.35M in Et2O, 0.80 mL, 1.1 mmol, 1.1 equiv.), The 
suspension was warmed for about 1 minute at ambient temperature where the CuBr·SMe2 
dissolved, and the mixture turned dark yellow before returning it to the -55 
°
C bath. Then 
2-methyl-1-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}propan-1-one (155.0 mg, 1.0 mmol, 1.0 
equiv.) in 5.0 mL of CH2Cl2 was added dropwise and stirred for 4hr. It was then worked-
up to obtain after flash chromatography, light yellow oil. (Yield = 127 mg, 60%; Rf = 
0.25 in 15% EtOAc/ 85% hexane): 
1
H-NMR (500 MHz, CDCl3) δ 0.86 (s, 9H), 0.97 (d, J 
= 6.9 Hz, 3H), 1.08 (d, J = 6.9 Hz, 3H), 1.14 (d, J = 7.3 H, 3H), 1.97 (quint., J = 8.3 Hz, 
1H), 2.90 (quint., J = 6.9 Hz, 1H), 3.80 (d, J = 5.1 Hz, 1H), 4.67 (dd, J = 7.8 Hz, 4.6 Hz, 
1H), 5.29 (dd, J = 15.1 Hz, 7.8 Hz, 1H), 5.89 (dd, J = 15.2 Hz, 9.2 Hz, 1H); 
13
C-NMR 
(125 MHz, CDCl3) δ 15.3, 17.6, 19.1, 27.4, 32.9, 35.7, 47.2, 77.2, 125.7, 140.7, 214.1; 
HRMS (EI) calculated for [C13H24O2]
+
 212.1776, found 212.1776.  
 (5E)-4-hydroxy-2,7-dimethyldeca-5,9-dien-3-one (34g): Following general procedure 
3 and using allylmagnesium chloride (0.86 M in Et2O, 1.16 mL, 1.0 
mmol, 2.0 equiv.), CuBr·SMe2 (103.0 mg, 0.5 mmol, 1.0 equiv.), and 





equiv.) in CH2Cl2 at -55 
°
C. The reaction mixture was allowed to stir at -55 
°
C for 4 hours 
during which the reaction mixture changed from dirty green color to orange yellow. After 
the work up, the crude was purified flash chromatography (silica) with 15% EtOAc/85% 
hexane. (Yield = 88.3 mg (90%), Rf = 0.30 in 15% EtOAc/85% hexane): 
1
H-NMR (500 
MHz, CDCl3) δ 1.04 (d, J = 6.9 Hz, 3H), 1.09 (d, J = 6.9 Hz, 3H), 1.15 (d, J = 6.9, 3H), 
2.11-2.12 (m, 2H), 2.31 (quint. J = 6.9 H, 1H), 2.92 (quint. J = 6.9 Hz, 1H), 3.80 (d, J = 
4.6, 1H), 4.67 (dd, J = 7.8 Hz, 4.1 Hz, 1H), 5.00-5.04 (m, 2H), 5.31 (ddd, J = 7.5 Hz, 8.0 
Hz, 1.0Hz, 1H), 5.70-5.78 (m, 1H), 5.86 (dd, J = 16.1 Hz, 7.8 Hz, 1H); 
13
C-NMR (125 
MHz, CDCl3) δ 17.8, 19.1, 19.7, 35.6, 36.4, 41.0, 77.1, 116.1, 124.7, 136.6, 142.2, 214.1; 
HRMS (EI) calculated for [C12H20O2]
+
 196.1463, found 196.1461.  
(5E)-7-cyclohexyl-4-hydroxy-2-methyloct-5-en-3-one (34e): Following general 
procedure 3 using cyclohexylmagnesium chloride (1.82 M in Et2O, 
0.29 mL, 0.525 mmol, 1.05 equiv.), CuBr·SMe2 (20.5 mg, 0.1 mmol, 
0.2 equiv.), and dienone 33 (77.1 mg, 0.50 mmol, 1.0 equiv.) in CH2Cl2 
at -55 
°
C. The reaction mixture was allowed to stir at -55 
°
C for 4 h before quenching 
with NH4Cl (aq) and extracting with Et2O (3x). The combine ethereal phase was washed 
once with phosphate buffer (pH = 7.0) and dried with anhydrous MgSO4. After the work 
up, the crude was purified flash chromatography (silica) with 15% EtOAc/85% hexane. 
(Yield = 91 mg, 76%; Rf = 0.29 in 15% EtOAc/85% hexane): IR (neat) 3449 (br), 2925 
(s), 2854 (s), 1803 (m), 1718 (s), 1687 (s), 1656 (m), 1450 (s), 1384 (s)1032 (s); 
1
H-NMR 
(500 MHz, CDCl3) δ 0.87-0.98 (m, 3H), 1.00 (d, J = 7.0 Hz, 3H), 1.10 (d, J = 7.0 Hz, 




1), 2.87-2.94 (m, 1H), 4.68 (d, J = 8.0 Hz, 1H), 5.28 (dd, J = 15.5 Hz, 8.0 Hz, 1H), 5.85 
(dd, J = 15.5 Hz, 8.5 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 17.3, 17.7, 19.2, 26.5, 
26.6, 30.4, 35.7, 42.3, 43.0, 77.2, 124.9, 141.9, 214.1 
 (5E)-4-hydroxy-2-methyl-7-phenyloct-5-en-3-one (34h): The PhMgBr (2.0 equiv.) 
was prepared from bromobenzene (0.157 g, 1.0 mmol, 2.0 equiv.), 
magnesium chips (100 mg, 2.0 mmol, 4.0 equiv.), and crystal of iodine 
in THF (2.0 mL) by employing method 2. Following general procedure 3 
and using the PhMgBr prepared above, CuBr·SMe2 (103 mg, 0.5 mmol, 1.0 equiv.), and   
2-methyl-1-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}propan-1-one (77.0 mg, 0.5 mmol) in 
CH2Cl2  at -78 
°
C for 4h. The cuprate was stirred at -78 
°
C for 15min before epoxyenone 
was added.  The crude was purified on silica (15% EtOAc:85% hexane) to obtain yellow 
oil. (Yield = 77.8 mg, 67%; Rf = 0.22 in 15% EtOAc/85% hexane): 
1
H-NMR (500 MHz, 
CDCl3) δ 1.04 (d, J = 6.9 Hz, 3H), 1.12 (d, J = 6.9 Hz, 3H), 1.41 (d, J = 6.9 Hz, 3H), 2.84 
(quint., J = 6.9 Hz, 1H), 3.55 (quint., J = 6.9 Hz, 1H), 4.71 (d, J = 7.3 Hz, 1H), 5.39 ( dd, 
J = 15. 1 Hz, 7.8 Hz, 1H), 6.14 (dd, J = 15.1 Hz, 6.9 Hz, 1H), 7.20-7.25 (m, 3H), 7.33 (t, 
J = 7.6 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 17.7, 19.0, 20.8, 35.8, 77.0, 125.0, 
126.3, 127.1, 128.5, 141.2, 144.7, 213.9.  
 (5E)-4-hydroxy-7-(4-methoxyphenyl)-2-methyloct-5-en-3-one (34j): The Grignard 
reagent was prepared by employing an existing literature procedure
21
 as 
follows: In a flame-dried flask under argon was dissolved 4-iodoanisole 
(0.234 g, 1.0 mmol, 2.0 equiv.) in dry THF (2.0 mL) and stirred at rt. To 
this was added 
i





resulting mixture was stirred at rt for 1h after which it was transferred via syringe to 
CH2Cl2 (3.0 mL) solution of CuBr·SMe2 at -60 
°
C in a dropwise manner. The yellow 
mixture was stirred at this temperature for additional 30 min before the 2-methyl-1-{3-
[(1E)-prop-1-en-1-yl]oxiran-2-yl}propan-1-one (0.0771 g, 0.50 mmol, 1.0 equiv.) in 
CH2Cl2 was added dropwise. The reaction mixture was then stirred at this temperature for 
3.5h before quenching with phosphate buffer (pH = 7.0) and extracting with CH2Cl2 and 
drying with MgSO4, filtered, and the solvent removed under reduced pressure. The crude 
was purified by flash chromatography (15% EtOAc/85% hexane) to obtain oil (yield = 
99.7 mg, 76%, Rf = ): 
1
H-NMR (500 MHz, CDCl3) δ 1.06 (d, J = 6.9 Hz, 3H), 1.12 (d, J 
= 7.3 Hz, 3H), 1.38 (d, J = 6.9 Hz, 3H), 2.84 (quint., J = 6.9 Hz, 1H), 3.50 (quint., J = 6.9 
Hz, 1H), 3.80 (s, 3H), 4.70 (d, J = 7.8 Hz, 1H), 5.36 (ddd, J = 15.1 Hz, 7.8 Hz, 1.4 Hz, 
1H), 6.11 (ddd, J = 15.6 Hz, 6.9 Hz, 0.9 Hz, 1H), 6.86 (d, J = 8.7 Hz, 2H), 7.12 (d, J = 
8.7 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 17.7, 19.0, 20.8, 35.7, 41.1, 55.2, 77.0, 
113.8, 124.7, 128.0, 136.7, 141.5, 158.0, 213.8; HRMS (EI) calculated for [C16H22O3]
+
 
262.1569, found 262.1562.  
 (5E)-7-[4-(dimethylamino)phenyl]-4-hydroxy-2-methyloct-5-en-3-one (34i): The 
Grignard reagent was prepared from N, N-dimethyl-4-bromoaniline 
(0.200 g, 1.0 mmol, 2 equiv.), magnesium chips (88.0 mg, 4.0 mmol, 4.0 
equiv.), and a crystal of iodine in THF (4.0 mL) by employing method 2 
and refluxing for 1h. Quarter of the volume of this Grignard reagent (1.0 mL, 1.0 mmol, 
2.0 equiv.) was used with CuBr·SMe2 (103.0 mg, 0.5 mmol, 1.0 equiv.), and epoxyenone 




a crude which was purified by flash chromatography (silica). The column was first eluted 
with 15% EtOAc/85% hexane before changing to 1%MeOH/ 99% CH2Cl2 (yield = 103.3 
mg, 75%): 
1
H-NMR (500 MHz, CDCl3) δ 1.08 (d, J = 6.9 Hz, 3H), 1.12 (d, J = 6.9 Hz, 
3H), 1.38 (d, J = 6.9 Hz, 3H), 2.94 (s, 6H), 3.47 (quint. J = 6.9 Hz, 1H), 3.84 (d, J = 4.6 
H, 1H), 4.70 (dd, J = 7.8 Hz, 4.4 Hz, 1H), 5.36 (ddd, J = 15.6 Hz, 7.8 Hz, 1.4 Hz, 1H), 
6.11 (dd, J = 15.2 Hz, 6.2 Hz, 1H), 6.74 (d, J = 8.3 Hz, 2H), 7.09 (d, J = 8.3 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 17.7, 19.0, 20.8, 35.6, 40.8, 40.9, 77.0, 113.0, 124.3, 
127.7, 132.8, 141.9, 149.0, 214.0. 
 (5E)-4-hydroxy-2-methyl-7-(naphthalen-1-yl)oct-5-en-3-one (34k): The 
naphthylmagnesium bromide (1.0 mmol, 2.0 equiv.) was prepared 
from 1-bromonaphthalene (0.207 g, 1.0 mmol, 2.0 equiv.), 
magnesium chips (96 mg, 4.0 mmol, 4 equiv.), a crystal of iodine in THF by following 
method 2 and refluxing for 1h.  Then general procedure 3 employed as follows: To a 
flame-dried flask with a stir-bar under argon was added CuBr·SMe2 (103 mg, 0.50 mmol, 
1.0 equiv.), and 3.0mL of CH2Cl2. The mixture was stirred at rt for 5 min before cooling 
it to -78 
°
C followed by the dropwise addition of the Grignard reagent described above. 
After the addition, the reaction mixture remained cloudy due to the undissolved 
CuBr·SMe2. The flask was taken out of the -78 
°
C bath and stirred at rt for few minutes 
until it became clear-yellow as the CuBr·SMe2 dissolved and the cuprate formed. The 
flask was taken back to the -78 
°
C bath and stirred for additional 30 minutes before 
CH2Cl2 solution of 2-methyl-1-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}propan-1-one (77.1 




quenching with NH4Cl(aq). It was extracted with CH2Cl2 and washed once with phosphate 
buffer (pH = 7.0) and then dried with anhydrous MgSO4, filtered, and solvent removed 
under reduced pressure to give a crude material which was purified with 15% EtOAc/ 
85% hexane. (Yield = 109.0 mg, 77%; Rf = 0.20 in 15% EtOAc/85% hexane): IR (neat) 
3462 (br), 3049 (m), 2972 (s), 2934 (m), 2875 (m), 1713 (s), 1597 (m), 1510 (m), 1467 
(s), 1385 (s), 1122 (s), 1007 (s), 799 (s); 
1
H-NMR (500 MHz, CDCl3) δ 0.99 (d, J = 7.0 
Hz, 3H), 1.08 (d, J = 7.0 Hz, 3H), 1.58 (d, J = 7.0 Hz, 3H), 2.77 (sept, J = 7.0 Hz, 1H), 
3.90 (d, J = 5.0 Hz, 1H), 4.38 (quint. J = 6.5 Hz, 1H), 4.73 (dd, J = 8.0 Hz, 5.0 Hz, 1H), 
5.47 (qd, J = 7.5 Hz, 1.5 Hz, 1H), 6.28 (qd, J = 7.0 Hz, 1.0 Hz, 1H), 7.41-7.54 (m, 4H), 
7.77 (d, J = 8.0 Hz, 1H), 7.89 (d, J = 9.5 Hz, 1H), 8.09 (d, J = 7.5 Hz, 1H); 
13
C-NMR 
(125 MHz, CDCl3) δ 17.6, 19.0, 20.4, 35.7, 36.9, 76.9, 123.2, 123.6, 125.4 (2-carbons), 
125.5, 125.8, 127.0, 128.9, 131.2, 133.9, 140.5, 140.8, 213.8. 
 (3E)-2-hydroxy-5-methyl-1-phenylhex-3-en-1-one (36a): Following general 
procedure 4 and using CuBr·SMe2 (123.4 mg, 0.60 mmol, 1.0 equiv.), 
and MeMgBr (3.0 M in Et2O, 0.4 mL, 1.2 mmol, 2.0 equiv.) in dry THF 
(6.0 mL). The mixture turned yellow and gradually changed to orange after complete 
addition of the MeMgBr. After the formation of the cuprate, THF solution of phenyl{3-
[(1E)-prop-1-en-1-yl]oxiran-2-yl}methanone (113.0 mg, 0.60 mmol, 1.0 equiv.) was 
added dropwise. After stirring at -50 
°
C for 4hr and the usual work-up, the product was 
purified by flash chromatography on silica to obtain oil. (Yield = 93.1 mg, 76%; Rf = 0.23 
in 15% EtOAc/85% hexane): 
1
H-NMR (500 MHz, CDCl3) δ 0.93 (d, J = 4.6 Hz, 3H), 
0.94 (d, J = 4.6 Hz, 3H), 2.27 (sext. J = 6.9 Hz, 1H), 4.06 (s, 1H), 5.41-5.45 (m, 2H), 
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5.96 (dd, J = 14.2 Hz, 6.5 Hz, 1H), 7.48 (t, J = 7.6 Hz, 2H), 7.60 (t, J = 7.1 Hz, 1H), 7.99 
(d, J = 7.8 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 21.7, 30.8, 74.3, 124.3, 128.6, 129.0, 
133.4, 133.8, 143.0, 199.3; HRMS (EI) calculated for [C13H16O2]
+
 204.1150, found 
204.1148. 
 (3E)-5-methyl-1-phenylhex-3-ene-1,2-dione (39b): This compound was formed from 
the oxidation of the corresponding α-hydroxyketone from the crude 
when it was allowed to stand at rt over 24 hrs. It is yellow oily liquid 
(Yield = 73.0 mg, 60%; Rf = 0.42 in 15% EtOAc/85% hexane): 
1
H-NMR (500 MHz, 
CDCl3) δ 1.12 (d, J = 6.9 Hz, 6H), 2.58 (sext., J = 6.4 Hz, 1H), 6.44 (dd, J = 16 Hz, 1.2 
Hz, 1H), 6.92 (dd, J = 16.5 Hz, 6.4 Hz, 1H), 7.52 (t, J = 7.6 Hz, 2H), 7.66 (t, J = 7.3 Hz, 
1H), 7.98 (d, J = 7.4 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 20.9, 31.9, 124.3, 128.8, 
130.0, 132.7, 134.6, 161.4, 193.8.  
 (3E)-2-hydroxy-5-methyl-1-phenylhept-3-en-1-one (36b): Following general 
procedure 4 and using CuBr·SMe2 (0.1234 g, 0.60 mmol, 1.0 equiv.), 
EtMgCl (1.60 M in THF, 0.75 mL, 1.2 mmol, 2.0 equiv.), phenyl{3-
[(1E)-prop-1-en-1-yl]oxiran-2-yl}methanone (0.113 g, 0.60 mmol, 1.0 equiv.), in dry 
THF (7.0 mL). The suspension was warmed briefly at 0 
°
C where the CuBr·SMe2 
dissolved. After the usual work-up, the product was purified by flash chromatography on 
silica to obtain oil. (Yield = 0.1077 g, 82%; Rf = 0.28 in 15% EtOAc/85% hexane): 
1
H-
NMR (500 MHz, CDCl3) δ 0.72 (t, J = 7.3 Hz, 3H), 0.95 (d, J = 6.9 Hz, 3H), 1.22-1.32 
(m, 2H), 2.01 (quit. J = 6.9 Hz, 1H), 4.08 (d, J = 6.0 Hz, 1H), 5.41-5.50 (m, 2H), 5.84 





= 7.3 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 11.5, 19.7, 29.3, 38.3, 74.5, 125.7, 128.6, 




 (3E)-2-hydroxy-5-methyl-1-phenylnon-3-en-1-one (36d): Following general 
procedure 4 and using CuBr·SMe2 (123.4 mg, 0.60 mmol, 1.0 
equiv.), 
n
BuMgCl (1.23M in THF, 1.0 mL, 1.2 mmol, 2.0 equiv.), 
phenyl{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}methanone (113.0 mg, 
0.60 mmol, 1.0 equiv.), in dry THF (7.0 mL). The suspension was warmed briefly at 0 
°
C 
where the CuBr·SMe2 dissolved. After the usual work-up, the product was purified by 
flash chromatography on silica to obtain oil. (Yield = 110.1 mg, 74%, Rf = 0.33 in 15% 
EtOAc/85% hexane): 
1
H-NMR (500 MHz, CDCl3) δ 0.77 (t, J = 6.9 Hz, 3H), 0.95 (d, J = 
6.9 Hz, 3H), 1.02-1.09 (m, 2H), 1.14-1.28 (m, 4H), 2.06 (quint., J = 6.9 Hz, 1H), 4.05 (d, 
J = 5.5 Hz, 1H), 5.40 (dd, J = 15.1 Hz, 7.4 Hz, 1H), 5.48 (t, J = 6.0 Hz, 1H), 5.83 (dd, J = 
15.6 Hz, 8.3 Hz, 1H), 7.49 (t, J = 7.8 H, 2H), 7.61 (t, J = 7.4 Hz, 1H), 8.00 (d, J = 7.4 Hz, 
2H); 
13
C-NMR (125 MHz, CDCl3) δ 13.9, 20.3, 22.6, 29.4, 36.4, 36.7, 74.6, 125.5, 128.6, 
129.0, 133.5, 133.9, 142.6, 199.5; HRMS (EI) calculated for [C16H22O2]
+
 246.1620, 
found 246.1619.  
(3E)-5-methyl-1-phenylnon-3-ene-1,2-dione (39a): This compound was formed from 
the oxidation of the corresponding α-hydroxyketone from the crude 
when it was allowed to stir at rt over 24 hours. It is a yellow oily 
liquid (Yield = 102.6 mg, 70%; Rf = 0.48 in 10% EtOAc/90% 
hexane).
 1





1.23-1.32 (m, 4H), 1.37-1.43 (m, 2H), 2.41 (sept. J = 7.0 Hz, 1H), 6.44 (d, J = 16.5 Hz, 
1H), 6.93 (dd, J = 16.0 Hz, 8.0 Hz, 1H), 7.52 (t, J = 8.0 Hz, 2H), 7.65 (t, J = 7.0 Hz, 1H), 
7.98 (d, J = 8.0 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 13.9, 18.9, 22.6, 29.3, 35.4, 
37.5, 125.2, 128.8, 129.9, 132.7, 134.5, 160.9, 193.7, 193.8.   
 (3E)-2-hydroxy-5,6-dimethyl-1-phenylhept-3-en-1-one (36c): Following general 
procedure 4 using CuBr·SMe2 (123.4 mg, 0.60 mmol, 1.0 equiv.), 
i
PrMgCl (0.96M in THF, 1.25 mL, 1.2 mmol, 2.0 equiv.), phenyl{3-
[(1E)-prop-1-en-1-yl]oxiran-2-yl}methanone (113.0 mg, 0.60 mmol, 1.0 equiv.), in dry 
THF (5.0 mL). The suspension was warmed briefly at 0 
o
C where the CuBr·SMe2 
dissolved to form a brownish-violet color. After the usual work-up, the product was 
purified by flash chromatography on silica to obtain oil. (Yield = 105.0 mg, 75%, Rf = 
0.30 in 15% EtOAc/85% hexane): 
1
H-NMR (500 MHz, CDCl3) δ 0.72 (d, J = 6.9 Hz. 
3H), 0.74 (d, J = 6.9 Hz, 3H), 0.93 (d, J = 6.9 Hz, 3H), 1.47 (sext., J = 6.9 Hz, 1H), 1.92 
(sext., J = 7.3 Hz, 1H), 4.05 (d, J = 6.4 Hz, 1H), 5.40 (dd, J = 15.1 Hz, 7.8 Hz, 1H), 5.49 
(t, J = 6.4 Hz, 1H), 5.86 (ddd, J = 15.2 Hz, 8.3 Hz, 0.9 Hz, 1H), 7.49 (t, J = 7.8 Hz, 2H), 
7.61 (t, J = 7.8 Hz, 1H), 7.99 (d, J = 8.0 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 17.1, 
19.4, 19.8, 32.9, 42.9, 74.6, 126.4, 128.6, 129.0, 133.5, 133.9, 140. 8, 199.6; HRMS (EI) 
calculated for [C15H20O2]
+
 232.1463, found 232.1462.                                
 (3E)-2-hydroxy-5,6,6-trimethyl-1-phenylhept-3-en-1-one (36e): Following general 
procedure 4 using CuBr·SMe2 (123.4 mg, 0.60 mmol, 1.0 equiv.), 
t
BuMgCl (1.69 M in Et2O, 0.71 mL, 1.2 mmol, 2.0 equiv.), phenyl{3-





THF (6.0 mL). The suspension was warmed for about 1 minute at rt where the 
CuBr·SMe2 dissolved. After the usual work-up, the product was purified by flash 
chromatography on silica to obtain oil. (Yield = 102.0 mg, 78%, Rf = 0.32 in 15% 
EtOAc/85% hexane):  
1
H-NMR (500 MHz, CDCl3) δ 0.70 (s, 9H), 0.89 (d, J = 6.9 Hz, 
3H), 1.81-1.87 (m, 1H), 4.05 (d, J = 6.0 Hz, 1H), 5.35 (dd, J = 15.6 Hz, 7.6 Hz, 1H), 5.47 
(t, J = 6.9 Hz, 1H), 5.88 (dd, J = 15.1 Hz, 9.4 Hz, 1H), 7.46 (t, J = 7.8 Hz, 2H), 7.58 (t, J 
= 7.4 Hz, 1H), 7.96 (d, J = 7.8 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 15.1, 27.2, 32.9, 
47.0, 74.6, 126.7, 128.6, 128.9, 133.5, 133.8, 140.0, 199.6; HRMS (EI) calculated for 
[C16H22O2]
+
 246.1620, found 246.1622.  
 (3E)-2-hydroxy-1,5-diphenylhex-3-en-1-one (36f): The PhMgCl (1.2 mmol, 2.0 equiv.) 
was prepared from bromobenzene (1.2 mmol, 2.0 equiv) by employing 
method 2 and refluxing for 1hr and then following general procedure 4 
and using CuBr·SMe2 (123.4 mg, 0.60 mmol, 1.0 equiv), phenyl{3-
[(1E)-prop-1-en-1-yl]oxiran-2-yl}methanone (113.0 mg, 0.60 mmol, 1.0 equiv), in dry 
THF (6mL). The suspension was warmed briefly at 0 
°
C where the CuBr·SMe2 dissolved. 
After the usual work-up, the product was purified by flash chromatography on silica to 
obtain oily liquid. (Yield = 118.0 mg, 73%, Rf = 0.22 in 15% EtOAc/85% hexane):  IR 
(neat) 3449 (br), 3066 (m), 3032 (m), 2971 (m), 2931 (m), 1719 (s), 1687 (m ), 1459 (m), 
1267 (m), 1070 (w), 700 (s); 
1
H-NMR (500 MHz, CDCl3) δ 1.23 (d, J = 7.4 Hz, 3H), 3.36 
(quint., J = 6.9 Hz, 1H), 4.00 (d, J = 6.0 Hz, 1H), 5.38-5.47 (m, 2H), 6.05 (dd, J = 15.2 
Hz, 6.9 Hz, 1H), 6.99 (d, J = 7.4 Hz, 2H), 7.09 (t, J = 7.4 Hz, 1H), 7.15 (t, J = 7.4 Hz, 






(125 MHz, CDCl3) δ 20.6, 41.9, 74.4, 126.1, 126.2, 127.1, 128.4, 128.7, 129.0, 133.4, 
133.9, 140.6, 144.7, 199.2..  
 (3E)-5-[4-(dimethylamino)phenyl]-2-hydroxy-1-phenylhex-3-en-1-one (36g): The 
N,N-Me2NPhMgCl (1.2 mmol, 2.0 equiv.) was prepared from N,N-
dimethyl-4-bromoaniline (1.2 mmol, 2.0 equiv.) by employing method 
2 and refluxing for 1h before and then following general procedure 4 
and using CuBr·SMe2 (123.4 mg, 0.60 mmol, 1.0 equiv), phenyl{3-[(1E)-prop-1-en-1-
yl]oxiran-2-yl}methanone (113.0 mg, 0.60 mmol, 1.0 equiv), in dry THF (6.0 mL). The 
suspension was warmed briefly at 0 
°
C where the CuBr·SMe2 dissolved. After the usual 
work-up, the product was purified by flash chromatography on silica treated with Et3N 
and 20% EtOAc/80% hexane to obtain oil. (Yield = 154.0 mg, 83%; Rf = 0.32 in 30% 
EtOAc/70% hexane): 
1
H-NMR (500 MHz, CDCl3) δ 1.81 (d, J = 6.9 Hz, 3H), 2.93 (s, 
6H), 3.39 (quit. J = 6.9 Hz, 1H), 5.49-5.55 (m, 2H), 6.14 (dd, J = 14.2 Hz, 6.9 Hz, 1H), 
6.67 (d, J = 8.7 Hz, 2H), 6.99 (d, J = 8.7 Hz, 2H), 7.49 (t, J = 7.8 Hz, 2H), 7.63 (t, J = 7.8 
Hz, 1H), 8.00 (d, J = 8.3 Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 20.7, 40.8 (2-carbons), 
74.4, 112.8, 125.5, 127.6, 128.6, 129.0, 132.7, 133.5, 133.8, 141.4, 149.2, 199.3; HRMS 
(EI) calculated for [C20H23NO2]
+
 309.1729, found 309.1729.  
1-phenylpentan-1-one (42): To the epoxyketone (94.1 mg, 0.5 mmol) in THF (10 mL) 
under argon was added CuCN (45.0 mg, 0.5 mmol, 1.0 equiv.) and 




BuMgCl (1.0 mmol, 2.0 equiv.) was added dropwise. After the addition, the reaction 
mixture was stirred for additional 8 h at -78 
°





allowing it to warm to rt during overnight stirring at which the reaction mixture had 
turned dark green. It was then diluted with Et2O (10 mL) and quenched with NH4Cl (aq) 
before extracting with Et2O (3x15 mL). The combined organic layer was dried with 
anhydrous MgSO4, filtered and the solvent removed under reduced pressure. (Yield = 123 
mg, 76%; Rf = 0.45 in 10% Et2O /90% pet. ether).
 1
H-NMR (500 MHz, CDCl3) δ 0.94 (t, 
J = 7.5 Hz, 3H), 1.39 (quin, J = 7.7 Hz, 2H), 1.70 (quin, J = 7.5 Hz, 2H),  2.95 (t, J = 7.5 
Hz, 2H), 7.43 (t, J = 8.0 Hz, 2H), 7.53 (t, J = 7.0 Hz, 1H), 7.94 (d, J = 8.5 Hz, 2H);  
13
C-
NMR (125 MHz, CDCl3) δ 13.8, 22.3, 26.3, 38.2, 127.9, 128.4, 132.8, 136.9, 200.6.        
 (5E)-4-hydroxy-2-methyl-7-phenylnon-5-en-3-one (38): Following general procedure 
4 using CuBr·SMe2 (123.3 mg, 0.60 mmol, 1.0 equiv.), EtMgCl (1.82 
M in Et2O, 0.66 mL, 1.2 mmol, 2.0 equiv.), 2-methyl-1-{3-[(E)-2-
phenylethenyl]oxiran-2-yl}propan-1-one (129.8 mg, 0.60 mmol, 1.0 equiv.), in dry THF 
(6.0 mL). The reaction was quenched after stirring for 4 h at -78 
°
C. After the usual work-
up, the product was purified by flash chromatography on silica to obtain oily liquid. 
(Yield = 0.105 g, 71%; Rf = 0.25 in 15% EtOAc/85% hexane): IR (neat) 3465 (br), 3028 
(w), 2969 (s), 2933 (s), 2875 (m), 1712 (s), 1453 (m), 1383 (m), 1010 (m); 
1
H-NMR (500 
MHz, CDCl3) δ 0.87 (t, J = 7.4 Hz, 3H), 1.07 (d, J = 6.9 Hz, 3H), 1.12 (d, J = 7.4 Hz, 
3H), 1.76 (sext., J = 7.4 Hz, 2H), 2.88 (sept, J = 6.9 Hz, 1H), 3.21 (q, J = 7.4 Hz, 1H), 
3.84 (s, 1H), 4.69 (d, J = 7.4 Hz, 1H), 5.38 (dd, J = 15.1 Hz, 7.6 Hz, 1H), 6.09 (dd, J = 
15.2 Hz, 7.3 Hz, 1H); 7.16 (d, J = 6.9 Hz, 2H), 7.20 (t, J = 7.3 Hz, 1H), 7.30 (t, J = 7.6 
Hz, 2H); 
13
C-NMR (125 MHz, CDCl3) δ 12.1, 17.6, 19.0, 28.3, 35.7, 50.2, 76.9, 125.5, 




 (5E)-4-chloro-2,7-dimethylnon-5-en-3-one (48): To an acetonitrile solution (4 ml) of 
the alcohol 34a (184.0 mg, 1.0 mmol) in a flask under argon was added 
triphenylphosphine (PPh3) (0.341g, 1.3 mmol, 1.3 equiv.) and the 
mixture stirred at rt till the PPh3 dissolved. This was then cooled to 10 
o
C with water/ice 
and CCl4 (0.4 mmol, 5 equiv.) was added via syringe. After the addition, the reaction 
mixture was allowed to warm to 20 
°
C and stirred for additional 1 h at this temperature. 
Methanol (1.0 mL) was added and the solution stirred for 30 min before removing the 
solvent in vacuo. The crude material was purified with a short column to obtain the 




H-NMR (500 MHz, CDCl3) δ 0.83-0.91 (m, 3H), 1.00 (t, J = 7.8 Hz, 3H), 1.14 (d, J 
= 6.5 Hz, 6H), 1.26-1.38 (m, 2H), 2.11 (sext, J = 7.0 Hz, 1H), 2.99-3.05 (m, 1H), 4.86 (d, 
J = 9.0 Hz, 1H), 5.54-5.60 (m, 1H), 5.75-5.81 (m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 
11.5, 11.6, 18.9 (2-carbons), 19.0, 19.4, 29.2, 37.1, 37.2, 38.1, 38.2, 63.3, 63.4, 122.9 (2-
carbons), 143.8 (2-carbons), 196.1, 206.7.   
 (5E)-2,7-dimethyl-3-oxonon-5-en-4-yl acetate (46): To a flame-dried flask under argon 
was added CuBr.SMe2 (82.2 mg, 0.40 mmol, 0.2 equiv.), dry CH2Cl2 (10 
mL) and stirred at rt to dissolve it. The flask was then cooled to -78 
°
C 
and ethylmagnesium chloride (2.0 M in THF, 1.05 mL, 2.1 mmol, 1.05 
equiv.) was added dropwise to it via syringe. The reaction mixture was allowed to stir at 
this temperature for between 30 minutes to form the cuprate before CH2Cl2 solution of 
the epoxyenone 33 (308 mg, 2.0 mmol, 1.0 equiv.) was added dropwise via syringe to it. 





anhydride (0.192 mL, 2.1 mmol, 1.05 equiv.) was added in one portion to it. After the 
addition, the reaction mixture was allowed to stir at rt for 20 minutes before quenching 
with NH4Cl (aq) and extracted with Et2O to obtain light yellow liquid (147 mg, 65% 
yield; Rf = 0.21 in 10% Et2O/90% hexane):
 1
H-NMR (500 MHz, CDCl3) δ 0.85 (t, J = 7.5 
Hz, 3H), 1.00 (d, J = 7.0 Hz, 3H), 1.05 (d, J = 6.5 Hz, 3H), 1.16 (d, J = 7.0 Hz, 3H), 1.31-
1.37 (m, 2H), 2.10 (quint., J = 7.0 Hz, 1H), 2.13 (s, 3H), 2.84 (quint., J = 7.0 Hz, 1H), 
5.40 (ddd, J = 15.1 Hz, 8.2 Hz, 1.0 Hz, 1H), 5.53 (d, J = 8.3 Hz, 1H), 5.84 (dd, J = 15.6 
Hz, 7.8 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 11.6, 17.8, 18.9, 19.5, 20.7, 29.2, 36.8, 
38.4, 78.7, 120.3, 145.0, 170.0, 208.6;  
 (5E)-2,7,8-trimethyl-3-oxonon-5-en-4-yl acetate (47): Following the procedure above, 
this compound was prepared by using 
i
PrMgCl (1.75 M in THF, 1.2 mL, 
2.1 mmol, 1.05 equiv.), CuBr·SMe2 (82.2 mg, 0.40 mmol, 0.2 equiv.), 
dry CH2Cl2 (10 mL), epoxyenone 33 (308 mg, 2.0 mmol, 1.0 equiv.), and 
acetic anhydride (0.192 mL, 2.1 mmol, 1.05 equiv.) to obtain the product as a light 
yellow liquid (331 mg, 69% yield; Rf = 0.32 in 10% EtOAc/90% hexane):
 1
H-NMR (500 
MHz, CDCl3) δ 0.84 (t, J = 7.0 Hz, 6H), 0.97 (d, J = 7.0 Hz, 3H), 1.04 (d, J = 6.5 Hz, 
3H), 1.15 (d, J = 7.0 Hz, 3H), 1.55 (sext., J = 6.6 Hz, 1H), 2.01 (sext., J = 7.0 Hz, 1H), 
2.12 (s, 3H), 2.83 (quint., J = 7.0 Hz, 1H), 5.38 (dd, J = 15.5 Hz, 8.5 Hz, 1H), 5.53 (d, J = 
8.5 Hz, 1H), 5.86 (dd, J = 15.5 Hz, 8.0 Hz, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 16.8, 





Ethyl (3E)-2-hydroxy-5-methylnon-3-enoate (32b): Following general procedure 2 
and using  n-BuMgCl(1.61 M in THF, 0.62 mL, 1.0 mmol, 2.0 equiv.), 
ethyl 3-[(1E)-prop-1-en-1-yl]oxirane-2-carboxylate (78.1 mg, 0.5 mmol, 
1.0 equiv.), at -78 
°
C for 4h before allowing to it warm to rt and quenching. The crude 
product was purified by flash chromatography with 10% EtOAc: 90% hexane to obtain 
colorless oil. (Yield = 90.4 mg, 84%); 
1
H-NMR (500 MHz, CDCl3) δ 0.86-0.90 (m, 12.5), 
0.99 (t, J = 7.0 Hz, 13H),1.25-1.31 (m, 44H), 2.05 (s, 1H), 2.11-2.18 (m, 3H), 2.56-2.61 
(m, 1H), 3.00 (s, 3H), 4.21-4.28 (m, 9H), 4.59 (d, J = 5.5 Hz, 3H), 4.89 (d, J = 9 Hz, 1H), 
5.28 (t, J = 10 Hz, 1H), 5.42-5.49 (m, 4H), 5.71-5.80 (m, 3H); 
13
C-NMR (125 MHz, 
CDCl3) δ 14.0 (2-carbons), 14.1, 20.1, 20.3, 20.9, 22.7 (2-carbons), 22.8, 29.3, 29.4, 29.5, 
32.4, 36.2, 36.3, 36.4 (2-carbons), 36.8, 61.8 (3-carbons), 67.3, 71.3, 71.5, 124.3 (2-
carbons), 124.4, 140.2, 140.5, 142.3, 173.9 (2-carbons), 174.2. 
Ethyl (3E)-2-hydroxy-5,6-dimethylhept-3-enoate (32c): Following general procedure 
2 and using  
i
PrMgCl (1.12 M, 0.89 mL, 1.0 mmol, 2.0 equiv.), ethyl 3-
[(1E)-prop-1-en-1-yl]oxirane-2-carboxylate (78.1 mg, 0.5 mmol, 1.0 
equiv.), at -78 
°
C for 4h before allowing to it warm to rt and quenching. The crude 
product was purified by flash chromatography with 10% EtOAc: 90% hexane to obtain 
colorless oil. (Yield = 66.9 mg, 67%; dr: 60:40; Rf = in 10% EtOAc: 90% hexane); 
1
H-
NMR (500 MHz, CDCl3) δ 0.83-0.86 (m, 10H), 0.95-0.99 (m, 6H), 1.28 (t, J = 7.0 Hz, 
6H), 1.50-1.57 (m, 1H), 1.97-2.03 (m, 1.4H), 3.03 (t, J = 5.5 Hz, 1.5H), 4.20-4.28 (m, 
3H), 4.60 (s, 1.4H), 5.41-5.47 (m, 1H); 5.73-5.83 (m, 1.4H); 
13





CDCl3) δ 14.1, 16.6, 17.2, 19.5 (2-carbons), 19.8, 32.7, 32.9, 42.3, 42.8, 61.8 (2-carbons), 
71.4, 71.6, 125.3, 125.4, 138.6, 139.0, 173.9 (2-carbons). 
Ethyl (3E)-2-hydroxy-5-methylhept-3-enoate (32a): Following general procedure 4 
using CuBr.SMe2 (0.025 g, 0.12 mmol, 0.2 equiv.), EtMgCl (1.61 M in 
Et2O, 0.41 mL, 0.66 mmol, 1.1 equiv.), ethyl 3-[(1E)-prop-1-en-1-
yl]oxirane-2-carboxylate (91.3 mg, 0.6 mmol, 1.0 equiv.), in dry CH2Cl2 (4.0 mL). The 
reaction was quenched after stirring for 3hr at -78 
°
C. After the usual work-up, the 
product was purified by flash chromatography on silica to obtain oily yellow liquid. 
(Yield = 85.0 mg, 76%; dr: 80:20; Rf = 0.19 in 15% EtOAc: 85% hexane); 
1
H-NMR (500 
MHz, CDCl3) δ 0.85 (t, J = 7.3 Hz, 3H), 0.99 (d, J = 6.4 Hz, 3H), 1.28-1.37 (m, 5H), 2.08 
(sext., J = 7.1 Hz, 1H), 2.98 (d, J = 6.0 Hz, 1H), 4.25 (dd, J = 6.9 Hz, 2.3 Hz, 2H), 4.59 
(t, J = 5.5 Hz, 1H), 5.46 (dd, J = 15.6 Hz, 6.4 Hz, 1H), 5.74 (dd, J = 15.6 Hz, 7.8 Hz, 
1H); 
13
C-NMR (125 MHz, CDCl3) δ 11.6, 14.1, 19.8, 29.4, 38.1, 61.8, 71.5, 124.7, 140.2, 
173.9. 
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REACTIVITY STUDIES ON 6-HALO-α, β, γ, δ-UNSATURATED CARBONYL 
COMPOUNDS (DIENONES AND DIENOATES) 
 
4.1 Introduction 
The 6-halo-α, β, γ, δ-unsaturated carbonyls (dienones and dienoates) are rich with 
functional groups that make them ideal substrates for studying chemo, regio, and stereo 
selectivities of a reaction methodology. For instance, the reactivities of the two olefinic 
units can be investigated with the Simmon-Smith cyclopropanation reaction, or allylic 
alkylations and/or conjugate addition (1, 4 vs 1, 6) reactions catalyzed by Cu
I
 and Zn 
salts. Furthermore, the double bond can be converted to epoxides, which are in 
themselves useful substrates for studying an array of chemo, regio, and stereoselective 
reactions. In addition, the conjugated diene unit is a familiar coupling partner for the 
Diels-Alder reaction. Both the carbonyl carbon and the carbon bearing the halogen are 
ideal centers for nucleophilic attacks by both carbon and non-carbon nucleophiles. The 
extended dienones and dienoates have been the targets of various synthetic studies for 
many years. Yamamoto and co-workers achieved a highly regioselective 1,4-conjugate 
additions to methyl sorbate 1 and other α,β-unsaturated ketones and esters with RCu/BF3, 
while 1,6-addition to this extended Michael acceptor was obtained through Bu2CuLi (eq. 
1).
1
 In the same work, they also used 3 equivalents of RCu/BF3 to regioselectively 





On a related substrate, Feringa and co-workers reported CuBr·SMe2 mediated 1,6-
asymmetric conjugate addition (ACA) of Grignard reagents to linear dienoates using 
josiphos and taniaphos catalysts to achieve 99:1 regioselectivity and an enantiomeric 
excess (ee) exceeding 96% (eq. 2). The synthetic utility of their methodology was 
demonstrated when it was used to synthesize the sulfate alkene natural product 8 (Figure 






Figure 4.1. Sulfated alkene isolated from Echinus Temnopleurus hardwickii 
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Jørgensen and co-workers reported enantioselective 1,6-addition of β-ketoesters (both 
acyclic and cyclic) and bezophenone-glycine imine derivative to electron deficient δ-
unsubstituted dienes using catalytic amount of cinchona alkaloids under phase transfer 
conditions. The scope of the methodology was expanded by applying the protocol to 
dienes with sulfones, esters, and ketones to achieve good to excellent yields with 





Again, the synthetic usefulness of this methodology was demonstrated when it was 
applied in a two-step synthesis of bicyclo[3.2.1]octan-2-one, a bicyclic bridged structure 
commonly found in a number of natural products.
3
 They also applied the bezophenone-
glycine imine protocol in a two-step synthesis of the optically active disubstituted 
257 
 
pyrrolidine derivative which is a synthetic intermediate for carbapenam-3-caboxylic 
acid,
4




Other groups who have investigated similar extended systems include Urabe’s group who 
achieved 1,6-additions of aryl Grignard reagents to 2,4-dienoates and dienamides with 
catalytic amounts of FeCl2 to produce good to very good yields,
6
 and Hayashi and co-
workers who reported 1,6-addition of aryl boronic acids catalyzed by Iridium-COD 
(cyclooctadiene) complex to α, β-γ, δ-unsaturated ketones, esters, and amides to obtain 
only the cis isomer of the δ-substituted product.
7
 Several other notable works on these 
extended electron poor dienes have been reported including the work of Csákӱ and co-




Despite the extensive reports on additions to these extended electron-deficient Michael 
acceptors, reports on studies of extended electron-deficient α,β,γ,δ-unsaturated 
derivatives with leaving groups in the allylic position is almost none. Currently, there is 
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only one report by Onitsuka’s group on ruthenium-catalyzed asymmetric hydroxylation 
of methyl-6-chloro- 2,4-hexadienoate 21 with water as nucleophile, en route to the 
enantioselective total synthesis of (+)-chloriolide (24) (Figure 2).
9
 It is for this reason that 
the synthetic studies of these substrates are long overdue.  
                      
 
Figure 4.2. Structure of (+)-chloriolide 
Michael Initiated Ring Closure (MIRC) reactions are known for creating substituted 
cyclopropane units that are useful synthetic intermediates for functionalized 
cycloalkanes
10, 11
, and some natural products. However, this reaction is limited to 
conjugate additions to generate stabilized carbanion followed by in situ cyclization via 





, and phenyl vinyloxiranes.
14
 We wanted to 





and Zn salts to generate stabilized carbanion, followed by ring closure via SN2′ 
(substitution with rearrangement of the double bond) displacement; to extended Michael 
acceptors with leaving groups at the allylic position. The presence of additional double 
bond in the newly created substituted cyclopropane derivative provides an opportunity 
for further synthetic manipulations. 
 
4.2 Results and discussion 
Currently, reactions have been done with n-butyllithium and n-butylmagnesium chloride 
in THF catalyzed by stoichiometric amount of CuCN at -78 
°
C and stoichiometric amount 
of ZnBr2 at -20 
°
C. Both alkylcyanocuprate and dialkylcuprate prepared in situ have been 
tried on this substrate. The alkylcyanocuprates gave starting materials in THF. Both 
dialkylcuprates and the trialkylzincates undergo SN2 displacement on the allylic bromide 
substrate (table 1, entries 1-3) with moderate to very good yields. Dialkylzinc reagent 
was not reactive on this substrate. When the reaction was carried out with organolithium 
instead of Grignard reagent (table 1, entry 4), both SN2 and SN2′ products formed in a 
ratio of 63% to 37%. These results hinted that either the bromide enhances SN2 
substitution because of its being a good nucleofuge or the cuprates and the zincates of 
Grignard reagents favor SN2 over SN2′ product. Subsequently, the chloride analogue of 
the substrate was reacted with lithium triorganozincates which gave only the SN2′ product 
(entries 5, and 6). When this substrate was reacted with again magnesium cuprate, 25% 
of the SN2 product was formed (entry 7) compared with the 37% obtained with the 
bromide analogue (entry 4), thus confirming the hypothesis that both the good leaving 
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group ability of the bromide and the magnesium cuprate favor SN2 allylation. Attention 
was then focused on the lithium cuprates and exclusive formation of the SN2′ products 
were formed (entries 9-11). One example of catalytic Fe(acac)3 with Grignard reagent in 
toluene gave only SN2 product (entry 8). 
Some sodium cuprates made from organosodium were attempted but these gave only SN2 
products (entries 12, and 13) in very good yields. It is evident from these results that the 
conjugated ester moiety is quite unreactive toward conjugate addition and that the halide 
directs reactivity in the 6-halo-α, β, γ, δ-dienoates. Also, cuprates and zincates of 
Grignard reagents promote SN2 alkylation while the lithium version of the cuprates and 











Table 4.1. Allylic substitutions on ethyl-6-halo-α, β, γ, δ-hexadienoates with carbon 
nucleophiles 
 














BuMgCl (3.0) ZnBr2 (1.0 ) 26 THF -40
b
 3 28b 85 
2 
n
BuMgCl (1.2) ZnBr2 (0.1) 26 THF -20
c
 3 28b 73 
3 
n
BuMgCl (2.0) CuCN (1.0) 26 CH2Cl2 -78
d
 12 28b 65 
4 
n





  ZnBr2 (1.0 ) 25 THF -20
c 3 27b 68 
6 
n
BuLi (3.0) ZnBr2 (1.0 ) 25 THF -20
c 3 27b 77 
7 
n
BuMgCl (2.0) CuCN(1.0)e  25 THF -78d 6 27b, 28b 80 (75:25)g 
8 
n
BuMgCl (3.0) Fe(acac)3(0.1) 25 toluene -78
d 12 28b 77 
9 
n
BuLi (2.0) CuCN(1.0)e  25 THF -78d 6 27b 71 
10 
n
BuLi (1.0) CuCN(1.0)e  25 THF -78d 12 27b 44 
11 MeLi (1.1) CuCN(1.0)
e
  25 THF -78d 12 27a 40g,i 
12 NaCH(CO2Me)2(1.0) CuBr·SMe2 (0.5) 25 CH2Cl2 -78
d 12 28c 90 
13 NaCH(CO2Me)2(1.0) CuCN(1.0)
e
  25 THF -78d 12 28c 89 
a
All reactions were quenched with saturated NH
4
Cl solutions at room temperature. Yields are based on 
isolated product after flash column chromatography.
 b
Zincate was prepared at 0 
°
C and then cooled to -40 
°
C before starting material was added.
 c
Starting material was added to the zincate at -20 
°
C and allowed to 
warm to room temperature over the indicated time period.  
d
Reactions were stirred at -78 
°
C for at least 
three hours and then allowed to warm to room temperature and stirred for the combined total of the time 
shown before quenching. 
e
Used with 2.0 equivalents of anhydrous LiCl. 
f
Reaction mixture was allowed to 
stir for six hours at 78 
°
C before being allowed to warm to room temperature. 
g
Ratio based on the 
13
CNMR 
peaks of the alkene carbons. 
h
Used with 1.0 equivalent of TMSCl. 
i
About 60% of starting material was 
recovered.  
 
To rationalize these observations, the mechanism of the allylic substitution will have to 
be invoked. Consider the Corey-Boaz model for anti- selectivity of the cuprate allylic 
substitution reaction in Figure 3 (vide infra). The electron rich d
10
 orbital of the copper 
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simultaneously interacts with both the π*(LUMO) of the double bond and to a lesser 
extent with the anti- bonding σ*-orbital of the leaving group in the allylic system as 
depicted in Figure 3. This additional σ*-orbital interaction with the cuprate results in the 
preference of the incoming cuprate for an olefinic unit adjacent to a leaving group than 
one farther away. Thus in the case of our substrate, the cuprate will preferentially 
coordinate to the allylic double resulting in SN2 or SN2′ substitution than to the 
conjugated double bond leading to conjugate addition reaction as illustrated in the 
modified Corey-Boaz model in figure 4.3 (vide infra). 





Figure 4.3. Modified Corey-Boaz model for anti- displacement of leaving group 
To rationalize the formation of SN2 products with the Grignard cuprates against the SN2′ 
product with the lithium cuprates, consider the mechanism for the copper catalyzed 
allylic substitution in Scheme 1 (vide supra). The first step of the allylic substitution 
involves the coordination of the cuprate to the allylic olefin to form the π-complex. This 
is followed by oxidative addition of the cuprate to form the σ-allyl CuIII intermediate. The 
amount of both SN2 and SN2′ products formed in the end depends on the stability of this 
σ-allyl CuIII intermediate. Dialkyl CuIII intermediates are postulated
1
 to be stable enough 
to undergo equilibration between σ-allyl CuIII 31 and 34 due to the stabilizing effects of 
the electron rich alkyl groups to the CuIII. In the case of magnesium cuprates, the counter 








), as compared to Li
+
 in the lithium 
cuprates. The MgX
+
 counter ion is bulky and thus favors the primary σ-allyl CuIII 
complex 34, over the secondary σ-allyl CuIII
 
31, due to steric factors. Thus the rates, k2, 
and k3 are increased resulting in the formation of SN2 product. Since Li
+
 is small, the 
effect of steric factors is not significant for both 31, and 34 and k1 is far higher than k2, 





In summary, allylic substitutions to ethyl-6-halo-dienoates have been achieved in 
moderate to very good yields and in excellent regioselectivities employing both cuprates 
and zincates reagents. The halide leaving group appears to control the selectivity of the 
allylic substitutions of the substrates. The preliminary results show that the Grignard 
cuprates and zincates promote SN2 substitutions while their lithium counterparts yield 
SN2′ substitutions. Further experiments with different ligands will throw more light on 
the reactivity and the substitution pattern of this class of substrates to enable the 
extension of this methodology to construct interesting lactone units and substituted 
cyclopropanes.  
4.4 Experimental 
General:  All NMR spectra were recorded as CDCl3 solutions of the compounds unless 
otherwise stated. 
1
H-NMR chemical shifts are reported as δ values in parts per million 
(ppm) relative to CHCl3 (δ = 7.28 ppm) as internal standard. 
13
C-NMR chemical shifts 
are reported as δ values in parts per million (ppm) and referenced with respect to the 
CDCl3 signal (triplet, centerline δ = 77.0 ppm). Infrared (IR) spectra of liquid compounds 
were recorded as neat liquid films between NaCl plates. Gas chromatography-mass 
spectrometry measurements were performed on a GC coupled to a quadrupole detector at 
70 eV. Analytical thin layer chromatography (TLC) was performed on silica gel plates, 
200 mesh with F254 indicator. TLC visualization was achieved with UV light (254 nm), 
10% ethanol solution of phosphomolybdic acid (PMA) stain, and aqueous potassium 
permanganate solution (KMnO4). Products were purified by flash column 
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chromatography with 230-400 mesh silica gel unless otherwise stated. Yields are based 
on isolated products purified by flash column chromatography. 
 Anhydrous tetrahydrofuran (THF) and diethyl ether (Et2O) were obtained from sodium 
benzophenone ketyl distillation. Dichloromethane (CH2Cl2) and toluene used for 
reactions were dried over molecular sieves. 
n
BuLi (2.5 M in hexane), MeLi (1.6 M in 
Et2O), and 
t
BuLi (2.0 M in pentane) were available commercially and titrated using sec-




BuMgCl (2.5 M in 
THF/toluene), MeMgCl (3.0 M in Et2O), 
i
PrMgBr (2.0 M in Et2O),  EtMgCl (2.0 M in 
THF), and PhMgCl (2.8 M in Et2O) were available commercially and titrated with 
menthol and 1,10-phenanthroline monohydrate in THF. Benzyl bromide, 1-
bromonaphthalene, N,N-dimethyl-4-bromoaniline, 4-iodoanisole, 5-iodoindole, furan, 
thiophene, N-methylpyrrole, 1-hexyne, n-propylthiol, and 1,2-dibromoethane were all 
obtained from commercially available sources and were used as received without further 
purification. All glassware was flame-dried under high vacuum and purged with argon 
and then cooled under a dry argon atmosphere. Low temperature baths (up to -78 
°
C) 
were prepared in thermoflasks with dry ice- isopropyl alcohol slush bath mixtures or ice-
NaCl (-23 
°
C) mixture. All reactions were conducted under positive dry argon 






Synthesis of starting material 
 Ethyl (2E,4E)-6-bromohexa-2,4-dienoate (26): This compound was prepared from 





NMR (500 MHz, CDCl3) δ 1.29 (t, J = 8.0 Hz,  3H); 4.03 (d, J = 8.0 
Hz, 2H), 4.20 (q, J = 8.0 Hz, 2H), 4.92 (d, J = 15.5 Hz, 1H), 6.23 (quin, J = 8.0 Hz, 1H), 
6.38 (dd, J = 14.5 Hz, 11.5 Hz, 1H), 7.25 (dd, J = 15.5 Hz, 11.0 Hz, 1H);
 13
C-NMR (125 




C-NMR were consistent with that reported in the literature.
 9,15
 
 Ethyl (2E,4E)-6-chlorohexa-2,4-dienoate (25): This compound was prepared from 
ethyl (2E,4E)-6-bromohexa-2,4-dienoate by employing an established 
literature procedure.
15 1
H-NMR (500 MHz, CDCl3) δ 1.30 (t, J = 7.0 
Hz,  3H); 4.15 (d, J = 7.0 Hz, 2H), 4.21 (q, J = 7.0 Hz, 2H), 4.94 (d, J = 15.5 Hz, 1H), 
6.15-6.21 (m, 1H), 6.42 (dd, J = 15.0 Hz, 11.0 Hz, 1H), 7.26 (dd, J = 15.5 Hz, 11.0 Hz, 
1H);
 13





C-NMR were consistent with that reported in the literature.
15
 
General procedure A: Copper-mediated allylic substitution: To a flame-dried LiCl 
(2.0 equiv) in a flask containing a stir bar with rubber septum under argon was added 
powdered CuCN (1.0 equiv) followed by anhydrous THF. The mixture was stirred at 
room temperature until the CuCN dissolved before cooling it to -78 
°
C and the Grignard 
reagent or the organolithium (1.1 equiv) was added dropwise to it. After the addition, the 
reaction mixture was allowed to stir for 30 minutes at -78 
°
C and THF solution of ethyl 





the reaction mixture was allowed to warm gradually to room temperature with stirring. 
The reaction was then quenched with NH4Cl (aq) and extracted with Et2O (3x). The 
combined organic phase was dried with anhydrous MgSO4, filtered, and the solvent 
removed under reduced pressure to obtain clean crude material.  
General procedure B: Iron (III) acetylacetonate [Fe(acac)3]-catalyzed addition of 
Grignard reagents to substrate 25. To a flame-dried Fe(acac)3(17.0 mg, 0.05 mmol, 0.1 
equiv) in a flask under argon was added toluene (5.0 mL), substrate 25, and the mixture 




BuMgCl (1.70 M in THF, 0.88 mL, 
1.5 mmol, 3.0 equiv) was added dropwise to it. After the addition, it was allowed to 
warm up to rt during overnight stirring. It was quenched with 1.0 N HCl stirred for 15 
minutes and extracted with Et2O (3x). The combined ethereal phase was dried over 
anhydrous MgSO4, filtered and the solvent removed under reduced pressure to obtain a 
clean crude material. 
Ethyl (2E)-4-ethenyloct-2-enoate (27b): Following general procedure A using LiCl (42 
mg, 1.0 mmol, 2.0 equiv) , CuCN (45 mg, 0.50 mmol, 1.0 equiv), 
n
BuLi (2.5 M in THF, 0.25 mL, 0.55 mmol, 1.1 equiv), and substrate 
25 (87.3 mg, 0.5 mmol, 1.0 equiv)  in THF (4.0 mL)  and allowing to warm gradually to 
room temperature during stirring over six hours before quenching and workup to obtain a 
yellow oil (69.7 mg, 71%).  
1
H-NMR (500 MHz, CDCl3) δ 0. 89 (t, J = 7.0 Hz,  3H), 
1.25-1.34 (m, 7H), 1.46-1.51 (m, 2H), 2.58 (quint, J = 7.5 Hz, 1H), 4.17-4.22 (m, 2H), 




Hz, 8 Hz, 1H), 
13
C-NMR (125 MHz, CDCl3) δ 13.9, 14.2, 22.5, 29.2, 33.6, 46.4, 60.2, 
115.7, 120.8, 139.2, 151.1, 166.7. 
Ethyl (2E)-4-methylhexa-2,5-dienoate (27a): Following general procedure A using 
LiCl (0.042g, 1.0 mmol, 2.0 equiv) , CuCN (0.045g, 0.50 mmol, 1.0 , 
MeLi (1.6 M in THF, 0.25 mL, 0.55 mmol, 1.1 equiv) , and substrate 25 
(87.3 mg, 0.5 mmol, 1.0 equiv) in THF (4.0 mL)  and allowing to warm gradually to 
room temperature during stirring over night before quenching and workup to obtain 
yellow oil (About 60% of unreacted starting material was present in the mixture).
 13
C-
NMR (125 MHz, CDCl3) δ 18.7, 25.5, 39.9, 60.2, 114.7, 120.1, 140.1, 151.7, 166.7.  
Ethyl (2E,4E)-deca-2,4-dienoate (28b): To an ice cold solution of flame-dried ZnBr 
(0.225g, 1.0 mmol,  1.0  in THF (4.0 mL) under argon was added 
n
BuMgCl (1.75 M in THF, 1.77 mL, 3.1  and the reaction mixture 
was stirred for 30 minutes at 0 
°
C. The reaction flask was then cooled to -40 
°
C and 
substrate 26 (0.229 g, 1.0 mmol, 1.0 equiv) in THF (1.0 mL) was added dropwise to it. 
The resulting mixture was stirred overnight while warming to rt. The reaction was then 
quenched with NH4Cl/NH4OH aqueous buffer (pH = 7.0), filtered and the filtrate 
extracted with Et2O (3x 15 mL). The combined organic phase was washed with water (10 
mL), brine (10 mL), dried over anhydrous MgSO4, filtered and the filtrated removed 
under reduced pressure to obtain light yellow oil. (166.8 mg, 85%; Rf = 0.59 in 10% 
Et2O/ 90% hexane).    
1
H-NMR (500 MHz, CDCl3) δ 0. 90 (t, J = 7.0 Hz,  3H), 1.27-1.34 
(m, 7H), 1.43 (quint, J = 7.0 Hz, 2H), 2.17 (q, J = 7.0 Hz, 2H), 4.20 (q, J = 7Hz, 2H), 







(125 MHz, CDCl3) δ 14.0, 14.3, 22.4, 28.3, 31.3, 32.9, 60.1, 119.1, 128.3, 144.7, 145.1, 
167.3. 
6-Ethyl 1,1-dimethyl (3E,5E)-hexa-3,5-diene-1,1,6-tricarboxylate (28c): To a stiring 
suspension of NaH (24 mg, 1.0 mmol, 1.0 equiv) in THF under 
argon was added a THF solution of methylmalonate (0.132 g, 1.0 
mmol, 1.0 equiv) at room temperature and sirred until the mixture became clear colorless 
solution. To another flask containing a flame-dried LiCl (86.0 mg, 2.0 mmol, 2.0 equiv) 
under argon was added CuCN (90.0 mg, 1.0 mmol, 1.0 equiv) followed by the addition of 
THF and stirred at rt until it dissolved. This was then cooled to -78 
°
C and the previously 
prepared sodium methylmalonate enolate was transferred to it in a dropwise fashion. 
After the addition, the reaction mixture was allowed to stir at -78 
°
C for at least 45 
minutes before THF solution of the substrate 25 (175.0 mg, 1.0 mmol, 1.0 equiv) was 
added dropwise to it. The reaction mixture was allowed to stir at -78 
°
C for atleast 3 h 
before gradually warming up to rt over 12 h. It was then quenched with NH4Cl (aq) and 
extracted (3x) with Et2O. The combined ethereal phase was dried with MgSO4, filtered 
and the solvent removed under reduced pressure to obtain an oil (240.6 mg, 89%; Rf = 
0.41 in 20% EtOAc / 80% hexane).
 1
H-NMR (500 MHz, CDCl3) δ 1.27 (t, J = 7.0 Hz, 
3H), 3.73 (s, 6H); 4.12-4.27 (m, 5H), 5.91 (d, J = 15.5 Hz, 1H), 6.37-6.19 (m, 1H), 6.40 
(dd, J = 14.5 Hz, 11.5 Hz, 1H), 7.21-7.28 (m, 1H); 
13
C-NMR (125 MHz, CDCl3) δ 14.1, 
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